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ABSTRACT
Regulation of T Cell Activation by the CD5 Co-Receptor and Altered Peptides,
Characterization of Thymidine Kinase-Specific Antibodies,
and Integrating Genomics Education in Society
Kiara Vaden Whitley
Department of Microbiology and Molecular Biology, BYU
Doctor of Philosophy
Helper T cells (Th) are a vital component of the immune system responsible for directing
other immune cells to eliminate pathogens and cancer. Specifically, Th cells facilitate B cell and
cytotoxic T cell (Tc) activation and recruitment and enhance their function against cancer and
infectious diseases. Th cells are a valuable resource for improving Tc responses in cancer
treatment and have become a focus of immunotherapeutic research. While it is increasingly clear
that helper T cells serve an important role, the details about which entities produce an effective
Th cell response remain unclear. CD5 is a T cell co-receptor that negatively regulates T cell
activation and helps fine-tune the TCR repertoire by altering TCR signaling during the selection
process in the thymus. This work discusses the role of the co-receptor CD5 in influencing Th cell
metabolism, as well as the study of two T cells called LLO118 and LLO56 that have different
CD5 expression levels, and their functional response to altered peptides.
Antibodies have revolutionized the world of cancer research and accelerated the
development of therapies that trigger the immune system to target disease. In recent years, many
antibody-based immunotherapies have emerged as effective candidates for combating cancer due
to their refined specificity and ability to target a variety of epitopes. However, many therapies,
such as those that target CD19 on B cell cancers, are also present on healthy cells, destroying
both cancerous and healthy cells alike. Thymidine kinase 1 (TK1) is an enzyme involved in the
DNA salvage pathway that converts thymidine into the nucleotide thymine. Recently, TK1 has
been shown to be overexpressed on the surface of many cancers such as acute lymphoblastic
leukemia. Importantly, TK1 is not expressed on the surface of healthy cells, making it an ideal
cancer-specific antigen that can be targeted for cancer treatment. This work discusses our efforts
to characterize TK1-specific single-chain antibodies from a yeast display library.
According to the World Health Organization, genomics is defined as the study of all
genes and their related functions. In contrast to genetics, genomics analyzes the entire DNA
makeup of an organism rather than a single gene. In the past 20 years, the cost of genomic
sequencing has decreased dramatically, making it affordable and accessible. A key area that must
be addressed with genomic testing involves education about their promise, challenges, potential
consequences, and ethical considerations. Genomic testing provides a powerful opportunity to
educate everyone on scientific and ethical issues to increase understanding on the subject. This
work discusses the influence of personal genomics in society and focuses on the importance,
benefits, and consequences of genomics education in the classroom, clinic, and the public.
Keywords: CD5, co-receptor, helper T cell, metabolism, T cell receptor, proliferation, altered
peptide ligand, macrophage, thymidine kinase 1, yeast display, ADCC, genomics
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Chapter 1: Introduction to T Cell and Co-Receptor Function, Antibody Therapy, and Genomics

1.1 Introduction
T cells are an integral part of the adaptive immune system and provide a vast range of
functions necessary for maintaining a healthy immune system. Helper T (Th) cells act as
‘commanders’ of the adaptive immune system, as they primarily function to direct other immune
cells and support other T cells by counteracting exhaustion [1,2]. While the role of Th cells is
essential to maintain immune system function, what makes an optimal Th cell response remains
unclear. In this dissertation, we will discuss T cell signaling, metabolism, and co-receptor
influence in greater depth, as well as describe our work to characterize the co-receptor CD5’s
impact on metabolic function and altered peptide influence in a specific T cell system.
Antibody therapies have become one of the most prominent immunotherapeutic
treatments in the last 5 years and continue to have impressive success in the clinic [3]. Despite
this success, many antibody therapies are not cancer-specific and can have off-target effects such
as killing non-cancerous cells or producing an over-reactive immune response [4,5]. In this
dissertation, we will discuss antibody therapies more in depth as well as discuss our work to
characterize antibodies specific for thymidine kinase 1, a cancer-specific antigen.
Genomics is the study of all genes and their associated functions in relation to each other.
With genomic testing becoming more readily available, education at various levels is necessary
to help scientists, doctors, and consumers understand the importance of genomics as well as
challenges and societal issues surrounding genomic testing [6]. In this dissertation, we discuss
what has been implemented in various educational settings regarding genomics education as well
as potential improvements that could be made to increase understanding of genomics and its
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current issues.
1.2 T Cell Signaling
For a T cell to be activated and undergo differentiation, a series of signals are necessary.
Three primary signals are required for full T cell activation and they are: 1) Binding of the T cell
receptor (TCR) and peptide:MHC (pepMHC) complex presented by an antigen-presenting cell
(APC), 2) Interaction with co-receptors such as CD28 which positively enhance TCR signaling,
and 3) Cytokines released from the cell or provided by other cells to stimulate proliferation and
differentiation [7]. If one of these signals is missed or is received out of order, this results in T
cell anergy, which renders the T cell inoperable and unable to respond effectively to threats such
as infection or cancer [8,9]. These signals initiate a cascade of downstream effects, including gene
transcription that will promote metabolism, proliferation, differentiation, and cytotoxicity [10].
Upon engagement of the pepMHC complex with the TCR, there are three biological
classifications that are critical to studying T cells function: TCR affinity, avidity, and functional
avidity (Figure 1). TCR affinity measures the one-on-one binding interaction between one TCR
and one pepMHC (Figure 1A) [11]. Typically, this is measured using surface plasmon resonance
or biolayer interferometry and allows for the dissociation constant (KD) to be calculated [12,13].
TCR avidity consists of multiple TCR and pepMHC interactions, which can include interactions
from CD4 or CD8 co-receptors Figure 1B) [14]. Avidity is measured using fluorescently-labeled
T cells and tetrameric pepMHC complexes by flow cytometry or acoustic technology [15,16].
Functional avidity measures TCR avidity but also includes co-stimulatory or co-inhibitory
domains expressed on the surface (Figure 1C) [17]. This is measured from a functional standpoint
by measuring cytokine expression, proliferation, cytotoxicity, and signaling proteins [18]. When
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analyzing TCR signaling, it is best that each of these factors be analyzed as they individually and
collectively influence T cell signaling and T cell function [19].

Figure 1. T Cell Affinity, Avidity, and Functional Avidity.
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(a) Affinity is characterized by the interaction of one TCR and one pepMHC complex. (b)
Avidity is characterized by the interaction of multiple TCRs and multiple pepMHC complexes.
(c) Functional avidity takes co-stimulation into account and assesses T cell function as the
outcome. Adapted from [20].
1.3 T Cell Metabolism
After a T cell becomes educated in the thymus, there are three distinct T cell population
subsets: naïve, effector, and memory. Each subset is characterized by a distinct metabolic profile
that helps the T cell maximize its potential (Figure 2A). Naïve T cells are relatively quiescent
and rely predominantly on mitochondrial respiration to meet basal metabolic needs [21,22]. As T
cells become activated, their metabolic profile switches from mitochondrial respiration to
glycolysis [23]. While the glycolytic switch causes less efficient ATP production, rapid cell
proliferation is possible and critical intermediates are generated, such as ribose produced by the
pentose phosphate pathway that is necessary for cellular growth [21,24]. This significant
metabolic shift affects T cell activation, proliferation, and function [23,25,26]. However, the
switch to glycolysis becomes problematic when T cells enter the tumor microenvironment. Due
to the Warburg effect, where cancer cells increase glucose uptake, T cells do not have the
glucose necessary to maintain function, leading to T cell exhaustion [27,28]. Once T cells
transition to a memory phenotype, they become more quiescent than effector cells, but have
more metabolic activity in comparison to naïve T cells; this increased activity is thought to keep
memory cells metabolically prepared for when they encounter the antigen again [29].
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Figure 2. T Cell Metabolic Stages and Consequences of Metabolic Restriction.
(a) Outline of metabolic events occurring during in three T cell subsets: naïve, effector, and
memory. The height of the bar estimates how much nutrient uptake is taking place in each
subset. Adapted from [29]. (b) T cells rely on three main fuel sources and four metabolic
processes to maintain function. Glucose is used to fuel glycolysis and OXPHOS/TCA cycle,
fatty acids are utilized for fatty acid synthesis or oxidation, and amino acids are converted into
products needed for OXPHOS/TCA cycle and other metabolic pathways. Blue=metabolic
process, green=metabolic fuel, yellow=intermediate. (c) Restriction of specific metabolic
pathways affects T cell development and function. Each red X and associated text indicate what
happens to T cell function when these processes are blocked. Adapted from [30].
T cell metabolism primarily utilizes four metabolic pathways during its lifetime:
glycolysis, oxidative phosphorylation (OXPHOS) or the TCA cycle, fatty acid oxidation, and
fatty acid synthesis. To power these processes, three fuel sources are often used: glucose, fatty
acids, and amino acids (Figure 2B). Glucose is primarily used for glycolysis, but its end product,
pyruvate, can by utilized in the TCA cycle to improve OXPHOS. Fatty acids can be synthesized
to promote proliferation or oxidized to stimulate memory formation or differentiation [31].
Amino acids, such as glutamine, can be converted to glutamate for use in the TCA cycle or
catabolized into intermediates for other compounds such as lipids [32,33]. In T cells, blockade of
certain metabolic pathways or fuels influences T cell development and function (Figure 2C) [30].
Together, each metabolic process and fuel have an important role in regulating T cell metabolism
and function. Understanding how T cell metabolism can be targeted or enhanced will be
imperative to improving immunotherapy against cancer and infectious disease [26].
1.4 T Cell Regulation by the CD5 Co-Receptor
T cell co-receptors greatly influence T cell function by stimulating or inhibiting T cell
signaling [34]. These signaling proteins determine the magnitude of T cell activation, which
affects gene expression needed for cell proliferation and cytokine production, all of which are
required for a strong immune response [20,35,36]. Co-receptors such as CD28 or 4-1BB enhance
T cell signaling and provide necessary co-stimulation needed for activation; in contrast, co6

receptors such as PD-1 and CTLA-4 inhibit TCR signaling, potentially making the T cell anergic
and unable to respond to antigen [37]. Cancer cells often take advantage of this by upregulating
inhibitory co-receptors, preventing the T cells from killing them [38]. However, in recent years,
these inhibitory co-receptors have become instrumental targets for antibody-blockade cancer
immunotherapies, as this blockade prevents cancer cells from avoiding the immune system
[34,39,40].

CD5 is a T cell co-receptor that negatively regulates T cell activation. CD5 expression
levels correlate with TCR:pepMHC binding strength and help fine-tune the TCR repertoire by
altering TCR signaling during the selection process in the thymus [41,42]. It belongs to the group
B scavenger-receptor cysteine-rich (SRCR) superfamily, is associated with the TCR/CD3
complex and binds to CD5 on other cells, CD5 ligand (CD5L) that is transiently found on
activated splenocytes, and CD72 on B cells [43-47]. CD5 appears to regulate T cell signaling by
recruiting positive and negative TCR regulators which leads to context-dependent T cell
signaling regulation [48-50]. CD5-deficient T cells and anti-CD5 antibodies have been shown to
increase T cell proliferation, cytokine production, activation-induced cell death (AICD), and
modulate calcium mobilization [39,42,51]. Together these studies suggest that CD5 may be a
potential immunotherapeutic target.
1.5 Antibody Therapies
Antibodies have revolutionized the world of cancer research and accelerated the
development of therapies that trigger the immune system to target disease [52-54]. In recent years,
many antibody-based immunotherapies have emerged as effective candidates for combating
cancer and other diseases due to their refined specificity and ability to target a variety of epitopes
[55-57].

These treatments include using antibodies to directly target cancer cells to initiate
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antibody-dependent cellular cytotoxicity (ADCC) and activate the immune system, as well as
modified immune cells that have chimeric antigen receptors (CARs), a hybrid immunotherapy
comprised of an engineered antibody fragments with cell signaling domains that can efficiently
activate patient immune cells [3,56]. Together, these treatments provide the means to precisely
target cancer using independent and personalized cell-based systems.
A critical bottleneck for antibody-based therapeutics is the limited number of cancerspecific targets available and identification of specific antibodies for these targets. Some
successful cancer targets, such as CD19 on B cell cancers, are also present on healthy cells,
destroying both cancerous and healthy cells alike [58]. These immunotherapies also have
increased risk of major side effects, such as cytokine storm and systemic cytotoxicity, which if
left unchecked, can ultimately result in patient death [56]. Another obstacle for antibody-based
therapeutics is the generation of target-specific antibodies. Antibodies may bind well to the
biomarker of interest, but they can also target healthy cells, resulting in off-target tissue damage
and harmful immune responses against non-cancerous cells [59,60]. Thus, minimizing off-target
immunotherapy effects is pivotal to developing safer and more effective antibody-based cancer
therapies.
Antigen-specific antibodies can be isolated from and optimized using a variety of
different format and display systems (Figure 3) [61,62]. There are four popular antibody formats
that are being studied: monoclonal antibodies, antigen-binding fragment (Fab), single-chain
variable fragment (scFv), and single-domain/nanobodies (sdAb or Nb) [61]. Monoclonal
antibodies are traditional antibodies consisting of Fabs consist of a heavy and light chain with
associated constant domains [63]. Single-chain antibodies (scFvs) are comprised of only the
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heavy and light chains of a traditional antibody [64,65]. Single-domain antibodies (sdAb) or
nanobodies (Nb) consist only of the heavy chain of a traditional antibody [66].

Figure 3. Antibody Formats and Display Technologies.
(a) Antibodies and antibody fragments come in a variety of formats, four of which have been
highlighted here: the standard monoclonal antibody, the antigen-binding fragment (Fab), the
single-chain variable fragment (scFv) and the single-domain antibody (sdAb) or nanobody (Nb).
(b) Each antibody format can be utilized in yeast display, phage display, bacterial display,
mammalian display, or ribosome display.
1.6 Cancer Antigens and Thymidine Kinase 1
According to the American Cancer Society, cancer is the second leading cause of death in
the United States and continues to take thousands of lives each year [67]. Despite the incidence of
cancer dropping over the last several years with the advent of immunotherapies and increased
rates of early detection, cancer-specific therapies remain limited [68]. One of the most successful
targets for B cell lymphoma, CD19, is found on all B cells, thereby eliminating all B cells upon
immunotherapeutic treatment [5]. This dictates the need to find cancer neoantigens that are found
only on cancerous cells to spare healthy cells during cancer treatment.
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Thymidine kinase 1 (TK1) is an enzyme involved in the DNA salvage pathway that
converts thymidine to deoxythymidine 5’-monophosphate which is further phosphorylated into
the nucleotide thymine [69]. In normal cells, TK1 becomes elevated during the G1/S phase of the
cell cycle and declines through the rest of the cell cycle [70]. However, when DNA damage
becomes extensive like in cancer cells, TK1 is upregulated once again in the G2 phase and is
secreted into the serum [71]. Due to this, TK1 has been used as a cancer diagnostic and
prognostic tool, as elevated levels indicate the presence of cancer and can predict cancer stage
[72].

Recently, TK1 has been shown to be overexpressed on the surface of many cancers,

including acute lymphoblastic leukemia, Burkitt’s lymphoma, acute promyelocytic leukemia,
and T cell leukemia [73]. Importantly, TK1 is not expressed on the surface of healthy cells,
making it an ideal cancer-specific antigen that can be targeted for cancer treatment.
1.7 Genomics Education
With the completion of the Human Genome Project in 2003, the study of genomics has
rapidly evolved in the last 20 years. The vast amount of genomic information obtained over the
last several years has provided crucial insights into various health issues, improving diagnosis
and treatment for many diseases [74]. For example, patients with Clostridium difficile infection
have significantly benefited from microbiome transplants from healthy donors, thereby providing
an effective treatment for a highly morbid infection [75]. Advancements in genomics have
expanded to other fields, such as bacteriophages which are currently being characterized and
developed for agricultural treatments such as fire blight [76]. With many high-throughput
sequencing methods now readily available, the cost and time to obtain genomic data has
decreased significantly, going from millions of dollars and several years to several hundred
dollars and a few days [77].
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Despite the exciting technical advances in genomics, many societal, ethical, and scientific
concerns remain. The significant decrease in cost has made genomic sequencing more accessible
to businesses outside of academic and clinical research, leading to the development of direct-toconsumer genomic profiling [78]. While some studies have shown that direct-to-consumer
genomic profiling has been beneficial in identifying and preventing disease, other issues about
proper education, accessibility, and societal perception remain [78-82]. Therefore, education is
critical on various levels, public and private, to help patients, doctors, and others make educated
decisions about the impact of genomics in society [83]. Here, we summarize what has happened
with the advancement of genomics, the benefits, challenges, and demographics that need to be
educated (Figure 4).

Figure 4. The Benefits, Challenges, and Need for Genomics Education.
With the decreasing cost and accessibility of genomics information, education is needed in
various sectors, from academic to medical to public. While they can benefit health outcomes and
treatment, ethical and societal issues need to be considered.
11

1.8 Chapter Summaries
Chapter 2 is a published research paper that examines the role of the co-receptor CD5 in
T cell metabolism. We show that the metabolomic profile of CD5WT and CD5KO Th cells and
mouse serum have significantly different profiles, indicating that removing CD5 may play a role
in regulating metabolite availability and production. We also identified several metabolic genes
that were upregulated in CD5KO Th cells and bioinformatically mapped genes and metabolites
to pathways that may be affected by CD5 expression. We also measured glycolysis and
mitochondrial respiration of CD5KO Th cells and found that CD5KO Th cells have higher
glycolytic rates, increased spare respiratory capacity, and enhanced mitochondrial respiration in
comparison to CD5WT Th cells. We also found that unstimulated CD5KO Th cells derived from
mice have higher levels of memory cells in comparison to naïve T cells, which may explain
some metabolic differences between CD5WT and CD5KO Th cells. Together, our data suggests
that the removal of CD5 plays a role in regulating T cell metabolism.
Chapter 3 describes our work with two T cells, called LLO118 and LLO56, that we
stimulated with altered peptide ligands (APLs). Our preliminary work demonstrated differences
in LLO118 and LLO56 T cell response to altered peptides. Specifically, we saw proliferation
differences between LLO118 and CD5KO LLO118 T cells, suggesting that CD5 may influence
T cell proliferation against altered peptides. We also saw differences in IL-2 production between
CD5KO LLO118 and CD5KO LLO56 T cells. CD5KO LLO118 T cells produced more IL-2
over time while CD5KO LLO56 IL-2 production decreased over time. We also saw that IL-2
production and proliferation in CD5KO LLO118 T cells did not match, suggesting that CD5 may
regulate signaling strength against altered peptides. Studying the altered peptide response in vivo
revealed that LLO118 responded better to partial agonist peptides S194 and G194, whereas
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LLO56 proliferation was very similar to differences seen in vitro. Together, this preliminary data
suggests that TCR signaling strength and CD5 expression may play a critical role in the vastly
different functional responses of LLO118 and LLO56 T cells.
Chapter 4 is a research paper that is almost completed and ready for submission that
characterizes the isolation of single-chain antibody fragments (scFvs) specific for thymidine
kinase 1, a novel cancer biomarker. We identified ten unique clones from a yeast display library,
performed bioinformatical analysis of binding to TK1, and validated binding of the scFvs to TK1
protein. Characterization of these antibodies may lead to immunotherapeutic development.
Chapter 5 is a published review article about genomics education in various academic,
professional, and public settings. In this paper, we discussed genomics education in high school,
college, medical school, and health professional teaching. We also outlined initiatives that are
being used or could be used to promote genomics education in public and healthcare settings.
Together, we illustrated the importance of genomics education on many levels, the potential
benefits and consequences of genomic education, as well as ethical and societal considerations
necessary for understanding the impact genomics education could have.
Chapter 6 is the final chapter, where we discuss the main findings of each chapter. We
also discuss future research plans to further characterize the role of the co-receptor CD5, the
influence of altered peptides in LLO118 and LLO56 Th cells, antibody selection against TK1,
and genomics education.
Appendix I contains my curriculum vitae, which details publications, presentations,
funding, and awards achieved during my dissertation.
Appendix II contains the published manuscripts of first author and co-authored works
during my dissertation.
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Chapter 2: CD5 Deficiency Alters Helper T Cell Metabolic Function and Shifts the Systemic
Metabolome

The content of this chapter was published in Biomedicines. Whitley, K.V.; Freitas, C.M.T.;
Moreno, C.; Haynie, C.; Bennett, J.; Hancock, J.C.; Cox, T.D.; Pickett, B.E.; Weber, K.S. “CD5
Deficiency Alters Helper T Cell Metabolic Function and Shifts the Systemic Metabolome.”
Biomedicines 2022, 10, 704. https://doi.org/10.3390/biomedicines10030704. It has been
formatted for this dissertation, but it is otherwise unchanged. Personal contributions to chapter:
first co-author, conceptualization, data analysis and acquisition, investigation, writing – original
draft preparation and review and editing, visualization, and funding acquisition.
Abstract
Metabolic function plays a key role in immune cell activation, destruction of foreign
pathogens, and memory cell generation. As T cells are activated, their metabolic profile is
significantly changed due to signaling cascades mediated by the T cell receptor (TCR) and coreceptors found on their surface. CD5 is a T cell co-receptor that regulates thymocyte selection
and peripheral T cell activation. The removal of CD5 enhances T cell activation and
proliferation, but how this is accomplished is not well understood. We examined how CD5
specifically affects CD4+ T cell metabolic function and systemic metabolome by analyzing
serum and T cell metabolites from CD5WT and CD5KO mice. We found that CD5 removal
depletes certain serum metabolites, and CD5KO T cells have higher levels of several
metabolites. Transcriptomic analysis identified several upregulated metabolic genes in CD5KO
T cells. Bioinformatic analysis identified glycolysis and the TCA cycle as metabolic pathways
promoted by CD5 removal. Functional metabolic analysis demonstrated that CD5KO T cells
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have higher oxygen consumption rates (OCR) and higher extracellular acidification rates
(ECAR). Together, these findings suggest that the loss of CD5 is linked to CD4+ T cell
metabolism changes in metabolic gene expression and metabolite concentration.
2.1 Introduction
CD4+ helper T cells (Th) are a vital component of the immune system responsible for
directing other immune cells to eliminate pathogens and cancer [2,84,85]. Specifically, Th cells
facilitate CD8+ killer T cell recruitment and enhance killer T cell function against cancer and
infectious diseases [86,87]. Th cells also activate B cells via cytokines, which provide antibodies
that can target cells and foreign pathogens for destruction. Th cells are a valuable resource for
improving killer T cell response in cancer treatment and have become a focus of
immunotherapeutic research [88]. While it is increasingly clear that helper T cells serve an
important role, the exact details about which entities produce an effective Th cell response
remain unclear.
During an immune response, activated T cells undergo metabolic changes by
transitioning from mitochondrial respiration to glycolysis. This significant metabolic shift affects
T cell activation, proliferation, and function [23,25,26]. Naïve T cells remain relatively quiescent
and rely predominantly on mitochondrial respiration to meet basal metabolic needs [21,22]. As T
cells become activated, the glycolytic switch causes ATP to be less efficiently produced;
however, critical intermediates are produced via glycolysis, such as the pentose phosphate
pathway that provides ribose for cellular growth [21,24]. T cell activation requires signals
mediated by the T cell receptor (TCR) and co-receptors on the T cell membrane [89,90]. These
signaling proteins determine the magnitude of the glycolytic switch and affect gene expression,
controlling cell proliferation and cytokine production, all of which are required for a strong
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immune response [20,35,36]. Co-receptors on the surface of T cells also play a vital role in T cell
activation by regulating the T cell response through stimulation or inhibition [91]. Co-receptors
such as PD-1 and CTLA-4 inhibit the TCR-peptide-MHC signal, making them instrumental
targets for antibody-blockade cancer immunotherapies [34,39,40]. The removal of PD-1 alters T
cell metabolism, which also results in altered systemic metabolite levels and potential
consequences, such as altered animal behavior [26,92]. Together, this suggests that T cell coreceptor signaling not only changes T cell function but can also result in significant changes
outside the immune system.
CD5 is a T cell co-receptor that negatively regulates T cell activation during T cell
development in the thymus. It belongs to the group B scavenger-receptor cysteine-rich (SRCR)
superfamily and is associated with the TCR/CD3 complex [46,47]. CD5 expression levels
correlate with the strength of the signal between the TCR-self-pepMHC and help fine-tune the
TCR repertoire by altering TCR signaling strength during the selection process in the thymus
[41,42].

Evidence suggests that CD5 can bind to CD5 on other cells, CD5 ligand (CD5L) that is

transiently found on activated splenocytes, and CD72 found on B cells [43-45]. CD5 appears to
regulate T cell signaling by recruiting a signaling complex composed of adaptor proteins, as well
as positive and negative regulators of TCR signaling [49]. This is initiated by phosphorylation of
residue 429 on CD5, which serves as a docking station for these adaptor proteins and leads to
context-dependent positive or negative TCR signals [48-50]. CD5 has been shown to alter basal
NF-κB signaling based on self-peptide-induced TCR signaling strength [93]. CD5-deficient T
cells and anti-CD5 antibodies have been shown to increase T cell proliferation, cytokine
production, activation-induced cell death (AICD), and modulate calcium mobilization [39,42,51].
These inhibitory functions often cause or result in changes to T cell metabolism, suggesting that

16

CD5 may play a role in regulating metabolism and, like PD-1 and CTLA-4, be a potential
immunotherapeutic target.
Here, we investigated whether the removal of CD5 alters T cell metabolic function and
potential systemic consequences. We measured serum and Th cell metabolomics in CD5 wild
type (CD5WT) and CD5 knockout mice (CD5KO). We found that certain metabolites were
reduced in the serum of CD5KO mice and were increased inside CD5KO T cells. Specifically,
we observed that several metabolites important for glycolysis and mitochondrial respiration were
upregulated in CD5KO Th cells. We performed RNA-Seq on CD5WT and CD5KO Th cells and
identified 1442 genes that were differentially expressed. We found 774 differentially expressed
genes in CD5KO Th cells involved in metabolic function, including genes for five metabolite
transporters. Bioinformatic analysis of metabolomic and RNA-Seq data revealed that CD5 might
promote specific metabolic pathways, which consequently affects metabolite concentration and
usage. We tested the metabolic function of CD5WT and CD5KO Th cells and found that the
removal of CD5 promoted T cell metabolic function by increasing their glycolytic rate and
mitochondrial spare respiratory capacity. Together, these findings suggest that the loss of CD5 is
linked to Th cell metabolic changes on a transcriptional level and has systemic metabolic
consequences.
2.2 Materials and Methods
Mice
C57BL/6 mice (CD5WT) and C57BL/6 mice deficient in CD5 (CD5KO) were used in
this study and housed in a pathogen-free facility and fed Purina Rodent Chow #5001 (LabDiet,
St. Louis, MO, USA). T cells for these assays were acquired from mice aged 7–12 weeks old.
Mice were euthanized before spleen removal. All animal studies were approved by and
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performed in accordance with the BYU Institutional Animal Care and Use Committee (protocol
numbers 21-0308 and 18-0708).
T Cell Isolation
Spleens were isolated from CD5WT and CD5KO mice and homogenized into a single
cell suspension. Unstimulated CD4+ T cells were selected using positive selection CD4+ (L3T4)
microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany; kit #130-117-043) according to
manufacturer instructions. Naïve CD4+ T cells were isolated using the Naïve CD4+ T cell kit
(Miltenyi Biotec, Bergisch Gladbach, Germany; kit #130-104-453) according to manufacturer
instructions.
Serum and T Cell Metabolomics
T cells were isolated as described above, centrifuged, and media removed, then flash
frozen and stored at –80 °C. Approximately 3 × 106–5 × 106 T cells were used in each sample
(each derived from a single mouse), and cell count was reported so experiments could be
adjusted accordingly. Blood (150–200 µL) was collected from CD5WT and CD5KO mice and
allowed to coagulate at room temperature for 30 min, followed by centrifugation for ten minutes
at 4 °C. Serum was aliquoted into 50 µL and stored at –80 °C.
Cold 90% methanol (MeOH) solution was added to each sample to give a final
concentration of 80% MeOH for each cell pellet. Samples were then incubated at –20 °C for 1 h.
After incubation, the samples were centrifuged at 20,000× g for 10 min at 4 °C. The supernatant
was then transferred from each sample tube into a labeled, fresh microcentrifuge tube. Pooled
quality control samples were made by removing a fraction of collected supernatant from each
sample, and process blanks were made using only extraction solvent and no cell culture. The
samples were then dried en vacuo.
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All GC-MS analyses were performed with an Agilent 7200 GC-QTOF and an Agilent
7693A automatic liquid sampler (Agilent Technologies, Santa Clara, CA, USA). Dried samples
were suspended in 40 µL of a 40 mg/mL O-methoxylamine hydrochloride (MOX) (MP
Biomedicals, Irvine, CA, USA; #155405) in dry pyridine (MilliporeSigma, Burlington, MA,
USA; #PX2012-7) and incubated for one hour at 37 °C in a sand bath. Twenty-five microliters of
this solution were added to autosampler vials; 60 µL of N-methyl-Ntrimethylsilyltrifluoracetamide (MSTFA with 1% TMCS, Thermo Fisher Scientific, Waltham,
MA, USA; #TS48913) were added automatically via the autosampler and incubated for 30 min
at 37 °C. After incubation, samples were vortexed, and 1 µL of the prepared sample was injected
into the gas chromatograph inlet in the split mode with the inlet temperature held at 250 °C. A
5:1 split ratio was used for analysis for most metabolites. Any metabolites that saturated the
instrument at the 5:1 split were analyzed at a 50:1 split ratio. The gas chromatograph had an
initial temperature of 60 °C for one minute, followed by a 10 °C/min ramp to 325 °C and a hold
time of 10 min. A 30 m Agilent Zorbax DB-5MS with a 10 m Duraguard capillary column was
employed for chromatographic separation. Helium was used as the carrier gas at a rate of 1
mL/min. Below is a description of the two-step derivatization process used to convert nonvolatile metabolites to a volatile form amenable to GC-MS. Data was collected using
MassHunter software (Agilent Technologies, Santa Clara, CA, USA).
For metabolomics analysis, metabolites were identified, and their peak area was recorded
using MassHunter Quant. This data was transferred to an Excel spreadsheet (Microsoft,
Redmond, WA, USA). The Metabolite identity was established using a combination of an inhouse metabolite library at the University of Utah. The Metabolomics Core was developed using
pure pre-purchased standards, the NIST library, and the Fiehn library. Analysis was performed
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using MetaboAnalyst (www.metaboanalyst.ca, accessed on 1 March 2022) with the following
parameters: samples were analyzed based on peak intensity, normalized by sum, log
transformation, and Pareto scaling. Altered metabolites were identified using a p-value below
0.05 and a fold change of 1.5 [94]. MetaboAnalyst was also used to perform pathway analysis
using the metabolites upregulated in CD5KO T cells and downregulated in CD5KO serum as
input.
RNA-Seq and qPCR
Three CD5WT and three CD5KO RNA samples (each derived from a single mouse) were
isolated for CD4+ T cells. After T cell isolation, cells were centrifuged, supernatant removed,
flash-frozen in liquid nitrogen, and stored at –80 °C. Each sample had less than 1 × 107 T cells;
the smallest number of cells used was 1 × 106 T cells. Total RNA was isolated using the RNeasy
Mini Kit (Qiagen, Hilden, Germany) and sequenced at the University of Colorado at the Genetics
Microarray Core. Cell number and RNA concentration were reported to the University of
Colorado so that experimental adjustments could be made accordingly. RNA-Seq data were
analyzed using the BYU high-performance computing environment and processed using the
ARMOR Snakemake-based automated workflow within a dedicated Conda environment [95].
The Database for Annotation, Visualization, and Integrated Discovery (DAVID) was used to
categorize genes and perform pathway analysis. qPCR primers were designed to amplify 21
metabolic genes (Table S1). Beta-actin was used as an internal control. RNA for qPCR was
isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany) and converted to cDNA using
the High-Capacity RNA-to-cDNA Kit (Applied Biosystems, Waltham, MA, USA). qPCR was
performed using the Power SYBR™ Green PCR Master Mix (Thermo Fisher Scientific,
Waltham, MA, USA) on the StepOnePlus thermocycler (Applied Biosystems, Waltham, MA,
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USA). Conditions were as follows: 50 °C for 2 min, 95 °C for 10 min, 40 cycles of 95 °C for 15
s followed by 60 °C for 1 min, and melt curve analysis at 95 °C for 15 s, 60 °C for 15 s, and 95
°C for 15 s. ΔΔCт values were calculated using the StepOne software v2.3 (Applied Biosystems,
Waltham, MA, USA).
T Cell Metabolic Assays
The extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were
measured using an Extracellular Flux Analyzer XFp (Agilent Technologies, Santa Clara, CA,
USA). Seahorse XF RPMI Base Medium (Agilent Technologies, Santa Clara, CA, USA;
Cat#103336-100) replaced culture media; 200,000 T cells were seeded onto a Poly-D-Lysine
(Gibco, Waltham, MA, USA; #A3890401) coated Seahorse 8-well plate and pre-incubated at 37
°C for 60 min in the absence of CO2. To measure mitochondrial respiration and glycolysis, we
used the XFp Mito Stress Test kit (Agilent Technologies, Santa Clara, CA, USA; #103010-100).
Cells were resuspended in XF assay media supplemented with 25 mM glucose, 2 mM Lglutamine, and 1 mM sodium pyruvate. The OCR rate (pmoles/min) and ECAR (mpH/min) were
measured at baseline and in response to 1 µM oligomycin, 1.5 µM fluorocarbonyl cyanide
phenylhydrazone (FCCP), and 0.5 µM rotenone/antimycin A. All chemicals were purchased
from Seahorse Bioscience (Agilent Technologies, Santa Clara, CA, USA). Cell counts between
wild type and knockout T cells acquired by an Olympus automated cell counter were used to
normalize the data. Calculations for individual parameters represent the average of individuals
for each assay group. Error bars were calculated based on the individual well calculation for each
parameter.
Flow Cytometry
2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-Deoxyglucose (2-NBDG) (Cayman
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Chemical Company, Ann Arbor, MI, USA; #11046) glucose uptake was measured using flow
cytometry. Briefly, 500,000 CD4+ T cells were incubated with 2-NBDG for 20 min at 37 °C, 5%
CO2 in R10 media consisting of 1640 RPMI, 10% fetal bovine serum (Hyclone Laboratories
Inc., Logan, UT, USA), 1% Glutamax (Gibco), and 0.5% gentamycin (Life Technologies,
Waltham, MA, USA). Fifty thousand events were recorded using the BD Accuri flow cytometer.
Mitochondrial mass and membrane potential were measured using MitoTracker Green (Thermo
Fisher Scientific, Waltham, MA, USA) and MitoProbe DilC1(5) (Thermo Fisher Scientific,
Waltham, MA, USA), respectively, and stained according to the manufacturer’s instructions.
Propidium Iodide (PI) was used to gate out dead cells. T cells (5 × 106 CD4+) were isolated, and
50,000 events were recorded using the BD Accuri flow cytometer. FlowJo was used to analyze
the data and calculate the mean fluorescence intensity (MFI).
To measure activation state, 500,000 CD4+ T cells were labeled with the following
panel: anti-mouse CD4 FITC (eBioscience, Waltham, MA, USA; clone GK1.5), antimouse/human CD44 APC (Biolegend, San Diego, CA, USA; clone IM7), and anti-mouse
CD62L PE (Miltenyi Biotec, Bergisch Gladbach, Germany). To measure subset polarization,
500,000 CD4+ T cells were labeled with the following panel: anti-mouse CD4 FITC
(eBioscience, clone GK1.5) and anti-mouse CD25 (eBioscience, clone PC61.5). Fifty thousand
events were recorded using the Beckman-Coulter Cytoflex flow cytometer.
Statistical Analysis
Statistical analyses were performed in Graphpad PRISM version 7.0 (San Diego, CA,
USA). Analyses included unpaired Student’s t-test (metabolomics), paired t-test (functional
metabolic assays), or analysis of variance (ANOVA) for metabolomics.
2.3 Results
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2.3.1 Removal of CD5 Decreases Serum Amino Acid Levels in CD5KO Mice.
We wanted to quantify any changes in metabolite concentration in the serum of wildtype
and CD5 knockout mice. To do so, we performed non-targeted GC-MS of the serum metabolome
of CD5WT and CD5KO mice. Subsequent data analysis revealed the detection of 125 different
metabolites in the serum comprised of amino acids, fatty acids, sugars, nucleic acid products, and
glycolysis/TCA cycle products (Figure 5A).
Of the 125 metabolites detected, 65 were confirmed after calculating the coefficient of
variance to determine each metabolite’s reliability (Figure 5B). Partial least-squares discriminant
analysis (PLS-DA) demonstrated that the serum metabolome of CD5KO mice was considerably
different in comparison to CD5WT mice (Figure 5C). Heatmap analysis of the top 25
deregulated metabolites (as determined by t-test and ANOVA) also indicated clear differences in
the serum metabolome composition between CD5WT and CD5KO mice (Figure 5D). To
determine metabolite enrichment between groups, we analyzed which metabolites had a fold
change > ±1.5 or a p-value < 0.05 (Figure 5E). Of these metabolites, 15 metabolites had lower
concentrations in CD5KO serum, while 12 had higher concentrations in CD5KO serum. A
volcano plot analysis determined which metabolites met both requirements of fold change and pvalue (Figure 5F). The volcano plot analysis identified 10 metabolites that had both a 1.5-fold
change and a p-value below 0.05 (Figure 5G). Of these metabolites, six had lower concentrations
in CD5KO serum (L-glutamic acid, L-aspartic acid, L-phenylalanine, glycine, L-serine, and
pyroglutamic acid), while four had higher concentrations in CD5KO serum (hypoxanthine, 3hydroxybutyric acid, gluconic acid, and inosine). Together, these results suggest that CD5
systemically affects the serum metabolome.
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Figure 5. The Serum Metabolome of CD5KO Mice is Significantly Different Than CD5WT
Mice.
Serum metabolites were measured using GC-MS and characterized using MassHunter software
(Agilent) and analyzed with the MetaboAnalyst software tool. Samples were normalized to
assume a Gaussian distribution (n=3). (a) 125 different metabolites were measured, comprising
37 amino acids, 31 fatty acids, 15 sugars, 14 nucleic acids and byproducts, and 18 metabolites
involved in glycolysis or the TCA cycle. (b) Reliability of metabolites was measured using
coefficient of variance and revealed 65 reliable metabolites. (c) Partial-least squares discriminant
analysis of CD5WT and CD5KO serum metabolome. (d) Heat map representing the 25
metabolites with the greatest relative intensity between three samples of CD5WT and CD5KO
mice, as determined by student t tests. Blue indicates lower metabolite concentrations, while red
indicates higher metabolic concentrations. (e) 27 metabolites were substantially different, either
by fold change (±1.5) or p-value (<0.05). Of these 27 metabolites, 15 metabolites were
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diminished in CD5KO serum, while 12 metabolites were increased in CD5KO serum. 10
metabolites that were not statistically different (p>0.05) had a fold change of ±1.5 (L-lysine,
ornithine, 2-hydroxybenzoic acid, uric acid, uracil, L-proline, L-alanine, D-mannose, palmitoleic
acid, and D-fructose). Eight metabolites were significantly different (p≤0.05) but not 1.5-fold
different (nonanoic acid, myo-inositol, benzoic acid, fumaric acid, D-malic acid, capric acid, and
urea). 10 metabolites had significant fold change but were not statistically significant. (f)
Volcano graph highlighting significant metabolites based on p-value (y-axis) and fold change (xaxis) on a logarithmic scale. Parameters for significance in the Volcano graph were set at a pvalue of less than 0.05 and a fold change of ±1.5 or higher. (g) Analysis identified ten
metabolites that are significantly different between CD5WT and CD5KO mouse serum. Of the
ten significant metabolites, six of the metabolites (L-glutamic acid, L-aspartic acid, glycine, Lserine, pyroglutamic acid, and L-phenylalanine) were significantly decreased in the serum of
CD5KO mice in comparison to CD5WT. Four of the metabolites (Hypoxanthine, 3hydroxybutyric acid, gluconic acid, and inosine) were significantly increased in the serum of
CD5KO mice in comparison to CD5WT. Metabolites with a negative fold change were lower in
CD5KO serum while metabolites with a positive fold change were higher in CD5KO serum.
2.3.2 CD5KO Th Cells Have Elevated Levels of Many Metabolites
To determine whether serum metabolome changes were reflective of metabolome
changes in unstimulated Th cells, we performed non-targeted GC-MS on T cells from CD5WT
and CD5KO mice. Data analysis revealed that 108 different metabolites were detected in Th
cells (Figure 6A).
Of the 108 metabolites detected, 60 were confirmed after calculating the coefficient of
variance to determine each metabolite’s reliability (Figure 6B). Partial least-squares discriminant
analysis (PLS-DA) demonstrated that the T cell metabolome of CD5KO mice is considerably
different from that of CD5WT mice (Figure 6C). Heatmap analysis of the top 25 deregulated
metabolites (as determined by t-test and ANOVA) also indicate CD5KO T cells have higher
levels of several metabolites (Figure 6D). To determine metabolite enrichment between groups,
we analyzed which metabolites had a fold change greater than ±1.5 or a p-value of 0.05 or lower.
This analysis revealed 44 metabolites that had a substantial fold change and/or had a p-value
below 0.05 (Figure 6E). Of these metabolites, 30 metabolites had higher concentrations in
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CD5KO T cells, while 14 had higher concentrations in CD5WT T cells. 29 metabolites had both
a 1.5-fold change and a p-value below 0.05 and included nine amino acids (Figure 6F), seven
fatty acids (Figure 6G), and thirteen other metabolites (Figure 6H), many of which are important
metabolites in glycolysis and the TCA cycle. Of the nine amino acids to be significantly
different, eight had higher concentrations in CD5KO T cells (L-glutamic acid, L-phenylalanine,
L-aspartic acid, asparagine, 2-aminoadipic acid, L-theronine, L-proline, and ornithine), while one
(taurine) was higher in CD5WT T cells. Of the seven fatty acids that were significantly different,
two had higher concentrations in CD5KO T cells (O-phosphoethanolamine and glycerol-3
phosphate), while five had higher concentrations in CD5WT T cells (lauric acid, nonanoic acid,
1-monomyristin, 1-palmitoylglycerol, and 1-steroylglycerol), illustrating that fatty acid oxidation
may be lower in CD5KO T cells. Of the thirteen other significant metabolites, two had higher
concentrations in CD5WT T cells (phosphate and oxalic acid). The other eleven metabolites that
had higher concentrations in CD5KO T cells included fumaric acid, uracil, nicotinamide,
glucose-6-phosphate, citric acid, ribitol, D-glucose, hypoxanthine, 3-hydroxybutyric acid, Dmalic acid, and myo-inositol.

26

Figure 6. Increased Intracellular Metabolites are Found in CD5KO Unstimulated Th Cells.
T cell metabolites were measured using GC-MS and characterized using MassHunter software
(Agilent) and analyzed with the MetaboAnalyst software tool. Samples were normalized to
assume a Gaussian distribution (n=4). (a) 108 different metabolites were measured, comprising
33 amino acids, 26 fatty acids, 14 sugars, 12 nucleic acids and byproducts, and 16 metabolites
involved in glycolysis or the TCA cycle. (b) Reliability of metabolites was measured using
coefficient of variance and revealed 60 reliable metabolites. (c) Partial-least squares discriminant
analysis of CD5WT and CD5KO T cell metabolome. (d) Heat map representing the 25
metabolites with the greatest relative intensity between four samples of CD5WT and CD5KO T
cells, as determined by student t tests. Blue indicates lower metabolite concentrations, while red
indicates higher metabolic concentrations. (e) 44 metabolites were significantly different, either
by fold change (±1.5) or p-value (<0.05). (f-h) 29 metabolites were statistically different in fold
change. This included (f) nine amino acids (eight upregulated and one downregulated), (g) seven
fatty acids (two upregulated and five downregulated), and (h) thirteen other metabolites (eleven
27

upregulated and two downregulated). Metabolites with a negative fold change were lower in
CD5KO T cells while metabolites with a positive fold change were higher in CD5KO T cells.
2.3.3 RNA-Seq Identified Several Genes Involved in Metabolism That are Upregulated in
CD5KO Th Cells
To understand how the loss of CD5 is linked to metabolic gene expression in
unstimulated Th cells, we performed RNA-sequencing to analyze the transcriptome of CD5WT
and CD5KO Th cells. Of the 13,977 genes identified, 1,442 genes were shown to be
differentially expressed in CD5WT and CD5KO Th cells (Figure 7A).

Figure 7. RNA-Seq Illustrates Several Metabolic Genes may be Regulated by CD5 in
Unstimulated Th Cells. (a) Volcano plot illustrating differentially expressed genes. Of the 1442
differentially expressed genes, we identified 936 genes that were upregulated in CD5KO T cells
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while 506 genes were downregulated in CD5KO T cells (bar graph). (b) Using the Functional
Annotation Tool in DAVID, all differentially expressed genes were mapped into broad
categories, 14 of which were statistically significant (Benjamini value <0.05) (c-e) Genes were
classified into three metabolic categories: glycolysis, fatty acid oxidation, and amino acid
metabolism. Transcripts with a negative fold change had decreased expression in CD5KO T cells
while transcripts with a positive fold change had higher expression in CD5KO T cells. (c) Of the
eleven transcripts assigned to glycolysis, nine were upregulated in CD5KO T cells and two were
downregulated. (d) Of the seven transcripts assigned to fatty acid oxidation, four were
upregulated in CD5KO T cells and three were downregulated. (e) Of the ten transcripts assigned
to amino acid metabolism, nine were upregulated in CD5KO T cells and one was downregulated.
(f) Five metabolite transporters were significantly upregulated in CD5KO T cells: Slc1a4
(ASCT1), Slc5a3 (SMIT), Slc7a10 (ASC1), Slc43a1 (LAT3), and Slc25a13 (CITRIN).
Of those 1,442 genes, 936 genes were upregulated in CD5KO Th cells, while 506 genes
were downregulated in CD5KO Th cells. Using the Functional Annotation Tool on DAVID, all
genes were organized into different functional categories (Figure 7B). Of the 14 pathways listed,
three categories were of interest: signaling, metabolic process, and immune system process. Of
the 774 genes categorized in the metabolic process category, 501 genes were upregulated in
CD5KO Th cells. Of these genes, we categorized metabolic genes of interest into three
categories: glycolysis, fatty acid oxidation, and amino acid metabolism (Figure 7C-7E,
supplementary table 2). Of the eleven transcripts assigned to glycolysis, nine (ENO1b, GAPDH,
GALM, PDK3, TPI1, PGAM1, GCG, PGK1, and ALDOC) were upregulated in CD5KO T cells.
Of the seven transcripts assigned to fatty acid oxidation, four (ECHDC2, DECR1, PPA1, and
ACLY) were upregulated in CD5KO T cells. Of the ten transcripts assigned to amino acid
metabolism, nine (ODC1, ASNS, BCAT1, GSTT3, GOT1, GOT2, FAH, GLDC, and SCCPDH)
were upregulated in CD5KO T cells. In addition, five metabolite transporters were significantly
upregulated in CD5KO Th cells (Figure 7F). Four metabolite transporters are expressed on the
cell surface – SLC1a4 (glutamate/neutral amino acid), SLC5a3 (inositol), SLC7a10 (Dserine/neutral amino acid), and SLC43a1 (phenylalanine/large neutral amino acid). One is
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expressed on the mitochondrial surface – SLC25a13 (glutamate). All transporters bring in
metabolites that we found elevated in CD5KO Th cells (Figure 6F) or depleted in CD5KO serum
(Figure 5G). These results suggest that CD5 is linked to Th cell metabolism changes through
transcriptional expression of metabolic transporters.
2.3.4 Metabolomic and Transcriptomic Pathway Analysis Revealed That CD5 may be Linked to
Specific Metabolic Pathways
To determine if the loss of CD5 involves specific metabolic pathways on a metabolomic
and/or transcriptomic level, we performed bioinformatic analysis of all significant metabolites
using MetaboAnalyst 5.0 (www.metaboanalyst.ca). We included metabolites that are decreased
in CD5KO serum given that intracellular metabolite increase may be caused by metabolite
removal from the serum [92]. Using the Pathway Analysis tool, we found 8 pathways were
statistically significant with a p-value less than 0.05 (Figure 8A and 8B).
Of these 8 pathways, 4 were statistically significant with an FDR of <0.05 (Figure 8B).
Given these results, we analyzed the top three metabolic pathways and mapped where our
upregulated and downregulated metabolites were in these pathways using KEGG as the
reference. The top three pathways include the alanine, aspartate, and glutamate pathway, the
arginine biosynthesis pathway, and the aminoacyl-tRNA biosynthesis pathway. In the
aminoacyl-tRNA biosynthesis pathway, we found ten upregulated metabolites and three
downregulated metabolites that could be used for tRNA synthesis. This suggests that CD5 may
be linked to DNA translation and amino acid sensing. In the arginine biosynthesis pathway, four
upregulated metabolites are involved: ornithine, glutamate, aspartate, and fumarate (Figure 8D).
Four of these metabolites feed directly into (ornithine and aspartate) or are a byproduct (fumarate
and urea) of the urea cycle. Glutamate affects the urea cycle more indirectly as it is used to
produce ammonia from which is formed L-citrulline, which enters the urea cycle. In the alanine,
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aspartate, and glutamate pathway, upregulated metabolites included aspartate, L-asparagine,
fumarate, and glutamate (Figure 8E). Interestingly, four of the five metabolites feed directly or
indirectly into the TCA cycle. These results suggest that CD5 may be linked to metabolic
pathways that are significant for T cell activation and function.
We also desired to see if our RNA-Seq data could help us understand how CD5 may be
linked to metabolism on a transcriptomic level. To do this, we used the Functional Annotation
Tool in DAVID. 16 pathways were statistically significant (supplementary table 3). Of these 16
pathways, three were directly involved with metabolism: biosynthesis of amino acids, carbon
metabolism, and glycolysis/gluconeogenesis. Using KEGG as a reference, we found that many
of the upregulated genes were involved in glycolysis and mitochondrial respiration. In
glycolysis, eight genes for glycolytic enzymes were upregulated (Figure 8F). Interestingly, every
enzyme involved in the conversion of fructose-1-6-bisphosphate to phosphoenolpyruvate was
upregulated in CD5KO Th cells. We also found that the enzyme that converts galactose to
glucose-6-phosphate (galactose mutarotase) was upregulated. In mitochondrial respiration, five
genes were upregulated (Figure 7G). Glutamic-oxaloacetic transaminase 1 and 2 (GOT1 and
GOT2) are primarily responsible for the reversible conversion of glutamate to aspartate,
glutamate to α-ketoglutarate, and aspartate to oxaloacetate; together, this is known as the malateaspartate shuttle [96]. Given that we saw an upregulation of aspartate, glutamate, and malate in
CD5KO Th cells, this suggests that CD5 may influence the malate-aspartate shuttle on a
transcriptomic level. We also saw an upregulation of branched chain amino acid transaminase 1
(BCAT1), which converts leucine, isoleucine, and valine into substrates that produce glutamate
as a byproduct. Interestingly, we saw decreased amounts of isoleucine and valine in CD5KO T
cells (Figure 6E), suggesting that increased transcription of BCAT1 may provide increased
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amounts of glutamate available for use in CD5KO CD4+ T cell metabolism. We also saw an
upregulation in succinate dehydrogenase complex iron sulfur subunit B (SDHB), which is a
subunit of succinate dehydrogenase that converts succinate to fumarate and is part of Complex II
in the electron transport chain [97]. We also saw an upregulation of the aldehyde dehydrogenase
7 family member A1 gene (ALDH7A1), which converts acetaldehyde to acetate, which can be
converted to acetyl-CoA and be used in the TCA cycle. Together, this pathway analysis suggests
that the loss of CD5 is linked to metabolic gene expression which, in turn, may modulate
metabolite availability.
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Figure 8. Bioinformatic Pathway Analysis Demonstrates that CD5 Affects Important Metabolic
Pathways in Unstimulated Th Cells.
(a-e) Pathway analysis was performed using MetaboAnalyst 5.0 to determine pathway impact
and significance based on our metabolomics data. (a) Significant pathways were plotted against
p-value (-log10) and pathway impact factor. (b) 8 pathways were statistically significant by pvalue (<0.05), while four pathways were statistically significant by false discovery rate (FDR,
<0.05). (c-e) Based on FDR significance, we selected the top three pathways involved with
metabolic function using KEGG as reference. Metabolites highlighted in orange represent
metabolites that were significantly decreased in CD5KO T cells or higher in CD5KO mouse
serum, metabolites highlighted in green represent metabolites that were significantly increased in
CD5KO T cells or lower in CD5KO mouse serum, and metabolites highlighted in blue represent
intermediate metabolites. (c) In the aminoacyl-tRNA biosynthesis pathway, 13 significant
metabolites are involved. (d) In the arginine biosynthesis pathway, five significant metabolites
are involved. (e) In the alanine, aspartate, and glutamine metabolism pathway, five significant
metabolites are involved (glutamate, citrate, fumarate, aspartate, and asparagine). (f, g) DAVID
was used to analyze pathway enrichment based on our RNA-Seq data. 16 KEGG pathways were
statistically significant. Of these 16 pathways, we focused on three pathways directly involved in
metabolism (biosynthesis of amino acids, glycolysis/gluconeogenesis, and carbon metabolism).
Based on these three pathways, we combined our metabolomic and RNA-Seq data to
demonstrate metabolite and gene involvement in glycolysis (f) and the TCA cycle (g).
Metabolites highlighted in orange represent metabolites downregulated in CD5KO T cells,
metabolites highlighted in green represent metabolites upregulated in CD5KO T cells or
downregulated in CD5KO mouse serum, and metabolites highlighted in blue represent
intermediate metabolites. Metabolic enzymes that were significantly upregulated in CD5KO T
cells are highlighted in yellow. Bright blue boxes indicate upregulated metabolite transporters in
CD5KO T cells. Dark blue boxes indicate other pathways that may be involved.
2.3.5 Quantitative PCR Validates That CD5 Removal is Linked to Transcriptional Upregulation
of Metabolic Genes
To validate the results of our RNA-Seq data, we performed quantitative PCR to calculate
the expression of metabolism-related genes between CD5WT and CD5KO unstimulated Th cells.
We analyzed 21 candidate genes based on our RNA-Seq and bioinformatic pathway data
analysis (Figure 9).
Of the 21 metabolic genes measured, only 4 genes (Eno1b, Pgk1, Sdhb, and GOT2) did
not conclusively show substantially higher fold change in CD5KO T cells in comparison to
CD5WT. Interestingly, of the nine genes involved in glycolysis (Figure 9A), GCG (glucagon)
had the highest fold change and corresponded to our RNA-Seq data (Figure 9D). Many of the
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genes that were found in our bioinformatic pathway analysis of glycolysis were validated
(ALDOA, ALDOC, GALM, GAPDH, PGAM1, and TPI1), indicating that CD5 plays a
transcriptional role in regulating unstimulated Th cell glycolysis (Figure 9F). Of the seven genes
involved in amino acid metabolism or the TCA cycle (Figure 9B), ASNS (asparagine synthetase)
had the highest fold change and mirrors results seen in RNA-Seq (Figure 9E). Surprisingly, only
one of the four metabolic genes involved in the TCA cycle, ALDH7a1, was validated. However,
we observed that all genes involved with amino acid metabolism (BCAT1, FAH, GOT1and
ASNS) were upregulated using quantitative PCR. These results indicate that CD5 is involved in
the transcriptional regulation of genes involved with L-glutamic acid (BCAT1, GOT1, and
ASNS) [98,99], phenylalanine (FAH) [100], and asparagine (ASNS) [98], which we saw
upregulated in CD5KO T cells (Figure 6F). FAH is also responsible for forming fumaric acid,
which is used in the TCA cycle [101]. Therefore, this suggests that CD5 may be involved in
regulating the TCA cycle by controlling metabolite concentration mediated by other genes. Of
the metabolite transporters we validated, all but SLC25a13 had an average 2-fold increase in
transcription or more (Figure 9C). Similar changes in fold change were seen in our RNA-Seq
data (Figure 9F). Given that many measurements in fold change seen in RNA-Seq in comparison
to qPCR were not the same, this is likely due to sample processing differences between the two
methods. These results indicate that CD5 is linked to the upregulation of T cell metabolic genes
involved in metabolite transporters, glycolysis, and amino acid metabolism.
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Figure 9. Comparative qPCR Validated Several Upregulated Metabolic Genes in Unstimulated
CD5KO Th Cells.
(a-c) 21 metabolic genes were selected for validation. Fold change was measured using CD5WT
as reference and beta-actin as the endogenous control, (n=3). Fold changes were calculated using
the formula 2-ΔΔCт . (a) Of the nine genes involved in glycolysis, all but two (Eno1b and Pgk1)
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exhibited an average fold change of 1.5 or higher. (b) Of the seven genes involved in the TCA
cycle or amino acid metabolism, all but two genes (Got2 and Sdhb) demonstrated an average
fold change above 1.5. (c) Of the five metabolite transporters we measured, all but SLC25a13
(mitochondrial glutamate) had at least an average 2-fold change. Pale yellow=average less than
1.0-fold change, yellow=average 1.0-fold change or higher, pale orange=average 1.5-fold change
or higher, dark orange=average 2.0-fold change or higher, red=average 3.0-fold change or
higher, dark red=average 5.0=fold change or higher. (d-f) Comparison of qPCR average fold
change and RNA-Seq fold change of metabolic genes involved in glycolysis (d), amino acid
metabolism or the TCA cycle (e), and metabolite transporters (f). Red patterned bars represent
qPCR fold change, dark blue patterned bars represent RNA-Seq fold change. Only two genes
(Gcg and Eno1b) had drastically different fold changes.
2.3.6 CD5KO Th Cells Have Different Metabolic Profiles Compared to CD5WT Th Cells
To determine if CD5 functionally affects T cell metabolism, we measured the glycolytic
profile and mitochondrial respiration using the Mito Stress Test (Agilent). We examined the
metabolism of unstimulated CD5WT and CD5KO Th cells (Figure 10A-10G).
Unstimulated CD5KO T cells had an increased oxygen consumption rate (OCR) in
comparison to CD5WT T cells (Figure 10A). The basal rate of CD5KO T cells, the last
measurement before the addition of oligomycin, was significantly higher than CD5WT T cells
(Figure 10B), as well as the maximal rate, the first measurement after FCCP injection (Figure
10C). The spare respiratory capacity (SRC), which is the OCR difference between the maximal
and basal rates, was also significantly higher in CD5KO T cells than CD5WT T cells (Figure
10D). Similar differences were seen in published work described by Milam, et al., where CD5lo
cells had higher basal and maximal rates, as well as higher SRC [102]. Together, these results
suggest that the removal of CD5 is linked to increases in Th cell mitochondrial respiration. We
also measured mitochondrial mass and membrane potential to see if mitochondrial structure or
physiology played a major role in these metabolic changes. We saw no statistical difference
between CD5WT and CD5KO T cells, suggesting mitochondrial dynamics may not play a
significant role in regulating CD5KO T cell metabolism (Supplementary Figure 1). Unstimulated
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CD5KO T cells also had an increased extracellular acidification rate in comparison to CD5WT T
cells (Figure 10E). The basal rate and maximal rate were also significantly higher in CD5KO T
cells (Figures 10F and 10G). We also performed flow cytometric analysis of glucose uptake in
unstimulated Th cells using the fluorescent glucose analog 2-NBDG (Figure 10H). CD5KO T
cells have a slightly higher uptake of glucose in comparison to CD5WT T cells. These results
suggest that the removal of CD5 on unstimulated Th cells is linked to glycolysis and may alter
the metabolic profile of unstimulated Th cells.

Figure 10. Removal of CD5 Functionally Increases Glycolysis and Mitochondrial Respiration in
Unstimulated Th Cells.
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(a, e) Using a standard Seahorse protocol, approximately 200,000 CD4+ T cells were seeded into
an 8-well XFp plate and analyzed for metabolic function using stepwise injections of
oligomycin, carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP), and rotenone plus
antimycin A. Three wells were plated for each mouse and the average was taken for each
analysis. Both measurements for glycolysis and mitochondrial respiration were acquired from
each individual sample. (a-d) Oxygen consumption rate (OCR) was used as a readout to measure
mitochondrial respiration via the Agilent Seahorse Mito Stress Test (n=6). (b) Basal OCR, the
measurement before the oligomycin injection, was measured. Each plot point represents the
average of three wells; p=0.0088 by paired student t test. (c) Maximal OCR, the first
measurement after FCCP injection, was measured. Each plot point represents the average of
three wells; p=0.004 by paired student t test. (d) Spare respiratory capacity (SRC), the difference
between maximal and basal rate, was measured. Each plot point represents the average of three
wells; p=0.0047 by paired student t test. (e-g) Extracellular acidification rate (ECAR) was used
as a readout to measure the glycolytic rate via the Agilent Seahorse Mito Stress Test (n=6). (e)
Basal ECAR, the measurement before the oligomycin injection, was measured. Each plot point
represents the average of three wells; p=0.0163 by paired student t test. (g) Maximal ECAR, the
first measurement after FCCP injection, was measured. Each plot point represents the average of
three wells; p=0.0203 by paired student t test. (h) 2-NBDG, a fluorescent glucose analog, was
used to monitor glucose uptake in CD5WT and CD5KO unstimulated Th cells (n=5); p=0.0184
by paired student t test. (* = p<0.05; ** = p<0.01).
2.3.7 Unstimulated CD5KO CD4+ T Cells Have Phenotypic Differences in Comparison to
CD5WT CD4+ T Cells
We used flow cytometry to phenotype CD5WT and CD5KO CD4+ T cells to see if there
were any phenotypic differences in activation state or Th subset polarization (Figure 11).
We found that unstimulated CD5KO CD4+ T cells have higher levels of CD44 in
comparison to CD5WT CD4+ T cells (Figure 11A). We also found that there are higher numbers
of naïve T cells within the CD5WT CD4+ T cell populations; however, we saw higher numbers
of memory T cells in the CD5KO CD4+ T cell populations (Figures 11B and 11C). While we did
not see a significant increase in CD4+CD25+ T cells in the CD5KO T cell population, the
CD5KO CD4+ T cells may have altered T cell subset phenotypes. To determine if our results
suggest metabolic differences based on activation state or subset phenotype, we measured naïve
T cell metabolism using the Mito Stress Test (Supplementary Figure 2A). We also measured
gene expression of naïve CD5WT and CD5KO CD4+ T cells using qPCR (Supplementary
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Figure 2B). Both experiments demonstrated similar trends seen in unstimulated CD4+ T cells but
there was no statistical significance between naïve CD5WT and CD5KO CD4+ T cells.

Figure 11. Unstimulated CD5KO Th Cells are Phenotypically Different from CD5WT CD4+ T
Cells.
(a) CD4+ T cells were stained with CD44, CD62L, and CD25 to determine activation state and
subset polarization. (b) Gating strategy to determine naïve and memory populations between
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CD5WT and CD5KO CD4+ T cells. (c) Naïve (CD44 low, CD62L high) and memory (CD44
high, CD62L low) populations were measured within CD4+ T cells. **=p value<0.01.
2.4 Discussion
CD5 is a T cell co-receptor that plays a critical role during early T cell development by
negatively regulating TCR signaling strength with the self-peptide-MHC complex. Evidence of
CD5 importance in T cell signaling was evident in CD5KO thymocytes and CD5KO naïve T
cells, which are hyperresponsive to TCR stimulation and produce higher cytokine levels [42,103].
Given how T cell signaling and metabolism are intricately connected, we hypothesized that the
negative regulation of CD5 alters T cell metabolism. In this report, we have shown that the
removal of CD5 drastically changes T cell metabolism through transcriptional mechanisms. We
found that the serum metabolome composition in CD5KO mice was significantly different
compared to CD5WT mice. Specifically, we saw a significant decrease in the levels of six
different amino acids or derivatives and a significant increase in four metabolites. We have also
shown that Th cells lacking CD5 had increased levels of several key metabolites. In analyzing T
cell and serum metabolomics, we found 17 metabolites that were differentially regulated in both
T cell and CD5KO mouse serum. Eleven metabolites were higher in CD5KO T cells but lower in
CD5KO mouse serum (fumaric acid, uracil, ornithine, L-phenylalanine, L-proline, L-serine, Laspartic acid, L-glutamic acid, pyroglutamic acid, D-malic acid, and myo-inositol). Two
metabolites, capric acid and nonanoic acid, were lower in CD5KO T cells but higher in CD5KO
mouse serum. Interestingly, three metabolites, D-fructose, 3-hydroxybutric acid, and inosine,
were both higher in CD5KO T cells and CD5KO serum. These results suggest that CD5KO Th
cells take up more of certain metabolites and utilize them for metabolic function [92]. Given these
drastic changes involved in both CD5KO mouse serum and CD4+ T cell metabolome, these
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results suggest that removal of CD5 may mediate changes in the serum metabolome via Th cell
metabolism.
However, we cannot firmly conclude this as our CD5KO mouse model is completely
devoid of CD5 expression, and given that other immune cells, such as B1 B cells and dendritic
cells, also normally express CD5. Recent findings have shown that CD5 expression on B1 B
cells drastically changes their ability to fight infection [104]. Dendritic cells that lack CD5
expression have also been shown to enhance CD4+ and CD8+ T cell activation and produce
better anti-tumor responses [105]. These factors necessitate further examination in establishing
the cause of CD5KO mouse serum changes. Further studies involving a T cell-specific CD5KO
mouse or adoptive T cell transfer into T cell-deficient mice would provide further insight in
determining if this phenotype is T cell-dependent.
Of the significant metabolites found differentially regulated in CD5KO Th cells and
serum, we found eight significant pathways that these metabolites may affect. Of the 20 amino
acids that are used for tRNA synthesis, we found that 13 of these amino acids are differentially
regulated in CD5KO CD4+ T cells. Five metabolites (ornithine, L-glutamic acid, L-aspartic acid,
fumaric acid, and urea) are involved in the arginine biosynthesis pathway. While we did not see
increased levels of arginine, two metabolites involved in this pathway, (L-glutamic acid and
ornithine) are particularly critical for the synthesis of polyamines needed in active T cells for
differentiation and proliferation [106]. Five metabolites (L-glutamic acid, L-aspartic acid, Lasparagine, citric acid, and fumaric acid) were significant in the alanine, aspartate, and glutamate
metabolism pathway. Since we have also seen increases in glucose-6-phosphate, myo-inositol,
and D-fructose, these results suggest that CD5 may be linked to glucose breakdown and TCA
cycle regulation [107]. Together, this evidence suggests that the removal of CD5 increases
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metabolite concentration that could be used for specific metabolic pathways important for T cell
function.
We performed bioinformatic pathway analysis using our RNA-Seq data and found 16
significant pathways that may be affected by the loss of CD5. We showed that CD5 might
directly impact glycolysis and the TCA cycle via increased metabolite concentration or
transcriptionally regulated metabolic genes. Specifically, we saw an increase of glucose-6phosphate and an increase in the transcription of galactose mutarotase (GALM), suggesting that
CD5 may be linked to galactose usage in CD4+ T cells. As we did not find upregulation of other
enzymes involved in the galactose-to-glucose pathway, future functional validation of this
conclusion would require measuring T cell metabolism in the presence of galactose to assure that
the increased presence of glucose-6-phosphate is due to increased galactose conversion.
While we primarily focused on three metabolic pathways in our bioinformatic analysis,
we also noticed that the MAPK pathway was significantly involved in CD4+ CD5KO T cells.
Previous studies have shown that there may be a connection between CD5 and the
PI3K/AKT/mTOR pathway [108], and our study also suggests this. Briefly, we found that PKC
(protein kinase C) and CamK (calmodulin-dependent kinase) were upregulated in CD5KO CD4+
T cells (data not shown). PKC affects calcium signaling, which plays a role in regulating
metabolism, suggesting that the loss of CD5 may be linked to increased metabolism through
calcium modulation. CamK indirectly affects the transcription of other genes, such as GAPDH,
PGK1, ALDOA, which we found were also upregulated. Given that these genes are involved in
glycolysis, this suggests that the increase of CamK transcription may be linked to the loss of
CD5 and the subsequent changes in metabolism. Further studies involving MAPK signaling and
CD5 metabolism would be beneficial to validate these conclusions.
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While we did not find a significant pathway that involved fatty acid oxidation, it is
important to note that in CD4+ T cells, we found that many fatty acid metabolites and fatty acid
oxidation metabolic genes are lower in CD5KO mice, suggesting that CD5 may be linked to
decreases in fatty acid oxidation. This is especially interesting given that PD-1 knockout T cells
rely more on fatty acid oxidation [26]. Future studies investigating fatty acid oxidation in CD5KO
CD4+ T cells are necessary to determine the role of fatty acids in Th cells.
Validation of metabolic gene expression revealed that several metabolic genes involved
in glycolysis, the TCA cycle, amino acid metabolism, and metabolite transportation were
upregulated in CD5KO unstimulated Th cells. Of the 21 metabolic genes analyzed, all but four
genes demonstrated at least an average 1.5-fold increase in CD5KO T cells in comparison to
CD5WT T cells. Seven genes involved in glycolysis were validated; however, only one directly
involved in the TCA cycle was validated. Despite this, we saw upregulation in four genes
involved with amino acid metabolism, which confirmed some of our previous metabolomics
results. Of these genes, BCAT1 has also been shown to convert glutamate to α-ketoglutarate [99]
and FAH converts fumaroacetate to fumaric acid [101], indicating that CD5 is linked to
transcriptional regulation of amino acid production needed for the TCA cycle. We also validated
that all significant metabolite transporters were upregulated in CD5KO T cells using qPCR,
indicating that CD5 is also linked to transcriptional regulation of metabolite transporters to
increase the uptake of metabolites. Further confirmation of surface-expressed metabolite
transporters is important for future studies on CD5KO CD4+ T cells.
Metabolic profiling of CD5KO T cells revealed that unstimulated Th cells have an
increased glycolytic rate and increased mitochondrial spare respiratory capacity. CD5KO Th
cells also had a slight increase in glucose uptake, indicating that CD5 is linked to functional
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metabolic changes in Th cells. Increased metabolic regulation has the potential to metabolically
prime the T cell to function better under stressful conditions, such as a nutrient-deprived tumor
microenvironment [109]. However, it is possible that the metabolic differences we have seen may
also be due to activation state or subset polarization in unstimulated CD4+ T cells. We saw a
significant difference in naïve and memory subsets between CD5WT and CD5KO CD4+ T cells.
Previous studies have suggested that the removal of CD5 polarizes CD4+ T cells toward a Treg
phenotype; while we did not see a significant CD4+CD25+ T cell difference between CD5WT
and CD5KO unstimulated T cells, others have seen an increased presence of Tregs among
CD5KO CD4+ T cells [110]. While performing metabolic assays and qPCR illustrated a similar
trend between naïve and unstimulated CD5KO CD4+ T cells, further studies would be necessary
to determine how the removal of CD5 changes for naïve, activated, Treg, and memory subsets.
Due to these T cell metabolic changes, CD5 has the potential to impact health and
disease, such as chronic infection and cancer immunotherapy [111]. Inhibitory signaling
from co-receptors such as PD-1 has been shown to aggravate T cell exhaustion during
infection because of metabolic changes initiated by the co-receptor [112]. CD5 has also been
shown to promote infection by the hepatitis C virus, indicating that the blockade of CD5
may be beneficial in treating certain chronic infections [113]. Inhibitory co-receptors such
as PD-1 and CTLA-4 have become prominent targets for immune checkpoint inhibition in
cancer immunotherapy, allowing for T cells to be activated in cancerous environments [114].
Effects of PD-1 blockade have demonstrated changes in amino acid concentration in T cells,
much like we have demonstrated with the removal of CD5 [92]. Blockade of CD5 also
demonstrated increases in both CD4+ and CD8+ T cell responses to cancer, indicating that
its inhibitory effects can be halted by antibody blockade [44,51]. Together, this evidence
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suggests that CD5 may be a potential immunotherapeutic target for antibody blockade
to increase T cell activation and allow T cells a better metabolic advantage in a glucose-depleted
tumor microenvironment.
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2.6 Supplemental Materials
Supplementary Table 1: qPCR Primers Used for RNA-Sequencing Validation.
Gene

Forward Primer

Reverse Primer

GOT1

TGCTACTGGGATGCGGAGAAGA

TGCATGACAGCAGCGATCTGCT

GOT2

GCGGTTTTGACTTCTCTGGAGC

ACGGACGCTATCTCCTTCCACT

GALM

GAAGGAGTACCACCTGCCAGTT

TGGACGCCATTGGTCAACACCT

ALDOA

CACGAGACACTGTACCAGAAGG

TTGTCTCGCCATTGGTTCCTGC

ALDOC

CACTCAATGCCTGGAGAGGACA

CGCCATCTCCACTGCCTTCATA

TPI1

GGCAACTGGAAGATGAACGGGA CTGGCAAAGTCGATGTAAGCGG

GAPDH

CATCACTGCCACCCAGAAGACTG ATGCCAGTGAGCTTCCCGTTCAG

PGK1

GATGCTTTCCGAGCCTCACTGT
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ACCAGCCTTCTGTGGCAGATTC

PGAM1

CCCCTTCTACAGCAACATCAGC

GCTCTGGCAATAGTGTCCTTCAG

ENO1b

GATTCGCACCTAACATCCTGGAG TTCAGAGGCAGCCACATCCATG

BCAT1

CTGCCTCTGTTTTGCACTACGC

TCCTCACAGCAGATCGGCACAT

SDHB

TGCGGACCTATGGTGTTGGATG

CCAGAGTATTGCCTCCGTTGATG

ALDH7a1 CCTCGTTAGTGTGGCTGTCACA

AAGGACAGCAGGTTCACACGCT

GCG

CCTTCAAGACACAGAGGAGAACC CTGTAGTCGCTGGTGAATGTGC

ASNS

TTACCTGTCTCTGCCGCCAGAT

CACTGAAGGCTTCTTTGGGTCG

GSTT3

CAGGTGCTAGAGGACAAGTTCC

GATTTTGCAGCCAGCACTGACAG

Fah

GTTCAGAGGCAAGGAGAATGCG GGCACCATACACAGGAGGCTTT

SLC25a13 TGGCAACAGGAAAGACGTGGAG CCGCTCAATGTCTGCTAAGGTC
SLC1a4

GAGGGAGAAGACCTCATCCGAT

GTCACCAGCATGACGATGTCCT

SLC5a3

CCTGGTGACAAAGGAGAGCTGT

GGCTGATGACTTCGCTATTCTCG

SLC7a10 TGCTACGGAGTCACTATCCTGG

GCTGAAGACCAGTAGGAATGCC

SLC43a1 TTCCTGTGGAGCCTTGTCACCA

CTCCACCTTCTGTCTCTGCTCA

beta Actin CATTGCTGACAGGATGCAGAAGG TGCTGGAAGGTGGACAGTGAGG
Supplementary Table 2: Metabolic Gene Abbreviations.
Gene Abbreviation
ACLY
ACSF2
ACSS1
ACSS2
ALDOA
ALDOC
ALDH7a1
ASNS
BCAT1
DECR1
ECHDC2
ENO1b
FAH
GALM
GAPDH
GCG
GLDC
GOT1
GOT2
GSTT3

Gene Name
ATP citrate lyase
acyl-CoA synthetase family member 2
acyl-CoA synthetase short-chain family member 1
acyl-CoA synthetase short-chain family member 2
Aldolase A
Aldolase C
aldehyde dehydrogenase family 7, member A1
asparagine synthetase
branched chain aminotransferase 1, cytosolic
2,4-dienoyl CoA reductase 1, mitochondrial
enoyl Coenzyme A hydratase domain containing 2
enolase 1b
fumarylacetoacetate hydrolase
galactose mutarotase
glyceraldehyde-3-phosphate dehydrogenase
Glucagon
glycine decarboxylase
glutamic-oxaloacetic transaminase 1, soluble
glutamatic-oxaloacetic transaminase 2, mitochondrial
glutathione S-transferase, theta 3
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H6PD
HAL
ODC1
PDK1
PDK3
PGAM1
PGK1
PPA1
SCCPDH
SDHB
TPI1

hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
histidine ammonia lyase
ornithine decarboxylase 1
pyruvate dehydrogenase kinase, isoenzyme 1
pyruvate dehydrogenase kinase, isoenzyme 3
phosphoglycerate mutase 1
phosphoglycerate kinase 1
pyrophosphatase (inorganic) 1
saccharopine dehydrogenase
succinate dehydrogenase complex, subunit B
triosephosphate isomerase 1

Supplementary Figure 1. Mitochondrial Mass and Membrane Potential Were Not Significantly
Different Between CD5WT and CD5KO CD4+ Unstimulated T Cells.
(Left) 5x106 CD4+ T cells were stained with MitoTracker Green (Thermofisher) and incubated
for 30 minutes at 4°C (n=6, p-value=0.5168 by paired t test). 50,000 events were recorded using
the BD Accuri flow cytometer. (Right) 5x106 CD4+ T cells were stained with MitoProbe
DilC1(5) (Thermofisher) and incubated for 30 minutes at 4°C (n=6, p-value=0.8387 by paired t
test). 50,000 events were recorded using the BD Accuri flow cytometer. MFI was determined
using the mean as calculated by FlowJo.
Supplementary Table 3: Functional Analysis of RNA-Seq Hits using DAVID.
Pathway

Number of
Gene Hits

p-value

Benjamini

Cell Cycle

29

1.20 x 10-8

4.00 x 10-6

Pathways in cancer

65

7.10 x 10-6

1.10 x 10-3
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DNA Replication

12

1.20 x 10-5

1.30 x 10-3

MAPK signaling pathway

38

1.80 x 10-4

1.40 x 10-2

Inflammatory bowel disease

14

2.10 x 10-4

1.40 x 10-2

Carbon metabolism

20

4.70 x 10-4

2.40 x 10-2

Chemokine signaling pathway

27

5.30 x 10-4

2.40 x 10-2

HIF-1 signaling pathway

19

6.10 x 10-4

2.50 x 10-2

Biosynthesis of amino acids

15

7.60 x 10-4

2.50 x 10-2

PD-L1 expression and PD-1 checkpoint
pathway in cancer

16

7.60 x 10-4

2.50 x 10-2

Progesterone-mediated oocyte maturation

16

1.20 x 10-3

3.40 x 10-2

Cytokine-cytokine receptor interaction

35

1.30 x 10-3

3.40 x 10-2

C-type lectin receptor signaling pathway

18

1.40 x 10-3

3.40 x 10-2

Glycolysis/Gluconeogenesis

13

1.60 x 10-3

3.70 x 10-2

Th17 cell differentiation

17

1.80 x 10-3

3.80 x 10-2

Th1 and Th2 cell differentiation

15

2.20 x 10-3

4.50 x 10-2
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Supplementary Figure 2. Naïve CD5KO CD4+ T cells Demonstrate Somewhat Similar
Metabolic Profiles in Comparison to Unstimulated CD5KO CD4+ T Cells.
(a) The Mito Stress Test (Agilent) was used to measure naïve T cell metabolism between CD4+
CD5WT and CD5KO T cells (n=1). (b) qPCR of 18 metabolic genes compared between naïve
CD5KO CD4+ T cells and naïve CD4+ T cells (n=1). Pale yellow=less than 1.0-fold change,
yellow= 1.0-fold change or higher, pale orange=1.5-fold change or higher, dark orange=2.0-fold
change or higher, red=3.0-fold change or higher.
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Chapter 3: The Role of TCR Avidity and the CD5 Co-Receptor in Helper T Cell Function

Personal contributions to chapter: Conceptualization, data analysis and acquisition, investigation,
writing – original draft preparation, visualization, and funding acquisition.
Abstract
Helper T cells are a vital component of the immune system that are responsible for
regulating immune cell activation and function, such as activating killer T cells or directing B
cells to produce antibodies against cancerous cells. Helper T cells serve an important role, yet the
details about what produces an effective helper T cell response remain unclear. Avidity, defined
as the strength of TCR-mediated binding, primarily determines the quality of T cell activation
through a series of signaling events. Co-receptors, such as CD5, also play an integral part of
helper T cell activation in response to cancer cells, as they can enhance or inhibit T cell
signaling. To understand how avidity and co-receptor CD5 affect helper T cell activation, we
characterized a helper T cell system comprising of two helper T cells, called LLO118 and
LLO56, and their CD5 knockout (CD5KO) counterparts. We tested them against a panel of
altered peptide ligands (APLs) which retain specificity but affect avidity. We preliminarily
characterized the T cell response by measuring signaling proteins, in vitro proliferation, cytokine
production, and in vivo proliferation. Together, these processes can provide valuable insight
about T cell avidity and co-receptor influence in a variety of different settings. Understanding
how TCR signaling affects T cell function has the potential to improve cancer immunotherapies
and vaccine design so T cells can more effectively target and kill cancerous or infected cells.
3.1 Introduction
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Helper T (Th) cells are essential elements of the immune system responsible for
regulating immune cell activation and function, such as directing other immune cells to eliminate
mutated targets [2,84,85]. Specifically, Th cells have been shown to mediate killer T cell function
against cancer cells via cytokine secretion as well as improving regression in cancer patients by
facilitating cytolysis and killer T cell recruitment [86,87,115,116]. Helper T cells serve an
important role, yet the details about what produces an effective helper T cell response remain
unclear. T cell activation requires certain signals; the first signal is mediated by the T cell
receptor (TCR) on the T cell membrane [7,117]. The TCR binds to antigen peptides presented by
antigen-presenting cells (APCs) [118,119]. TCR binding to peptide complexed to the major
histocompatibility complex (pepMHC) upregulates genes involved in activation, proliferation,
migration, and intracellular signaling, thereby generating an effector T cell ready to respond to
infection [89,90,118-121]. The strength of TCR: pepMHC interactions, or avidity, determines T cell
activation and differentiation which influences the outcome of the immune response to infection
[122-125].

A predominant theory in immunology is that stronger avidity produces better T cell
activation [126,127], meaning a better primary response is produced when the pathogen is first
encountered. A solid primary response produced by stronger TCR: pepMHC interactions
consequently enhances memory formation, meaning a better secondary response is produced
when the pathogen is encountered again [128,129]. Recent research, however, contradicts this
model. Two particular studies analyzed TCR: pepMHC interactions in Th cells and cytotoxic T
cells and demonstrated that low avidity interactions could produce memory cells [130,131]. Other
studies have also shown that intermediate TCR avidity was optimal for CD4+ Th and CD8+
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cytotoxic T cell function [130,132]. The contradictory nature of these studies elicits the need to
determine the optimal TCR avidity for Th cell function.
T cell co-receptors also play an important role in T cell signaling and have significant
functional impacts on T cell function. Co-receptors affect TCR: pepMHC avidity by stabilizing
weak interactions and enhancing or dampening its signaling strength to consequently affect the
functional outcomes for the T cell [19,133,134]. Co-receptors, such as CD28, 41BB, or OX40,
have a positive impact on T cell signaling, while other co-receptors such as PD-1 and CTLA-4
negatively regulate T cell signaling [34,40,135]. Together, the effect of the strength of
TCR:pepMHC interactions, co-receptor influence, and other signaling molecules such as IL-2, is
called functional avidity [20]. Shedding light on optimal Th functional avidity will provide
insights for the improvement of vaccines or immunotherapies to produce more beneficial and
prolonged effects in developing and maintaining immunity [116].
We wanted to expand our understanding of how TCR avidity and co-receptor interactions
alter helper Th cell functional avidity by characterizing two helper T cells, called LLO118 and
LLO56, which both recognize a protein, listeriolysin O (LLO190-201), found on Listeria
monocytogenes. These T cells have similar TCRs and TCR affinity; however, they have vastly
different functional responses [136]. In vitro analysis of LLO118 and LLO56 demonstrated similar

responses to L. monocytogenes; however, in vivo analysis demonstrated significantly different
responses: LLO118 responded more robustly to primary antigen exposure, while LLO56
produced a better memory response upon secondary antigen exposure [137,138].
These differing responses could be a result of TCR avidity for the LLO peptide or the
level of expression of CD5 [137]. Previous results obtained by our lab suggest that CD5 may play
a role in calcium signaling, which would affect downstream processes like proliferation [139]. To
test these hypotheses, we used a novel panel of mutant L. monocytogenes whose LLO190-205
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peptides are altered to produce different strengths of T cell activation in vitro. In this chapter, we
will discuss efforts to characterize the functional avidity of LLO118 and LLO56 in the context of
altered peptides and CD5 expression. To do this, we measured proliferation in vitro and in vivo,
as well as measured signaling proteins Nur77 and IκBα, and IL-2 production. Characterization of
this T cell system in these contexts will provide important foundational knowledge to understand
and improve immunotherapy strength and longevity.
3.2 Materials and Methods
Generation of altered peptides and 3H-Thymidine incorporation assay
The LLO peptide was mutated using scanning mutagenesis, which individually
substituted each amino acid for lysine or glutamic acid (if it was already a lysine). Following
mutagenesis, a DP dulling assay was used to determine which altered peptides stimulated
LLO118 and LLO56 T cells [140,141]. S194 and G194 were identified and selected as partial
agonists, and A195 was identified and selected as a control null agonist. LLO118 or LLO56
splenocytes were plated in 96-well plates (1 × 105 cells per well) and rested overnight. The next
day dilutions of peptide or L. monocytogenes were added. In the case of infection, bacteria were
grown to mid log phase at 30 °C in BHI, measured by optimal density (600-nm absorbance), and
washed three times with PBS before infection. Infected cells were washed 3× with PBS at 30
min post-infection and gentamycin (50 μg/mL) was added at 1 h post-infection. Tritiated
thymidine was added to wells 48 h after the addition of peptide or L. monocytogenes and cultures
were harvested and proliferation was assessed 24 h later by the level of tritiated thymidine
incorporation.
Bone marrow-derived Macrophage and T cell isolation and cell culture

54

C57/BL6 mice were used to harvest bone marrow for macrophage differentiation. One
mouse femur and tibia were dissected for each plate. Using a 25G needle, bone marrow was
extracted from the bones using macrophage media consisting of high glucose DMEM (Gibco),
10% fetal bovine serum, 5% horse serum, 20% L cell conditioned media (LCM),1mM sodium
pyruvate, 1.5mM L-glutamine, and 0.5% Pen/Strep. For L cell conditioned media, L929 cells
were cultured in high glucose DMEM (Gibco), 10% fetal bovine serum, 1mM sodium pyruvate,
1.5mM L-glutamine, and 0.5% Pen/Strep for 7 days, then media was harvested and stored at -80
°C before use in macrophage media. Bone marrow was plated using macrophage media into
143cm2 large culture dishes and cultured for 7 days at 37 °C and 5% CO2. Macrophages were
loaded with 2.25nM peptide, 500,000 cells were plated into a 12 well suspension plate and
incubated overnight at 37 °C and 5% CO2.
LLO118, LLO56, CD5KO LLO118, and CD5KO LLO56 were isolated from transgenic
Rag1-/- mice using the CD4+ T cell Isolation Kit (Miltenyi) according to manufacturer’s
instructions. T cells were seeded at a 1:1 ratio with peptide-loaded macrophages in R10 media
consisting of RPMI-1640, 10% fetal bovine serum, 1% Glutamax, and 0.5% gentamicin, and
cultured for 3 days or 7 days. All animal studies were approved by and performed in accordance
with the BYU Institutional Animal Care and Use Committee (protocol numbers 21-0308, 180708, 15-801 and 15-802.
Flow Cytometry
For the CFSE proliferation assay, T cells were incubated with 5µM CFSE for ten minutes
at room temperature, washed three times with 1X PBS and 5% FBS, then resuspended in R10
and seeded into 12-well suspension plates with peptide-loaded macrophages. T cells and
macrophages were incubated for 3 days or 7 days. Cells were harvested and stained with a 1:100

55

dilution of CD45.1 Pe-Cy7 (Invitrogen, clone A20) for LLO118 or CD90.1 APC (eBioscience,
clone HIS51) for LLO56 for 30 minutes at 4 °C. Cells were washed once, then resuspended in a
1:20 dilution of propidium iodide (50µg/mL) and incubated at room temperature for 5 minutes.
20,000-50,000 events were recorded on the BD Accuri C6.
For intracellular staining, once T cells were stained with surface markers (CD45.1 PeCy7, Invitrogen, clone A20, or CD90.1 FITC, Invitrogen, clone HIS51) for 30 minutes at 4 °C,
cells were resuspended in 100µL of Cytofix/Cytoperm (BD) and incubated for 20 minutes at 4
°C with either Nur77 Alexa-Fluor 647 (Invitrogen, clone 12.14) or IκBα APC (Invitrogen, clone
MFRDTRK) at a 1:100 dilution. Cells were then washed and resuspended in 1x Perm/Wash
(BD).
For in vivo proliferation analysis, cells were stained with CD45.1 Pe-Cy7 (Invitrogen,
clone A20), CD90.1 APC (eBioscience, clone HIS51), CD4 APC-eFluor 780 (eBioscience, clone
GK1.5), CD8a FITC (eBioscience, clone 53-6.7), B220/CD45R FITC (eBioscience, clone RA36B2), and CD11lb FITC (eBioscience, clone M1/70). The entire sample was resuspended in
500uL of PBS with 1% bovine serum albumin and 1% paraformaldehyde and run on the Attune
flow cytometer (ThermoFisher).
IL-2 ELISA
100µL of R10 media was removed from cultured T cells and diluted 1:2 in 1X ELISA
buffer. The mouse IL-2 kit (Invivogen) was used according to manufacturer’s instructions. After
reading the plate at 450nM, the 570nM measurement was subtracted. The average reading of the
blank wells was subtracted from each well. Using a standard curve and the dilution factor, the
average IL-2 concentration (pg/mL) was calculated.
In vivo proliferation
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60,000 isolated LLO118 and LLO56 were combined in PBS and retro-orbitally injected
into C57/BL6 mice. The following day, mice were retro-orbitally injected with 100µL of 2x104
CFU/mL of Listeria monocytogenes. 7 days post-infection, mice were euthanized, and spleens
were harvested. Cells were incubated with a 1:100 dilution of CD16/32 (eBioscience, clone 93).
Cells were incubated with 1:100 dilution of biotinylated anti-CD45.1 (eBioscience, clone A20)
and anti-CD90.1 (eBioscience, clone HIS51), then a 1:100 dilution of streptavidin microbeads
(Miltenyi). LLO118 and LLO56 T cells were enriched using an LS column (Miltenyi) according
to the manufacturer's instructions.
Data Analysis
Flow cytometry analysis was performed using FlowJo. Statistical analysis. Graphical
presentation and statistics were determined using Prism.
3.3 Preliminary Results
3.3.1 Summary of Current Findings and Generation of Altered Peptides
To summarize what the current literature has found regarding the functional
characteristics of LLO118 and LLO56 and their CD5KO counterparts, the following table was
constructed (Table 1).
Table 1. Summary of LLO118 and LLO56 Response to L. monocytogenes.

TCR affinity [136]
In vitro proliferation (CSFE) [138]
In vitro calcium signaling [139]
In vitro IL-2 production [136]
In vitro metabolism [102]
In vivo primary expansion [138]
In vivo cell death [138]
In vivo secondary expansion [138]

LLO118

LLO56

+
+
++
+
+++
+++
+
+

+
+
+++
+++
+
+
+++
+++

57

CD5KO
LLO 118
N/A
?
++
?
?
?
?
?

CD5KO
LLO56
N/A
?
+
?
?
?
?
?

In brief, in vitro proliferation and TCR affinity between LLO118 and LLO56 T cells was
similar. TCR affinity measured by surface plasmon resonance revealed similar dissociation
constants, indicating that LLO118 and LLO56 T cell receptors had nearly identical affinities.
Naïve LLO56 T cells have higher calcium signaling and IL-2 production, while day 3 activated
LLO118 T cells had higher calcium signaling [136,138,139]. Naïve LLO118 T cells have higher
basal metabolic rates, glycolytic rate, and spare respiratory capacity in comparison to naïve
LLO56 T cells [102]. In vivo, LLO118 proliferate best upon primary antigen exposure, while
LLO56 T cells have higher cell death during the primary response. However, LLO56 T cells
have better proliferation upon secondary exposure to antigen [138].
To determine whether these differences are TCR-related, we developed a panel of altered
LLO peptides that would act as partial or null agonists for LLO118 and LLO56 Th cells. To do
this, the LLO190-201 peptide was mutated to determine TCR contact and MHC anchor residues
(Figure 12A).

58

Figure 12. Examination of LLO Amino Acid Residues and Selected Altered Peptides.
(a) Amino acids in the LLO190-205 peptide were mutated and analyzed for their ability to stimulate
proliferation in LLO118 and LLO56 T cells. Each amino acid was characterized as a TCR
contact residue (red), an MHC (specifically I-Ab) anchor residue or considered important for
both TCR contact and MHC anchoring (yellow). (b) Three altered peptides, S194, G194, and
A195 were selected for this study. Red amino acid letters indicate the original amino acid in that
position, blue indicates that serine was substituted at position 194, green indicates that glycine
was substituted at position 194, and bolded black indicates that alanine was substituted at
position 195. This data was generated by K. Scott Weber, Stephen Persaud, David Donermeyer,
and Jennifer L. Racz.
Positions 190-192 and 197 were paramount to maintaining both TCR interaction and
peptide anchoring within the MHC. Positions 193, 196, 198, and 201 were important in
sustaining MHC anchoring. Positions 202-205 were crucial for LLO56 binding, so those residues
could not be changed [140]. Given the crucial role of these amino acid residues, it was determined
that positions 194 and 195 could be changed while maintaining LLO specificity.
3.3.2 CD5 Influences LLO118 Proliferation
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To measure proliferation in LLO118 and LLO56 Th cells, 3H-thymidine incorporation
was used to determine their response to the altered peptides. This data (generated by Dr. Scott
Weber (BYU), David Donermeyer (Washington University in St. Louis), and Jennifer L. Racz
(University of Michigan)) illustrates that LLO118 and LLO56 Th cells proliferate differently in
response to the altered peptides (Figure 13). LLO118 Th cells respond equally to the wild type,
S194, and G194 peptides, but have a decreased response to A195. In comparison, LLO56 Th
cells respond best to the wild type peptide, followed by S194 which elicits decreased
proliferation, while G194 and A195 produce minimal proliferation responses.

Figure 13. In vitro Affinity of LLO118 and LLO56 to Mutant L. monocytogenes Strains.
(a-b) LLO118 and LLO56 proliferation against peptide. (c-d) LLO118 and LLO56 proliferation
against L. monocytogenes mutants was measured using 3H-thymidine incorporation. (b) LLO118
affinity to the wild type, S194, and G194 epitopes was similar but wild type still produced the
highest affinity. A195 had the lowest affinity. (c) LLO56 affinity to the wild type epitope was
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strongest, followed by S194, G194, and A195 having the lowest affinity. This data was generated
by K. Scott Weber, David Donermeyer, and Jennifer L. Racz.
To measure proliferation in CD5KO LLO118 and CD5KO LLO56, we used CFSE to
determine if there were differences between their LLO118 and LLO56 counterparts. We found
that there were differences between CD5KO LLO118 and LLO118 T cells (Figure 14).
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Figure 14. LLO118 Th Cells and CD5KO LLO118 Th Cells Proliferate Differently in Response
to Altered Peptides.
(a) LLO118 vs CD5KO LLO118 proliferation on day 3 (left) and day 7 (right). On day 3,
LLO118 Th cells proliferate more than CD5KO LLO118 T cells. By day 7, however,
proliferation levels are not very different. (b) LLO118 Th cell proliferation on day 3 (left) and
day 7 (right). On day 3, all peptides stimulate LLO118 T cells equally except for A195. On day
7, the trend suggests that S194 and G194 peptides may stimulate LLO118 T cells more than the
wild type peptide. (b) CD5KO LLO118 proliferation on day 3 (left) and day 7 (right). On day 3
and day 7, we saw no significant difference in proliferation between all the peptides.
On day 3, LLO118 Th cells were stimulated by the wild type peptide more than CD5KO
LLO118 Th cells (Figure 14A, left). Also on day 3, LLO118 was stimulated equally with each
peptide except A195 (Figure 14B, left), consistent with previously acquired data (Figure 13C).
On day 7, however, little difference is seen between LLO118 and CD5KO LLO118 wild type
proliferation (Figure 14A, right). There is also a trend that suggests the possibility that LLO118
T cells may be stimulated more with the S194 or G194 peptides (Figure 14B, right). In contrast,
there were no significant differences in peptide stimulation of CD5KO LLO118 T cells, and the
level of proliferation is much lower than that of LLO118 T cells (Figure 14C, left). On day 7,
however, proliferation produced by the altered peptides more closely matches what is seen on
day 7 for LLO118 T cells (Figure 14C, right). Together, this suggests that CD5 may act as a
positive regulator for the proliferation of LLO118 T cells during early activation.
3.3.3 IL-2 Production of CD5KO T Cells Matches Proliferation of LLO118 and LLO56 T Cells
To measure IL-2 production from the altered peptides, media was removed at 3 and 7
days after co-culture with peptide-loaded macrophages. Interestingly, when analyzing CD5KO
LLO118 and CD5KO LLO56 IL-2 levels, both day 3 and day 7 profiles matched LLO118 and
LLO56 proliferation trends (Figure 15). For CD5KO LLO118, the wild type, S194, and G194
stimulation is not statistically different, but A195 stimulation is much lower than the other three
peptides. In contrast, CD5KO LLO56 T cells are stimulated along a gradient, with the wild type
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stimulating the most IL-2, followed by S194, then G194 and A195. However, proliferation and
IL-2 production do not match in CD5KO LLO118 T cells, suggesting that CD5 may play a more
important role in LLO118 T cell proliferation than IL-2 production. We also saw that CD5
LLO118 IL-2 production increased over time while CD5KO LLO56 IL-2 production decreased
over time.

Figure 15. IL-2 Production of CD5KO LLO118 and LLO56 T Cells.
(a) Measurement of IL-2 produced by CD5KO LLO118 T cells at day 3 (left, n=3) and day 7
(right, n=2) after co-culture with peptide-loaded macrophages. (b) Measurement of IL-2
produced by CD5KO LLO56 at day 3 (left, n=2) and day 7 (right, n=2) after co-culture with
peptide-loaded macrophages. Controls with macrophages with no peptide and T cells only were
used to account for IL-2 added to R10 media.
3.3.4 Altered Peptides Stimulate LLO118 T Cells More Than Wild Type Peptide in Vivo
Due to having similar responses of LLO118 and LLO56 T cell responses in vitro but
drastically different responses in vivo, we tested mutant Listeria monocytogenes strains in
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C57/BL6 mice with transferred LLO118 and LLO56 T cells. LLO118 T cells proliferated more
than LLO56 T cells upon primary infection with the altered peptides except A195, supporting the
previous finding that wild type peptide produced a higher proliferation response in LLO118 T
cells (Figure 16A) [138]. Interestingly, S194 and G194 peptides stimulated LLO118 T cells more
than the wild type peptide (Figure 16B). However, the in vivo profile of LLO56 (Figure 16C)
matched the in vitro proliferation profile measured by 3H thymidine incorporation (Figure 13C).

Figure 16. In vivo Proliferation of LLO118 and LLO56 T Cells Upon Altered Peptide
Stimulation is Significantly Different.
(a-c) LLO118-Ly5.1 and LLO56-Thy1.1 CD4+ T cells were isolated via negative selection and
6x103 of each T cell type was co-transferred into C57/B6 mice. 2x103 CFU of L. monocytogenes
was administered the following day. LLO118 and LLO56 T cells were collected from C57/B6
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mice 7 days post LM infection then analyzed via flow cytometry for proliferation by measuring
cell count. (a) LLO118 and LLO56 T cell proliferation were directly compared to each other
regarding altered peptide stimulation (n=12). All peptides except A195 produced better
proliferation in LLO118 T cells in comparison to LLO56 T cells. (b) Altered peptide stimulation
in LLO118 T cells showed that partial agonist peptides S194 and G194 produced a better
proliferation response. (c) Altered peptide stimulation in LLO56 T cells showed a gradient of
stimulation, with the wild type and S194 peptide stimulating proliferation the most, followed by
G194 and A195 producing the lowest proliferation.
3.4 Conclusions and Future Directions
This chapter details our preliminary findings in testing LLO118 and LLO56 (and CD5KO
counterpart) T cells against altered peptides. In the following table, we summarize what has been
accomplished with our work and what remains to be elucidated (Table 2)
Table 2. Summary of LLO118 and LLO56 Response to Altered L. monocytogenes.

In vitro
proliferation
(early)
In vitro IL-2
production
(early)
In vivo primary
expansion

In vitro
proliferation
In vitro IL-2
production
(early)
In vivo primary
expansion

WT
+++

LLO118
G194
S194
+++
+++

A195
+

WT
+

CD5KO LLO118
G194
S194
+
+

A195
+

++

?

?

?

+

+

+

+

++

+++

+++

+

?

?

?

?

WT
+++

LLO56
G194
S194
+
++

A195
+

WT
?

CD5KO LLO56
G194
S194
?
?

A195
?

+++

?

?

?

+++

+

++

+

+++

++

++

+

?

?

?

?

We have preliminarily shown that CD5 may play a role in the early activation of LLO118
T cells, as CD5KO LLO118 Th cells have significantly less proliferation on day 3 compared to
LLO118 Th cells. By day 7, however, both CD5KO LLO118 Th cells and LLO118 Th cells are
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proliferating very similarly in response to both wild type and altered peptides. Additional
biological replicates of LLO118 Th cell and CD5KO LLO118 Th cell proliferation at day 7 will
be necessary to conclude how CD5 influences late LLO118 proliferation.
We have preliminarily shown that CD5KO LLO118 and CD5KO LLO56 IL-2 production
illustrates a trend like LLO118 and LLO56 proliferation. We have also demonstrated that
CD5KO LLO56 IL-2 production was lower over time in comparison to CD5KO LLO118 T cells.
Additional biological replicates of this data would be needed to firmly make these conclusions.
Further experiments are necessary to see if IL-2 levels for LLO118 and LLO56 T cells are like
their CD5KO counterparts. We anticipate that LLO56 will have higher IL-2 levels than LLO118
as previously described in [136]. In addition to IL-2 experiments, it would be interesting to do a
panel of different cytokines using a cytometric bead kit to see if altered peptides affect the
differentiation profile of LLO118 or LLO56 T cells as they have a Th1 phenotype [142].
We have also shown that stimulation of LLO118 and LLO56 in vivo against the altered
peptides produced diverging responses in the T cells. As previously demonstrated, LLO118 T
cells proliferated more than LLO56 T cells when stimulated with the wild type peptide [138].
LLO56 T cells were stimulated in a gradient-like fashion very similarly to data seen in the 3Hthymidine incorporation assay (Figure 13C). However, the partial agonist peptides, S194 and
G194, stimulated LLO118 T cells much more in comparison to the wild type peptide. This was
surprising, as much of the literature has described altered peptides stimulate T cells less than the
wild type counterpart [143]. More in vivo studies will be crucial to fully elucidate why this is the
case, including performing experiments that measure proliferation during the memory response
and in CD5KO mouse recipients.

66

We attempted to study calcium signaling with this T cell system and altered peptides. To
do so, we utilized calcium microscopy to measure the 340/380 ratio of Fura-2, which would help
us determine the level of activation produced by each peptide. However, results were
inconsistent and labor-intensive, so we did not pursue this avenue. As calcium signaling is
critically important as a secondary cellular messenger in T cell signaling, it would be useful to
measure it using flow cytometry as outlined in this publication [139].
We also attempted to study intracellular signaling molecules, Nur77 and IκBα, as they
have been shown to indicate T cell signaling strength and have been associated with the coreceptor CD5 [49,93,144]. To do this, we used flow cytometry to measure the intracellular levels
of these signaling molecules. Again, results were inconsistent between samples, so we did not
continue with this method. To better measure these or other signaling proteins, it may be possible
to enrich the T cells using FACs sorting and perform qPCR or PhosphoFlow to determine if there
are true differences in the expression of these proteins [145].
As discussed in the introduction, TCR affinity and avidity are important measurements in
understanding T cell signaling. Tetramer decay and bio-layer interferometry will be used to
directly measure avidity and affinity, respectively, to further explore correlation between
affinity/avidity and functional avidity for CD4+ T cells as both methods have been shown to
accurately measure and detect differences in affinity/avidity by determining how long the TCR
interacts with its peptide [146,147]. Tetramer decay is a well-established technique which allows
us to determine TCR avidity [20]. It has been used to distinguish agonist, weak agonist, and
antagonist ligands [148], which will provide valuable insight for this project.
Bio-layer interferometry is another useful tool that can directly measure dissociation rates. Like
surface plasmon resonance, ligand is immobilized to an optical sensor to which analyte is added;
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analyte-ligand binding is then measured by a refractive index of the solution [149,150]. This
technology allows for affinity measurements to be made in real time, can better detect weak
interactions, as well as minimize the concern of the label interacting or interfering with the
analyte [150].
It would also be useful to measure the metabolism of LLO118 and LLO56 T cells when
stimulated by altered peptides. As TCR signaling and calcium mobilization affect metabolism
and other downstream T cell functions, it would give crucial insights into how altered peptides
affect T cell metabolism [151]. To do this, glycolysis and mitochondrial respiration could be
measured using the Seahorse XFp and associated kits, such as the Mito Stress Test or Glycolysis
Stress Test (Agilent). It would also be useful to measure glucose uptake using 2-NBDG, a
fluorescent glucose analog, to see if stimulation with different peptides promotes or inhibits
glucose uptake.
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Chapter 4: Characterization of Single-Chain Antibodies Specific for Thymidine Kinase 1 for
Cancer Immunotherapeutic Applications

This chapter is a drafted manuscript that reflects what has been completed thus far. The
completed manuscript will be submitted for scientific review soon. Personal contributions to
chapter: first co-author, conceptualization, data analysis and acquisition, investigation, writing –
original draft preparation, visualization, and funding acquisition.
Abstract
Thymidine Kinase 1 (TK1) is an enzyme responsible for the phosphorylation of
thymidine in the DNA salvage pathway. In a cancer patient, TK1 is often upregulated in the
serum and specifically expressed on the surface of cancerous cells. Its’ lack of expression on
normal cells provides a cancer-specific target for cancer immunotherapeutic applications and
diagnostic tools. In this report, we characterized ten unique single-chain antibodies isolated from
a yeast display library for TK1 specificity and analyzed their ability to bind to TK1. These TK1specific antibodies have the potential to produce effective cancer immunotherapies and
diagnostic tools useful in combating cancer.
4.1 Introduction
Antibodies have revolutionized the world of cancer research and accelerated the
development of therapies that trigger the immune system to target disease [52-54]. In recent years,
many antibody-based immunotherapies have emerged as effective candidates for combating
cancer and other diseases due to their refined specificity and ability to target a variety of epitopes
[55-57].

Direct antibody treatments include using antibodies to directly target cancer cells to

initiate antibody-dependent cellular cytotoxicity (ADCC) [152] and activating the immune system
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by using antibodies to block inhibitory domains such as PD-1 and CTLA-4 [153,154]. Modified
immune cells that have chimeric antigen receptors (CARs), a hybrid immunotherapy comprised
of engineered antibody fragments with cell signaling domains, have shown great promise in
efficiently activating patient immune cells against cancer cells [3,155,156]. Together, these
treatments provide the means to precisely target cancer using independent and personalized cellbased systems.
A critical bottleneck for antibody-based therapeutics is the limited number of cancerspecific targets available and identification of specific antibodies for these targets [157,158]. Some
successful cancer targets, such as CD19 on B cell cancers, are also present on healthy cells,
destroying both cancerous and healthy cells alike [159]. These immunotherapies also have
increased risk of major side effects, such as cytokine storm and systemic cytotoxicity, which if
left unchecked, can ultimately result in patient death [58]. Another obstacle for antibody-based
therapeutics is the generation of target-specific antibodies. Antibodies may bind well to the
biomarker of interest, but they can also target healthy cells, resulting in off-target tissue damage
and harmful immune responses against non-cancerous cells [59,60]. Thus, minimizing off-target
antibody-based immunotherapy effects is pivotal to developing safer and more effective
antibody-based cancer therapies.
Thymidine kinase 1 (TK1) is an enzyme involved in DNA synthesis and cell
proliferation. Used in the DNA salvage pathway, TK1 converts thymidine to deoxythymidine 5’monophosphate which is further phosphorylated into the nucleotide thymine [69]. In normal cells,
TK1 becomes elevated during the G1/S phase of the cell cycle and declines through the rest of
the cell cycle [70]. However, in cancer cells or when DNA damage becomes extensive, TK1 is
upregulated once again in the G2 phase [71]. This upregulation leads to protein secretion into the
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serum, so TK1 has been used as a cancer diagnostic and prognostic tool, as elevated levels
indicate the presence of cancer and can predict cancer stage [72]. Recently, TK1 has been shown
to be overexpressed on the surface of many cancers, including acute lymphoblastic leukemia,
Burkitt’s lymphoma, acute promyelocytic leukemia, and T cell leukemia cancer cells [73].
Importantly, TK1 is not expressed on the surface of healthy cells, making it an ideal biomarker
for cancer treatment.
Here, we isolated ten single-chain antibody fragments (scFv) using yeast display that
have shown specificity for TK1. Each scFv was mapped for complimentarity-determining
regions (CDRs) and compared them to determine similarities and differences between the amino
acid sequences of the CDRs. Each scFv was bioinformatically modeled and determined to bind
to certain areas of TK1. We also validated the binding of each scFv to TK1 using the yeast
display system. We are currently working on producing scFv-Fc fusion antibodies to analyze
binding to TK1+ cells and cytotoxicity when co-cultured with PBMCs isolated from human
blood.
4.2 Materials and Methods
Yeast culture and display
The scFv yeast library was cultured, induced, sorted, and analyzed according to the Yeast
Display scFv Antibody Library User’s Manual (Pacific Northwest National Laboratory,
Richland, WA). Briefly, two frozen aliquots containing 1x109 yeast were incubated overnight in
SD-CAA media at 30 °C on a shaker. Upon reaching 10x coverage of the library (1x1010 yeast),
the yeast culture was pelleted and washed once in wash buffer (1X PBS, 0.5% BSA, 2mM
EDTA), then resuspended in 500mL of SG-CAA media at 0.5 OD600/mL in 2L flasks. Cells were
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induced at 20 °C overnight on a shaker. Cells were washed once in wash buffer (1X PBS, 0.5%
BSA, and 2mM EDTA) before MACs or FACs sorting.
Individual clones were cultured in 5 mL of SD-CAA in a culture tube with dual position
caps (VWR) overnight at 30 °C on a shaker. Cultures were washed once in wash buffer, then
resuspended in 1-5mL of SG-CAA at 0.5 OD600/mL and induced at 30 °C. Cells were washed
once with wash buffer before staining for flow cytometry.
MACs and FACs sorting
For MACs sorting, TK1 (produced in E. coli) was incubated with biotinylated anti-His
Tag antibody (Invitrogen) for 40 minutes on ice, followed by incubation with streptavidin
microbeads (Miltenyi). Induced yeast displaying the scFv were co-cultured with 25µg of labeled
TK1 for 30 minutes at room temperature, followed by 10 minutes on ice. After incubation, yeast
and TK1 were washed three times, then resuspended in 50mL of wash buffer. The samples were
run on LS columns (Miltenyi) and isolated from the column according to manufacturer’s
instructions. After the first round of selection, cells were grown and induced as previously stated,
followed by another round of selection as described above, except for using anti-biotin
microbeads (Miltenyi) with TK1.
After the second round of MACs sorting, fluorescence-activated cell sorting (FACs) was
performed. After yeast and TK1 protein were incubated for 30 minutes at room temperature
followed by 10 minutes on ice, TK1 was incubated with biotin anti-His and yeast were stained
with 1:250 dilution of anti-c-myc antibody (Invitrogen, clone 9E10) for 40 minutes on ice. This
was followed with secondary staining with streptavidin-PE (Life Technologies) and goat antimouse IgG Alexa Fluor 488 H+L (Life Technologies) for 30 minutes on ice. Samples were
acquired on the BD FACSDiva™ and at least 100,000 events were sorted into 100µL of YPD.
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Yeast were gated on TK1 and c-myc expression and sorted based on fluorescence intensity of
these two markers into three categories: the top 5%, the top 1%, and the top 0.1%. Fractions of
the sorted yeast were cultured in YPD for one hour before being centrifuged and resuspended in
3mL of SDCAA for incubation at 30 °C overnight, 250rpm. The next day, another round of
FACs sorting was performed as described previously, except the secondary antibodies used were
streptavidin APC (Life Technologies) and goat anti-mouse IgG PE (Life Technologies).
Fingerprinting, PCR, and Sequencing
Before plasmid isolation, cultured yeast were treated using the following protocol:
samples were centrifuged and resuspended in 50µL of SD-CAA media. Cells were frozen at -20
°C for a period of 30 minutes. Samples were thawed at room temperature, then 10µL of 1M TrisHCl (pH 7.5) and 10µL of Lyticase (5 units/µL, Sigma) were added. Samples were incubated for
30-60 minutes at 37 °C, 250rpm. 20µL of 10% SDS was added, and samples were vortexed for 1
minute. Samples were frozen again at -20 °C for 30 minutes, then allowed to thaw at room
temperature. At this point, yeast plasmid was isolated using the ZR Plasmid Miniprep – Classic
(Zymo Research) according to manufacturer’s instructions.
To determine clone uniqueness, 1µL of yeast plasmid was digested with 10 units of
BstN1 (NEB) at 60 °C overnight. Samples were run on a 0.8% agarose gel stained with SYBR
Safe DNA Gel Stain (ThermoFisher) at 225 volts for 30 minutes and visualized. Unique clones
were amplified using the Q5 High Fidelity polymerase (NEB) and the following primers: pNL6
Forward, 5’ – GTACGAGCTAAAAGTACAGTG – 3’, pNL6 Reverse, 5’ –
TAGATACCCATACGACGTTC – 3’. The PCR conditions were as follows: 95 °C for 5
minutes, 35 cycles 95 °C for 30 seconds, 50 °C for 30 seconds, 72 °C for 45 seconds, followed
by 72 °C for 5 minutes, then stored at 4 °C. Samples were purified using ExoSAP-IT™ and sent
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to Eton Biosciences (San Diego) for sequencing. Geneious was used to map all constructs and
review sequencing data.
Bioinformatic scFv folding prediction, CDR prediction, and binding modeling analysis
scFv structural predictions were made using AlphaFold v2.0 monomer modeling without
amber relaxation due to computational restraints preventing otherwise completion [160]. Fasta
files containing the amino acid sequence for each scFv were submitted as input. Five ranked
output models were docked to TK1 monomer using the HDOCK server
(http://hdock.phys.hust.edu.cn/) [161]. AlphaFold v2.0 predicted structures with predicted
complimentarity-determining regions (CDRs) were used as input for the ligand while TK1
monomer structure obtained from [160,162] was used as the receptor ligand input on the HDOCK
server. To determine the CDRs of each scFv, both heavy and light chain amino acid sequences
were submitted to Parapred (https://www-cohsoftware.ch.cam.ac.uk/) [163]. Parapred recognized
three individual CDRs per chain (each including two additional residues on each side of the
CDR) and provided the binding probability of each amino acid to TK1. These CDR sequences
were utilized as input to improve docking predictions between the scFv and TK1.
Binding residue predictions were generated from the top 10 predictions for each docked
output. Amino acid residues identified to be within 5 A° of the docked scFv amino acid were
listed together in a frequency list. Frequency lists were combined from all five ranked AlphaFold
v2.0 docking scenarios that each yielded 10 top models from HDOCK. These lists were
combined, and the frequencies of each amino acid residue considered to be bound were
presented using Pymol (The PyMOL Molecular Graphics System, Version 2.0 Schrödinger,
LLC). The predicted binding site is displayed using Pymol plugin show_contacts.py to visualize
likely polar contacts between the scFv and TK1 monomer.
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Flow cytometry
Validation of individual clone binding to TK1 utilized fluorescent labeling of both HA
and c-myc expressed tags. Labeled yeast that had not been incubated with TK1 were used as
controls. Two sets of antibodies were alternatively used for validation: biotin-HA (Biolegend)
with streptavidin-PE (Life Technologies) and anti c-myc with anti-mouse IgG Alexa Fluor 488,
or anti-His FITC (Biolegend) and unconjugated c-myc with anti-mouse IgG PE. Primary
unconjugated antibodies were incubated at a 1:100 dilution with TK1 protein (Origene) in wash
buffer for 30 minutes at room temperature. Samples were gently mixed every 5 minutes. Each
sample was then incubated on ice for ten minutes, followed by centrifugation. Samples were
washed 1-2 times with wash buffer, then stained with a 1:200 dilution of secondary or
conjugated antibodies at 4 °C for 30 minutes. TK1 protein was labeled with a 1:200 dilution of
anti-FLAG APC at this time. Samples were pelleted and washed before being run on the BD
Accuri C6. 50,000 events were recorded, then analyzed using FlowJo.
4.3 Results
4.3.1 Isolation of Ten Unique scFv Clones That Bind to TK1
To isolate scFv antibodies specific for TK1, we utilized a yeast library (graciously donated by
the Dan Wittrup lab at MIT) with a diversity of 109 scFv antibodies (Figure 17A). The yeast
library utilized the pNL6 expression system to induce scFv expression on the AGA1/AGA2
complex of the yeast cell membrane under a galactose promoter. Each scFv was flanked by an
HA tag and a c-myc tag.
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Figure 17. Workflow Representation for Isolation of TK1-Specific scFv Antibodies From a
Yeast Display Library.
Using a yeast display library with 1 x 109 diversity of scFv antibodies, labeled TK1 was
incubated with yeast displaying the scFv on the Aga1/Aga2 complex. Two rounds of magnetic
selection were performed. (b) Fluorescence-activated cell sorting (FACS) was used to identify
the best potential binders and BstN1 was used to identify unique clones.
His-tagged TK1 labeled with streptavidin was incubated with the yeast library and sorted
for TK1 binding using a magnetic column. After two rounds of magnetic selection, yeast clones
and TK1 were labeled with fluorescent antibodies and clones specific for TK1 were sorted using
fluorescence-activated cell sorting (FACS) (Figure 17B). Clones were sorted into different
categories based on TK1 binding and c-myc expression: the top 0.1%, the top 1%, and the top
5%. Using fingerprinting with the BstN1 restriction enzyme, we were able to detect one unique
scFv clone from the top 0.1% and nine unique scFv clones from the top 1%. These ten clones
were sequenced and were comparatively different (Figure 18).
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Figure 18. scFv Sequences and Amino Acid Alignment.
Parapred was used to find the CDRs for the (a) heavy chain and (b) light chain. Each CDR is
highlighted in a different color font (orange=heavy CDR1, pink=heavy CDR2, red=heavy
CDR3, light blue=light CDR1, blue=light CDR2, and green=light CDR3). (c-d) CDRs were
manually aligned based on similarities to each other and grouped accordingly. Each letter
surrounded by a black box illustrates an amino acid that is unique among all ten clones.
Using Parapred, an antibody paratope prediction tool, we identified the CDRs for both
the heavy and light chain of each scFv (Figure 18A-18B). Parapred recognized three individual
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CDRs per chain (each including two additional residues on each side of the CDR). CDR
sequences were manually aligned to identify amino acid similarities (Figure 18C-18D). The
heavy chain CDRs between Clones D and W were identical, and Clones C and K were closely
matched. Clones B and E had the highest variance within the heavy chain CDR sequences.
Clones W and L had identical CDR1 light chain sequences, and Clones D and E had similar
CDR1 light chain regions. Clones I and K had the most diverse amino acid sequence within the
light chain CDR sequences. Except for the few identical CDR sequences in Clones D, L, and W,
nearly all other CDRs had at least two amino acids or more that were different in comparison to
each other. Given this data, we found that each scFv had distinct heavy/light chain combinations,
providing us with ten unique scFv antibodies to test for TK1 specificity. In using Parapred to
map the CDRs, the program also provides a probability score for each amino acid in the CDR to
bind to its cognate antigen, suggesting that residues within the CDR of each scFv will likely bind
to TK1 (Supplementary Figure 3).
4.3.2 Binding Predictions Indicate scFv Binding to TK1
To predict binding of the scFv clones to TK1, we created 3D models using AlphaFold
v2.0 and utilized both Parapred CDR prediction and AlphaFold v2.0 structural predictions to
dock the clones to TK1 using HDOCK (Figure 19A-19B). These binding predictions reveal a
preference of the isolated clones to bind to an alpha helix located along amino acid residues 30 to
49 with preference for residues 35, 36, 39, 40, 42, 43, 46, and 47. These are present on the
internal facing side of the alpha helix. Additionally, though with less binding preference than the
alpha helix noted, there is a beta sheet with high preference for amino acids 145 to 153 as well as
amino acids 158 to 160. The most frequently bound amino acid was the arginine located at
residue 39. Docking scenarios that are prominently bound to ARG39 are stabilized with binding
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along the beta sheet (Figure 19C). Upon further analysis, the consensus among these 10 clones
was to bind internally to the TK1 tetramer. Individual clone analysis revealed that Clone D,
followed by WHEELZ and Clone W, had more frequent binding on the external surface of TK1
tetramer (Figure 19D). TK1 monomeric and dimeric forms are associated with the cell
membranes in cancer cells whereas TK1 tetrameric form is found more frequently in the serum
in cancer [73]. Due to the locational differences of TK1 multimeric forms, clones that bind
internally may be more useful for binding to TK1 near the surface of cells while clones that show
the possibility of binding externally may be more useful for binding tetrameric TK1. These
results are still only predictive and require full validation to identify the binding regions.
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Figure 19. Bioinformatic Profiling of the scFv Constructs to Determine Binding to TK1.
(a) The workflow pipeline. The sequence of each scFv was folded using the AlphaFold program
and CDRs were mapped into the structure as predicted by Parapred. HDOCK was then used to
predict the binding of each scFv to TK1 (b) Schematic demonstration illustrating how each scFv
was modeled in PyMol using the structural (left) or surface (right) models. (c) Binding consensus
across all ten clones on the TK1 monomer (left), TK1 dimer (right), and TK1 tetramer (right).
Warmer color indicates more frequent binding to that area of TK1. (d-e) Binding modeling of the
clone WHEELZ to TK1. (d) Binding to the structural monomer model (far left), surface
monomer model (left), surface dimer model (right), and surface tetramer model (far right). (e)
Full-interaction of WHEELZ and TK1 in structural modeling (left) and where WHEELZ binds to
TK1 (two views, right).
4.3.3 Binding Validation to TK1 Protein
To validate binding of each clone to TK1, we utilized the pNL6 expression vector to
surface-express the scFvs in yeast and incubated them with FLAG-tagged TK1. Both the HA tag
and c-myc tag were labeled with anti-HA and anti-c-myc antibodies and TK1 was labeled with
anti-FLAG APC. Clones were gated on HA and c-myc tags to validate full expression of the
scFv. Using flow cytometry, we determined that each clone bound to TK1 in various degrees
(Figure 20A). At 100nM, our top 0.1% clone, named WHEELZ, had the greatest binding to TK1,
followed by Clone C, Clone V, and Clone E. Their affinity was determined using a dilution
series of TK1 and KD was calculated using the geometric mean fluorescence intensity (MFI)
using linear and semi-logarithmic fit (Figure 20B). According to linear fit, WHEELZ bound the
best to TK1 with an approximate KD of 0.34nM. Clone C, Clone V, and Clone E were estimated
to have a binding affinity between 4-8 KD, indicating that the best binders to TK1 exhibited a
nanomolar range of affinity. However, using semi-logarithmic fit, KD is approximated around 12µM, which is drastically different from using a linear fit, suggesting there may be non-specific
or multivalent binding occurring with our scFvs.
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Figure 20. Validation of Clone Binding and Affinity to TK1.
(a) A representative flow cytometry output measuring each clone’s ability to bind to TK1 at
100nM concentration (n=3). The geometric mean fluorescence intensity (MFI) was used to
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determine the best binders to TK1. (b) WHEELZ, Clone C, Clone E, and Clone V were
measured for their affinity to TK1. Using a gradient concentration of TK1, KD was determined
using Prism. Each clone (except C) was analyzed three different times, with the replicate that had
the best R2 displayed in the figure. The first affinity measurement is based on linear fit, while the
second affinity measurement is based on semi-log fit.
4.4 Conclusions and Future Directions
Thymidine kinase 1 (TK1) is a unique cancer biomarker as it is exclusively present on the
surface of cancer cells. Using yeast display, we were able to isolate and validate ten unique scFvs
that can bind to TK1. We found that clones C, D, and W had the most similar heavy chain CDR
regions, while clones D, E, L, and W had similar light chain CDR regions. Clones B, E, I, and K
had the most amino acid diversity among their CDRs overall. In our bioinformatic modeling of
scFv binding to TK1, it appears that the vast majority of our scFv constructs may preferentially
bind to an alpha helix on the TK1 monomer. Some clones, such as WHEELZ, were shown to
have some binding areas on a beta sheet that is more exposed on the dimeric and tetrameric
forms of TK1. Evidence suggests that the monomeric and dimeric forms of TK1 are presented on
the cancer cell surface, indicating that these scFv constructs will most likely bind to those forms
found on the cell surface [73].
We validated the binding of each scFv to human TK1 protein using flow cytometry. At
100nM concentration of TK1, each clone displayed some affinity for TK1. Of the ten clones,
WHEELZ had the most binding to TK1, followed by clones C, E, and V having high binding to
TK1. Estimating the KD using flow cytometry demonstrated that all four clones likely bind with
a nanomolar affinity to TK1. To determine the KD of each clone more precisely, utilization of
surface plasmon resonance or biolayer interferometry would be valuable in determining how
tightly each clone binds to TK1.
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To further validate scFv binding to TK1, we began cloning each scFv into the pFusehIgG1-Fc2 plasmid (InvivoGen) to add a constant domain to each scFv. To do so, we used NotIHF, NcoI, and EcoRV (New England BioLabs) restriction sites to insert the scFv in front of the
IgG1 constant domain. We were able to build scFv-Fc constructs with WHEELZ and Clones C,
D, E, I, V, and W. Clones inserted into pFuse-hIgG1-Fc2 were transfected into 100,000 CHO-K1
cells (ATCC) in 12-well plates. The transfection employed 2ul of the X-tremeGENE™ HP DNA
Transfection Reagent (Roche) and 3µg of plasmid per well. CHO-K1 cells were cultured with
transfection reagent in Ham's F-12K (Kaighn's) Medium (Gibco) supplemented with 10% FBS
and 500µg/mL Zeocin (InvivoGen) for 4 days at 37 °C and 5% CO2. Media was then changed to
CDM4CHO serum-free media (Cytivia) supplemented with 20% Cell Boost 4 (Cytivia),
500µg/mL Zeocin, and 1X protease inhibitor (ApexBio). Cells were cultured for 48-96 hours in
serum-free media which was harvested for antibody purification.
Antibody purification will be performed using the MagINDEX™ rProtein A Magnetic
Agarose according to the manufacturer’s instructions. After purification, Amicon Ultra 0.5mL
Centrifugal Filter Units (Millipore Sigma) will be used to concentrate the antibody by
centrifugation at 2000×g for 30 minutes at 4 °C. The Pierce™ BCA Protein Assay (Thermo
Scientific) will be used to quantify antibody concentration and antibody presence will be
confirmed via Coomassie-stained polyacrylamide gel. Once antibody presence has been
confirmed, we will test the scFv-Fc constructs for binding to TK1 using a dot blot assay. TK1
will be blotted onto a nitrocellulose membrane and incubated with the scFv-Fc, followed by an
anti-human IgG antibody conjugated to HRP. Dot blots will be developed on film to visualize
binding of the scFv-Fcs to TK1.
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Further validation of scFv-Fc binding to TK1 will include using flow cytometry to
analyze scFv-Fc binding to TK1+ cancer cell lines. Cancer cell lines used in this study will
include NCI-H460 (ATCC© HTB-177™), HT-29, and A549 (ATCC® CCL-185™) cell lines, all
of which express high levels of TK1. We will use an antibody-dependent cytotoxicity (ADCC)
assay to determine how well each scFv-Fc facilitates cancer cell death. To do this, human
PBMCs will be isolated from human blood using lymphocyte separation media and co-cultured
with the cancer cell lines described previously. scFv-Fc will be added and allowed to incubate
with the cells for 8 hours and 24 hours. After incubation, the WST-1 assay will be used to
measure cell viability.
If these scFvs have difficulty binding to surface-expressed TK1, the scFvs could be
shortened into a single-domain antibody format (sdAb) that would only utilize the heavy chain of
the scFv. A previous study using sdAb formats has proven successful in binding to and killing
TK1, so this could be a viable avenue to purse. Additionally, the scFvs could be modified using
site-directed mutagenic PCR to insert specific point mutations that may increase their binding to
other areas of TK1 or increase their binding affinity.
One complication that may arise with targeting TK1 as a biomarker is its presence in
patient serum. As TK1 levels become more elevated in a patient, it is possible that CARmodified immune cells may bind to the tetrameric form present in the serum and become
activated [164]. Too strong of a response from CAR-modified immune cells has been shown to
produce potentially life-threatening conditions such as cytokine storm during patient treatment
[165]. Based

on bioinformatic modeling, we demonstrated that our scFv constructs primarily bind

to the inside of the TK1 tetramer and are not predicted to bind well to the outside of the tetramer.
If CAR-modified immune cell binding to serum TK1 does pose a risk in the future, our scFv
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constructs may preferentially target surface-expressed monomeric or dimeric TK1 rather than
tetrameric serum TK1.
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Supplementary Figure 3. Parapred Prediction of Amino Acid Binding Probability for Each scFv
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Using Parapred, an online antibody paratope prediction tool, each amino acid in the CDR of each
scFv was given a probability value based on how likely each amino acid would bind to the
protein of interest. These values were used to create a heatmap illustrating where in the CDR the
scFv is most likely to bind to TK1.
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Abstract
Since the completion of the Human Genome Project in 2003, genomic sequencing has
become a prominent tool used by diverse disciplines in modern science. In the past 20 years, the
cost of genomic sequencing has decreased exponentially, making it affordable and accessible.
Bioinformatic and biological studies have produced significant scientific breakthroughs using the
wealth of genomic information now available. Alongside the scientific benefit of genomics,
companies offer direct-to-consumer genetic testing which provide health, trait, and ancestry
information to the public. A key area that must be addressed is education about what conclusions
can be made from this genomic information and integrating genomic education with foundational
genetic principles already taught in academic settings. The promise of personal genomics
providing disease treatment is exciting, but many challenges remain to validate genomic
predictions and diagnostic correlations. Ethical and societal concerns must also be addressed
regarding how personal genomic information is used. This genomics revolution provides a
powerful opportunity to educate students, clinicians, and the public on scientific and ethical
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issues in a personal way to increase learning. In this review, we discuss the influence of personal
genomics in society and focus on the importance and benefits of genomics education in the
classroom, clinics, and the public and explore the potential consequences of personal genomic
education.
5.1 Introduction
Genomics has become a central pillar driving modern scientific research and discovery.
Beginning with the Human Genome Project that was initiated in 1990 and completed in 2003,
the study of genomics has rapidly evolved in the last 30 years. Today, it is possible to rapidly
sequence an organism’s genome and determine critical insights into many areas including health,
ancestry, and traits [166]. The vast amount of genomic information obtained over the last decade
has provided crucial insights into various health issues, which have significantly improved
diagnosis and treatment for many diseases [74]. For example, personal genomics data is now used
to distinguish different cancers, such as Burkitt’s lymphoma and diffuse B-cell lymphoma, and
enables prediction of cancer sensitivity to drugs and treatment selection [167]. Additionally,
genomics data has been used in the clinic to help monitor the likelihood of graft rejection by
measuring gene expression in peripheral lymphocytes [168]. Important advancements in
genomics have expanded to other organisms, such as bacteriophages which are currently being
characterized and developed for agricultural treatments such as fire blight [76]. The use of
genomics to characterize bacteriophages allows their genomes to be analyzed for bacterial
specificity and to identify genes that may be beneficial or harmful in targeting specific bacterial
populations [169]. In addition, genomics has played a key role in ushering in new fields of
research such as the microbiome, providing many important basic science insights as well as
potential treatments for many diseases [170]. For example, patients with Clostridium difficile
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infection have significantly benefited from microbiome transplants from healthy donors, thereby
providing an effective treatment for a highly morbid infection [75]. Genomics provides
information regarding the healthy donor’s microbiome profile for healthcare providers to know
the characteristics and composition of the transplant bacterial community [171]. These rapid
advancements have been enabled by the arrival of next-generation sequencing in 2006, which
inspired a technological wave of new methods and applications that have revolutionized DNA
sequencing [166]. With many high-throughput sequencing methods now readily available, the
cost and time to obtain genomic data has decreased significantly. The Human Genome Project
took 13 years and cost $95,263,072, whereas today some companies charge less than $1000 to
sequence your entire genome in 24 hours [77].
Despite the exciting technical advances in genomics, many societal, ethical, and scientific
concerns remain. The significant decrease in cost has made genomic sequencing more accessible
to businesses outside of academic and clinical research, leading to the development of direct-toconsumer genomic profiling [78]. Some studies have shown that direct-to-consumer genomic
profiling has been beneficial in identifying and preventing disease [79]. However, many health
care professionals remain concerned about direct-to-consumer genomic profiling, as results may
lack clinical validity, can be misinterpreted by patients, and can psychologically impact some
patients’ well-being [78,80,81]. For these reasons, genetic counselors are trained to interpret
results and provide education to patients to help them make informed healthcare decisions, yet
many people are unlikely to utilize genetic counselors and opt to interpret their results on their
own or see a physician instead [172]. However, many healthcare professionals that are not
specialized in genomics, such as primary care physicians, feel unprepared to answer patient
questions about their genomic profile [173-175]. This rapidly moving field is uncovering societal
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challenges in how to properly incorporate and utilize genomics as a part of our understanding of
health and disease and medical practice.
The dramatic increase of public interest for genomic profiling from 29% to 37% between
2008 to 2011 also presents potential ethical issues [82]. The Genetic Information
Nondiscrimination Act of 2008 (GINA) prevents employment and health insurance
discrimination based on genetic information; however, ethical and privacy concerns remain,
primarily regarding data access [80]. Recently, law enforcement and public attention has focused
on using genealogical genomic profiling to find relatives and ancestors via direct-to-consumer
genetic testing [176]. Famously, the Golden State Killer was recently apprehended after police
used genomic information obtained through GEDmatch, a genealogy company, to trace the killer
through familial genomic profiling [177]. Currently, the Federal Bureau of Investigation is
addressing guidelines for using genealogy, stating that investigations only utilize this source of
information if CODIS reveals no matches and only using public databases which inform the
users of this possible forensic use [178]. More recently, the Pentagon advised all military
personnel against direct-to-consumer genetic testing [179]. The GINA does not apply to military
personnel, therefore, the discovery of unknown genetic markers or inaccurate results which
affect military physical requirements could jeopardize the member’s service, as well as
potentially affect military security through exposure of genetic information [180]. While personal
genomics is a valuable tool for police to identify and locate suspects, it raises privacy concerns
for the public and military and requires public discussion and education about the use of genomic
information [83].
As genomics remains an emerging discipline, much work still needs to be accomplished
for the genomic therapeutic potential of precision medicine to be fully realized. Most genome-
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wide association studies (GWAS) have data from subjects of European descent, limiting the
interpretation of and increasing uncertainty of disease risk for non-European subjects [181].
Cancer biomarkers such as BRCA1/2 are significant indicators of breast cancer; however, many
BRCA1/2 mutations and unknown genetic variants are poorly defined, making disease risk
uncertain and disease assessment and diagnosis complicated [74,182]. Unfortunately, these
complications in data interpretation create considerable issues, such as significant risk of
misdiagnosis, psychological impacts on patient and relatives, unnecessary medical procedures,
and decreased confidence in proper diagnosis and treatment [183]. Consequently, a lack of
genomic understanding regarding how to interpret genomic test results is an important need for
genomic education about what can and cannot be concluded from personal genomic information.
As genomics is a critical branch of genetics, it is equally important that a concrete understanding
of genetics preludes and accompanies genomic education. Beyond its potential in ancestry
identification, law enforcement, and health care, this personal genomics revolution provides a
powerful opportunity to educate students, clinicians, and the public on relevant scientific and
ethical issues. Effective genomic education enables healthcare professionals, students, and the
general public to understand the benefits of genomic discoveries with important applications in
ancestry, health, traits, and forensics [184-186]. In this review, we discuss recent literature on
personal genomics education in academic, professional, and public settings and examine the
benefits for enhanced student learning in the classroom and potential consequences of personal
genomic education.
5.2 Academic Genomics Education
5.2.1 High School Education
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High school is one of the earliest academic institutions where students are introduced to
genomics. As genomic information becomes more common, it is imperative that molecular and
genomics education begin early to not only provide background to future health professionals,
but to familiarize all citizens with the limits and possibilities of genomic information in
healthcare and beyond [187]. Genomic education in high school is also important because high
school biology is frequently not only the initial, but also the final formal exposure to genomics
for many Americans [188]. Many high school students have the interest, maturity, and
intelligence to learn and understand genomics, yet few studies involving high school students
and genomic education have been conducted in the past five years (Table 3) [189-199].
Table 3. Publications in the Last Five Years on High School Students and Genomics Education.
Paper Title
Mining the Genome: Using
Bioinformatics Tools in the
Classroom to Support
Student Discovery of
Genes [194]
*Introducing high school
students to the Gene
Ontology
classification system [192]
*Spitting for Science:
Danish High School
Students Commit to a
Large-Scale Self-Reported
Genetic Study [190]
*Using Next-Generation
Sequencing to Explore
Genetics and Race in the
High School Classroom

Year
2018

Learning model
Key Finding(s)
NCBI and Microscope
Development of effective
(MaGe) to map genomes class design

2018

Database of Annotation,
Visualization, and
Integrated Discovery
(DAVID)
Student DNA collection
to present genomics

Prepared students for future
Material enjoyable

2017

Next-generation
sequencing and analysis
by students

Learning gains, especially
for lower testing students
Engaged student interest

*Exploring the Effects of
Active Learning on High
School Students’
Outcomes and Teachers’
Perceptions of
Biotechnology and

2015

Apple Genomics Project
Active vs. passive
learning environment

Active learning had more
positive
Increase in knowledge
No difference in interest

[199]

2016

93

No need for costly class
Positive media coverage

Genetics Instruction [195]
*Teaching the Genome
Generation: Bringing
Modern Human Genetics
into the Classroom
Through Teacher
Professional Development
[193]

Teaching the Big Ideas of
Biology with Operon
Models [197]

2018

Education of teachers
via TtGG program

Teacher ability increased
More teaching confidence

2015

Bacterial operons

Learn complex systems and
abstract thinking
Application to other
academic areas
Critical thinking developed
toward media

*Frame Analysis in
2014 Information framing
Science Education: A
techniques
Classroom Activity for
Promoting Media Literacy
and Learning about
Genetic Causation [191]
*Knowledge of, and
2016 Assessment before and
Positive attitudes developed
Attitudes towards Healthafter genomics
Easy model implementation
Related Biotechnology
education
and student assessment
Applications amongst
Australian Year 10 High
School Students [198]
* indicates studies which surveyed student learning.
Each of these studies incorporated teaching genomic principles to high school students.
Of the nine studies identified, three utilized genomic online tools to teach concepts [192,194,199].
Many of the tools utilized in these studies, such as the NCBI database and next generation
sequencing, are critical for genomic studies in college. Utilizing these technologies in high
school classrooms can facilitate interest in and preparation for careers focused on genomics [189].
One interesting study utilized media representation of genomics to teach students to think
critically of media portrayal and framing of science topics [198]. With media being readily
available, it is essential for students to develop critical thinking and reasoning skills so they can
identify misconceptions in the media regarding science topics [200]. Teaching genomics to high
school students can also help public perception and understanding [190]. Athanasiadis and
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colleagues held an educational symposium for students and teachers across Denmark which
garnered positive media attention as the symposium was extensively broadcast on primetime
news and published online. These studies demonstrate the importance and influence of media in
teaching genomics.
Of the nine studies described in Table 3, seven studies surveyed student learning
(indicated by asterisk next to paper title in Table 3). Of the seven studies, six of the studies
demonstrated that student knowledge and interest increased as the model was implemented,
indicating these learning models have the potential to improve genomics education. Students felt
that learning genomics helped prepare them for future academic study [192] and created a more
positive learning experience [195]. Thus, these publications indicate that incorporation of
genomic education can be beneficial for high school student learning [190,195,198].
It is also important to recognize the need for teacher education and curriculum
development specific for this new field of genomics. Without training and updated curriculum,
teachers can be uncomfortable or hesitant to implement new teaching techniques. Programs such
as Teaching the Genome Generation (TtGG) are enabling teachers to become more confident in
genomic education as the programs teaches them hands-on laboratory skills that they can use to
teach students real-life case scenarios [193]. It is interesting to note that teaching style can also
impact learning experiences [195]. A recent study identified the importance of assessing student
knowledge and tailoring lessons based on student knowledge gaps in order to positively deepen
student knowledge and attitudes towards genomic information [198]. By helping to open
educational doors for teachers, they can be better prepared and equipped to engage their students
in learning genomic principles. Programs like TtGG can also provide collaboration opportunities
for teachers to discuss and potentially improve genomic curriculum [193]. A recent study found
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that of 11 selected textbooks, 73.8% of the genomic content only discussed classic single gene
diseases, such as sickle cell anemia, indicating that many high school textbooks likely need
updating to include multifactorial or complex conditions such as cancer or diabetes [188].
Understanding that many common diseases are controlled by numerous factors, including
genetics and the environment, could be pivotal for preparing students with knowledge needed for
a future filled with genomic applications [188]. Thus, these studies indicate that not only teaching
genomics to high school students is important but educating teachers and modernizing
curriculum is also vital to facilitate student learning.
5.2.2 Undergraduate and Graduate Education
Teaching undergraduate and graduate students is another key academic focal point of
genomic education. Over the last twenty years, studies involving genomic education of college
students has steadily increased (Figure 21). Of the 99 personal genomics studies we identified in
the past 19 years, nearly half of the studies were published in the last four years, indicating that
genomic education is being implemented at an increased rate in the college setting. Interestingly,
many studies performed earlier in the decade focused on teaching upper-level junior and senior
life science majors [201,202], but more recently introductory biology courses have begun to
incorporate genomics into their class curriculum [203,204].
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Figure 21. Number of College Genomic Education Publications Since 2000.Ninety-nine studies
from 2000 to 2019 were surveyed. Of the 99 published studies, 4 were published between 2000
and 2004, 11 were published between 2005 and 2009, 33 were published between 2010 and
2014, and 55 were published in the last five years (2015 to present).
College genomic education is also targeting a variety of student majors (Figure 22).
Many of the studies we surveyed did not specify their class’s major composition or the class
composition spanned multiple disciplines [205]; however, 32 of the studies focused on the
genomic education of life sciences majors, primarily focusing on biology and biochemistry
majors [206,207]. It is immensely important that genomics education be emphasized for life
science majors, as many of them will pursue healthcare careers and play an important role in
disseminating genomic information to their patients [208]. Surprisingly, only a few studies
focused specifically on non-science majors. It is possible that studies we surveyed that did not
specify their class target audience or composition had an impact on non-science majors taking
the class. Educating non-science majors in genomics will be an important avenue to educate
students who do not specialize in a science major and prepare them to understand and recognize
the importance and influence of genomics in society [209].
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Figure 22. Targeted or Reported College Student Major Composition of Undergraduate or
Graduate Classes.
Of the 99 personal genomics studies we surveyed, we analyzed the target student audience or the
reported class major composition. We found that 44 of the studies spanned multiple majors or
did not specify their target student audience, 32 of the studies were focused on life science
students, 15 on nursing students, 2 on pre-medicine students, 3 on non-science majors, and 4 on
other disciplines.
Remarkably, 15 of the studies were focused on examining genomic education for nursing
students. According to many studies, there is an increasing need for nursing students to be
educated in genomics as their knowledge of and attitude toward genomics is poor, and many do
not feel prepared to use genomics in the clinic [210-212]. Nurses are also crucial healthcare
providers that, alongside physicians, are part of the frontline in providing genomic education to
patients [213]. Studies have shown that providing genomic courses for nursing students improves
student confidence and genomic literacy [214,215]. Nurses are a critical part of the healthcare
workforce, and therefore it is important for nursing classes to incorporate genomics into their
curriculum [214].
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Of the studies surveyed, there were notable learning models and resources that have been
successfully used to teach college-level genomics, particularly to life sciences majors. Coursebased undergraduate research experiences (CUREs) are a major method of undergraduate
genomic education [216]. CUREs are designed to provide learning and hands-on research
experience to undergraduate students [217]. In surveying the literature, three studies about
genomic CUREs stood out. Olson et al. published a genomic CURE designed to screen gene
expression in Drosophila [218]. With over 250 co-authors, this study demonstrated significant
success in involving a large introductory class size in research-based genomic learning. This
study also positively impacted student learning and significantly increased the number of
undergraduate students that continued to pursue a STEM degree. Reeves et al. studied the
conservation of the methionine pathway in yeast to teach genomics to students in a CURE-based
setting [207]. Five semesters of teaching this course revealed that many students significantly
increased their knowledge base and research skills. Importantly, underrepresented minority
students had larger knowledge gains than other groups, indicating a positive movement toward
cultivating successful professionals to bring diversity to their field [219]. Bhatt and Challa
designed an introductory course which taught genomic principles through hands-on experience
with CRISPR-Cas9, which has become one of the most important genome-editing tools in
modern science [220]. The study utilized zebrafish to analyze genetic mutations with their
corresponding phenotype and allowed students to design and test CRISPR-Cas9 templates in
order to disrupt certain zebrafish genes. Additionally, this CURE demonstrated student
knowledge increases, and students also reported that they gained transferrable skills and insights
applicable outside of the CURE. Given these observations, CUREs are a vital educational means
for teaching genomics to college students.
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One of the most widespread CURE programs is the Genomics Education Partnership
(GEP). The GEP consists of over one hundred universities who are collaborating to bring
genomic learning to their classrooms through research-based methods. Students who participate
in GEP projects actively learn how to perform genome annotation of Drosophila and produce
gene profiles of specific portions of different Drosophila genes [221]. Students who have worked
on GEP projects have reported increased knowledge gains and value their learning experience
and contribution to science [222]. GEP projects are also very accessible to most universities as
only computers are needed and are versatile since projects can be short and be accomplished by
many students in comparison to a typical research-based class [221]. These studies have
demonstrated that GEP is a valuable teaching resource for undergraduate genomic education
[222].

Science Education Alliance Phage Hunters Advancing Genomics and Evolutionary
Science (SEA-PHAGES), also called Phage Hunters, is another CURE program which has been
instrumental in teaching undergraduates about genomics [223]. Phage Hunters was designed to be
a year-long course for beginning undergraduates where bacteriophages are isolated from soil
samples, sequenced, and characterized the following semester for putative gene function [224].
Seventy-three universities have implemented beginning courses of Phage Hunters and have
demonstrated that Phage Hunters increases student learning, interest, and pursuit of academic
education in STEM majors [204,224,225]. Some universities have modified the Phage Hunters
course so that the second semester of gene characterization is included into other biology classes
and have demonstrated equal academic value and success [204]. In addition to the benefits of
student learning, students often become authors on scientific publications of bacteriophage
characterization, thereby improving their academic portfolio as well [169]. These studies
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demonstrate that Phage Hunters is a valuable CURE which can be implemented in large
undergraduate classes and be advantageous for teaching genomics.
A valuable way to teach genomics to college students and significantly improve interest
and engagement is to personalize the data they are analyzing. We highlight two genomics
education studies performed at Brigham Young University. The first study examined the effects
of giving students personal genomics kits and found that just the anticipation of getting personal
data in the future improved student learning and interest in their related course material as
compared with students who were analyzing genomics data from an unidentified individual [202].
Students who were going to receive personal genomic results spent more time studying for their
lecture-based molecular biology, genomics, or immunology courses, which increased their
confidence to interpret the results they would receive as well as better understand the risks and
benefits of using direct-to-consumer genetic testing. The second study examined the effects of
giving students microbiome kits and found that students who analyzed their personal microbiome
were more engaged in learning and had a more positive attitude towards the class as a whole as
compared with students analyzing microbiome data from an unidentified individual [201].
Students who analyzed their own microbiome data also reported they visited more websites and
sources to learn about the microbiome, indicating that receiving personal microbiome kits
increased their interest in learning. Additionally, students who received microbiome kits felt the
course was more applicable to them than those who analyzed microbiome data from an
unidentified individual. While these studies did not directly involve students performing research
like in CUREs, it is important to note that students analyzing personal genomics or microbiome
data spent more time studying the topic and their interest increased in comparison to control
groups who only received data from an unidentified individual [201,202]. These studies indicate
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that providing genomics data that is personal to you is a valuable tool for increasing student
interest and engagement and educating undergraduate and graduate students in genomics topics.
5.2.3 Medical School Education
Genomics is becoming an integral part of medicine and physicians must be prepared to
understand and communicate complex genomic information to patients and the public in a
simple and accurate manner [226]. This critical need for genomics in medical school has already
been incorporated into many medical student training programs [227]. The Association of
Professors of Human and Medical Genetics has developed a core curriculum for medical
students, which focuses on understanding genomic variance, disease phenotype, genomic
technologies, and direct-to-consumer testing [227]. Despite this, there has been debate about the
most effective educational models with which to teach genomics to medical students [6]. Use of
personal genomics in medical school has had mixed results. One study found that student interest
did not increase and that many students did not think personal genomics was useful [228]. In
contrast, another study found that genomics enhanced learning and provided a positive learning
experience [229]. Interestingly, the difference between these two studies was the addition of
personal genomic testing to the genomics course. Students who did personal genomic testing had
significantly higher test scores and self-reported that their conceptual knowledge in genomics
had significantly increased [229]. These studies suggest that including personal genomics testing
into medical school classrooms may be beneficial in increasing student knowledge and interest
about genomics.
The Anatomy to Genomics (ATG) Start Genetics medical school initiative is another
promising method for teaching medical students about genomics [230]. The ATG initiative
incorporates first-year anatomy with genomics to teach students about genomic sequencing
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application and strengthen their understanding in anatomy. As part of the initial study at Lewis
Katz School of Medicine at Temple University, DNA samples were taken from the liver, skin,
cardiac, and skeletal tissue. Seven different cadavers were dissected, DNA samples were
analyzed, and students were asked to research single nucleotide polymorphisms (SNPs) (Figure
23). This ATG program allowed students to draw conclusions about the cadaver’s traits and
disease phenotype regarding its genomic profile. Another group performed a similar study on a
cadaver who had been diagnosed with idiopathic pulmonary fibrosis [231]. Interestingly, the
genomic characterization of the cadaver revealed that the individual could have died from
nonspecific interstitial pneumonia rather than idiopathic pulmonary fibrosis as had been
suspected by the attending physician. The students found that the cadaver had a SNP
(rs35705950) in the promotor region of the mucin glycoprotein MUC5B, which is associated
with risk of developing idiopathic pulmonary fibrosis, but the SNP had never been linked to
nonspecific interstitial pneumonia. These findings confirm that the SNP in MUC5B promotor is
related to the development of lung disease and that the cadaver was genetically predisposed to
lung disease. Together, these studies demonstrate that a combined anatomy and genomics
approach is advantageous to student learning and furthering clinical research.
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Figure 23. Workflow of First-Year Medical Anatomy Lab and Genomics.Cadavers are dissected
by students and traits about the cadaver are observed and recorded. DNA samples are isolated
from various organs, including the heart and liver. Samples are sequenced and professors assign
SNPs to different student groups who characterize the SNPs and associate them with cadaver
traits. The students present their research in a 15-minute PowerPoint presentation [230].
5.2.4 Education for Genetic Counseling Students
The need for genetic counselors has never been more important with the rise of genomic
technologies and healthcare services available to the public [232]. There has been a significant
increase in demand for genetic counselors due to the genomics revolution; however, lack of
funding, counseling supervision, and training slots has created a nationwide shortage of genetic
counselors [233]. Genetic counseling programs are designed to educate students to fill a
professional role in providing genomic-related medical advice to patients and medical
practitioners [234]. With specialized training and certification, it is extremely important that upto-date genomics and counseling education be emphasized in genetic counseling training
programs [235]. Genetic counseling instructors were surveyed about the incorporation of
genomics into genetic counseling training and found that the majority felt genomics was
important to include and that most topics were currently included or being established [236].
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Some institutions such as Stanford University are focusing on experiential learning
utilizing “rotations” for genetic counseling students to teach variant interpretation using a casebased system [237]. Three distinct “rotations” were created, focusing on different settings of
genetic counselors, i.e., clinical, research, or laboratory-based rotations. Students reported that
these rotations were particularly useful in preparing them for their chosen discipline. Another
study conducted at the University of North Carolina at Greensboro and Duke University found
that teaching clinical application of genomics testing should be emphasized [235]. Students in this
study reported that while genomics testing curriculum prepared them to pass the ABGC board
exam, 50% of students felt unprepared to fill the role of providing genomic testing interpretation
on a clinical scale. These studies emphasize the need to analyze genetic counseling student
training and perhaps incorporate more access to clinical or hands-on experiences to improve
genetic counselor preparation [235,237].
5.3 Genomics Education for Clinical Professionals and the Public
Advancements in genomic education on the academic level have rapidly expanded over
the past decade; however, educating healthcare professionals that are currently practicing and the
public is equally critical and must be addressed [238]. Current health professionals need to be
educated as they administer developing genomic technologies in the healthcare industry as they
may have been trained before the genomics era, and the public needs to be educated as the
influence of genomics is becoming more personal and frequent [205,239]. Here we will discuss
recent strategies and challenges in the education of practicing nurses, practicing physicians, and
the public.
5.3.1 Nurse Genomic Education
Nurses are a pivotal part of the healthcare workforce in implementing genomics into
everyday patient care as they lead changes in healthcare and ethical practices and interact
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frequently with patients [240]. However, many nurses lack understanding of genomic principles,
resulting in healthcare deficits that can be improved through genomic technologies [241].
Eighteen countries were recently surveyed on existing genomic education and three countries
(United Kingdom, Japan, and the United States) have genomics integrated into nursing student
classes and competencies, but only Israel requires all practicing nurses to take a mandatory 28 h
course in order to remain certified to practice [213]. Other studies have measured genomic
competence, knowledge, and attitudes and found that genomic integration into nursing practice is
currently lacking, but education programs improved competency [242]. These studies indicate
genomic competency desperately needs to be incorporated into continued nursing education.
Nursing professionals have begun developing initiatives to address genomic educational
needs. In 2012, the Genomic Nursing State of the Science Initiative established a blueprint to
improve genomic nursing education through development of infrastructure and research to guide
genomic healthcare [241]. More recently, the Global Genomics Nursing Alliance (G2NA) was
established in 2017 to focus genomic education and advancement in the general nursing
population [213]. Their efforts focus on improving teaching resource accessibility and increasing
collaboration between nurses around the world [240]. These efforts mark the beginning of
increasing genomic competency throughout the nursing profession.
5.3.2 Genomic Education for Practicing Physicians
Physicians are often the first healthcare professional with whom patients want to discuss
genetic test results; however, many practicing physicians who have not been trained in genomics
in medical school do not feel prepared to use or interpret genetic test results [243,244]. It has been
shown that physicians are more likely to utilize genomic technologies if they have institutional
guidelines, patient interest, and clinical validity, but most importantly the knowledge and
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confidence needed to successfully administer tests and understand results [245]. In response to
this need for genomic education for physicians, many options have become available to begin
filling gaps in physician knowledge. Two major organizations have been formed to support
genomic education for physicians, The Inter-Society Coordinating Committee for Practitioner
Education in Genomics (ISCC-PEG) and the Genetics in Primary Care Institute (GPCI).
The ISCC-PEG was formed in 2013 and designed to be a collaborative network in which
physicians can address educational gaps to subsequently improve genomic knowledge and
increase the use of genomics in practice [246]. The ISCC-PEG also provided a framework with
which physicians can use to critically analyze genomic competency called “entrustable
professional activities” or EPAs (Figure 24). Each EPA outlines principles which can guide the
physician’s learning so they can understand genomics and execute these principles [247]. These
principles can provide a critical foundation of genomics knowledge for physicians to utilize
genomic technologies. The GCPI was established in 2011 as an electronic resource aimed at
increasing genomic education and knowledge among physicians [227]. The website provides
webinars on various genomics topics and resources for educating physicians. Together, these two
organizations provide significant resources to aid physician genomic education and incorporation
of genomic technologies into mainstream medicine.
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Figure 24. Five “Entrustable Professional Activities” or EPAs.
These EPAs are necessary for physician instrumentation of genomics in the medical field and
areas of focus for analyzing physician genomic competency adapted from [246]. These EPAs
include family history, genomic testing, somatic genomics, and microbial genomics which all
play a vital role in improving patient treatment.
Outside of these two organizations, other resources and models for physician genomic
education are available. A recent study revealed that active learning modules used in training
physicians not only improved genomic knowledge and confidence, but also increased retention
of principles and subsequent changes in physician practice [248]. Educators in this study also
utilized principles of backward design to identify gaps in genomic knowledge and structured the
training to test genomic competency in those areas, which helped improve the educational
outcomes [249]. Aside from in-person training, many other resources sites, data repositories,
interprofessional education, and even emails are being used to disseminate genomic information
to physicians, indicating that incorporation of genomic education into medical practice is
becoming a reality [250,251].
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5.3.3 Public Education
The public is perhaps one of the most difficult demographics to educate about genomics
due to varying backgrounds, learning capacities, and attitudes about science [205]. However,
educating the public about genomics is critical because genomics is becoming more mainstream
and affects their personal lives; therefore, they need genomics education in order to make
educated decisions about healthcare for themselves and their families [234,252]. Currently, many
obstacles make educating the public about genomics challenging, including the media and
educational infrastructure [205].
There are many websites dedicated to providing foundational genomic understanding,
such as Genetic Alliance, Scitable, and the PHG Foundation [253]. The media can be a useful tool
for researching genomics; however, like many other science topics, the internet also provides
misleading or unhelpful information [191]. Often, people find information about genomics
through news headlines, which presents a dilemma primarily centered on journalism [200]. News
journalists are trained to write very differently from scientists as they generate engaging
headlines or article introductions that often lack the context needed to accurately understand the
genomic issue at hand [253]. Additionally, the audience may not finish reading or only skim
through the article, which can perpetuate confusion and misconceptions about genomic studies
[254].

To combat this challenge, more training of science policy in journalism is needed to

provide thorough coverage and discussion about scientific topics, thereby providing more
complete information to the public [255].
Educational infrastructure is another main concern of public genomic education. In a
recent study, genomic researchers and advisors were interviewed about educating the public and
found that much debate revolves around who is responsible for teaching the public about
genomics, who the target audience is, and how the subject should be approached [205]. This study
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also revealed that there is a need for some entity to lead and centralize public genomic education,
as well as develop an educational framework with which to educate the public. If a centralized
organization can address these challenges, public genomic education can become more effective
and beneficially help the public make decisions about their healthcare regarding genomics.
5.4 Benefits, Challenges, and Potential Strategies of Genomic Education
In this review, we have discussed genomic education on academic, professional, and
public platforms. There are substantial benefits and challenges in implementing genomic
education in all these areas (Table 4).
Table 4. Benefits and Challenges in Incorporating Genomic Education Into Academic,
Professional, and Public Settings.
Benefits of Genomic Education
Improves knowledge, interest, and engagement
Creates positive learning that can be scaled to
many
Drives and strengthens genomic research
Allows personal investment to drive learning
Increases retainment of STEM college majors and
enhances career skills and capabilities
Develops confidence in knowledge of and
communication skills about genomics

Challenges of Genomic Education
Gap in knowledge among healthcare
professionals
Cost, time commitment, competing
priorities
Complexity of subject material
Misconceptions from media
Genomic science still developing, making
implementation challenging
Lack of infrastructure or resources for
professional development

As previously described, there are many benefits that genomics brings to educating
students at any academic level. Numerous studies support the finding that genomic education
facilitates student interest and develops student confidence [206,256]. Genomic education can also
foster research ideas that increase our understanding about genomics and recruit more students to
study science and prepare for scientific careers [192,231]. Studies have also shown that genomics
can be scaled to teach many students and still provide meaningful learning experiences [204]. It is
also important to note that the personal aspect of genomics can improve interest and engagement
of learning by increasing personal investment in the learning material [201,202]. However, some
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challenges and barriers remain that must be addressed (Table 2). Cost and time commitments are
often a challenge in providing meaningful genomic education experiences [233]. Healthcare
professionals often have gaps in genomic knowledge, which can be neglected due to competing
priorities and time constraints [245]. Lack of educational foundation and limited resources can
hinder genomic education in different sectors [205]. Genomics complexity and misconceptions
perpetuated by society or the media can compound genomic education in the public space [253].
Most importantly, genomics is rapidly expanding with new information being learned each day.
Thus, it is critical to improve genomic education at the academic, professional, and public
platforms to reach as many people as possible and to realize the benefits of genomics discoveries
in understanding our ancestry, health, and traits (Figure 25) [184-186].
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Figure 25. Summary of the Importance of and Needs for Genomic Education Across Various
Academic, Professional, and Public Platforms. Despite the benefits and challenges of genomic
education, it is critically important that educational dissemination and teaching strategies be
addressed. Many educational approaches have been presented in this review, and here we
summarize some educational guidelines which have been shown to improve genomic learning
across various platforms as well as propose suggestions to address genomic education obstacles
(Table 5).
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Table 5. Strategies and Suggestions for Genomics Education in Academia, Professional, and
Public Settings.
Educational
Platform
High School

Strategies and Suggestions
•
•
•

Undergraduate
and Graduate
School

•

Medical School

•

•

•
Genetic
Counseling
Program

•

Professional
Development

•

Public Education

•

•

•

•

Incorporate basic principles of genomics into genetics or general
biology lectures using tools such as The Apple Genomics Project
or Genomic Analogy Model for Educators (GAME) [195].
Incorporate current genomics technology and tools, such as NCBI
[194].
Provide active learning environment through online modules or
lab-based exercises with limited teacher leading [195].
Provide personal learning experiences by incorporating personal
genomic data and analysis into the classroom [201,202].
Incorporate research-based learning experiences through CUREs
such as the GEP or SEA-PHAGES [221-223].
Integrate genomics into genetics, anatomy, or other medical
courses [230].
Institutions could require applying students to take genomics or
related course before admission
Create clinical, laboratory, or research-based rotations and handson experience [235,237].
Promote funding from external or internal sources to create and
provide training slots and training supervision [233].
Use backward design to fill in knowledge gaps of practicing
physicians and nurses [249].
Provide materials in easily accessible formats such as online
modules or emailing options [250,251].
To address lack of infrastructure and overarching entity, form an
organization like Global Genomics Nursing Alliance (G2NA) run
by a Science Education Division of the National Institute or other
governmental entity to promote public genomic education [213].
This government agency could require that direct-to-consumer
companies provide online educational modules to increase public
education

Many of these strategies and suggestions can easily be applied across multiple platforms;
for example, many academic platforms can incorporate personal learning experiences by having
students acquire and analyze their own genomic data [201,202]. Hands-on learning experiences
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that utilize genomic research are also a useful tool that can be utilized for many platforms
[193,223,231].

Backward education design is also a helpful education strategy to fill in existing

gaps in genomic knowledge and enhance retention and learning [249]. Many easily accessible
online tools, such as the Apple Genomic Project or the Genomic Analogy Model for Educators
(GAME), are of valuable educational benefit in designing genomic educational strategies [195].
Together, this demonstrates that there are many educational tools and strategies that can enhance
and promote learning of genomic principles.
We also have a few suggestions that educators, companies, and governments could utilize
to promote genomic education. We recommend that the incorporation of genomics education be
included in basic biology classes at the high school and college level in connection with human
and medical genetics, since genomics is dependent upon a strong genetic understanding [188]. In
regard to medical, graduate, and genetic counseling education, we suggest that educational
institutions consider requiring applying students to have taken a genomics-focused or genomicsrelated course in order to provide a foundational genomic knowledge for incoming students.
Genetic counseling programs currently struggle with providing training slots and supervision;
therefore, we suggest that funding from either external or internal sources be considered to
alleviate the strain on genetic counseling educators [233]. Physicians and healthcare professionals
have competing interests and time constraints, so we suggest that genomic education material
become more readily accessible through online formats such as email or computer-based
modules in order to facilitate continuing genomic education for practicing healthcare providers
[250,251].

Education for the public requires the most extensive efforts in providing accessible and

pertinent genomic information [205]. As many people have suggested the need for public
infrastructure and leadership over genomic education, we suggest that a public organization such
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as the Global Genomics Nursing Alliance (G2NA) be organized by a government entity such as
the Science Education Division of the National Institute of Health to fill these educational gaps
[213].

We also suggest that, with the increased use of direct-to-consumer genetic testing, these

companies be required to provide online educational modules to increase public genomic
education and improve public healthcare decisions [252]. In conclusion, these suggestions should
provide avenues for multiple platforms for integrating and strengthening genomic education at
academic and non-academic levels.
5.5 Conclusions
Effective genomics education is vital to advance our understanding of the rapidly
developing field of genomics that influences our understanding of health, ancestry, and traits.
Despite the challenges and barriers in implementing genomic education, there are vast benefits
for academic, professional, and public education (Figure 25). Effective genomic education would
not only advance genomic research, but also provide enhanced learning experiences, knowledge,
and confidence for students. It is also evident that genomic education of teachers, physicians, and
health care professionals should be a priority as it improves their knowledge, confidence, and
ability to help communicate critical genomic information simply and accurately to students,
patients, and the public. As genomics becomes more widespread and commonplace in society,
genomics education becomes increasingly vital for genomic technologies to be utilized
appropriately.
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Chapter 6: Concluding Remarks and Future Directions
The work presented in this dissertation summarizes our research efforts to characterize
the function of the CD5 co-receptor, effects of altered peptides on Th cell function, selection of
TK1-specific antibodies, and benefits of genomic education. In this final chapter, we will briefly
summarize our conclusions and address future directions for each of these research objectives.
6.1 The CD5 Co-Receptor
CD5 is a T cell co-receptor that negatively regulates T cell activation during T cell
development in the thymus. Belonging to the group B scavenger-receptor cysteine-rich (SRCR)
superfamily, CD5 associates with the TCR/CD3 complex and modulates TCR signaling strength
[41,42,46,47].

CD5-deficient T cells and anti-CD5 antibodies have been shown to increase T cell

proliferation, cytokine production, activation-induced cell death (AICD), and modulate calcium
mobilization and NF-κB signaling [39,42,51,93]. Given how T cell signaling and metabolism are
intricately connected, we hypothesized that the negative regulation of CD5 alters T cell
metabolism, and its removal would increase metabolic activity. To understand if the CD5 coreceptor plays a role in Th cell metabolism, we measured metabolite concentration in CD5KO
Th cells and mouse serum, metabolic gene expression, and metabolic profiles of CD5WT and
CD5KO Th cells. We also bioinformatically analyzed metabolic pathways potentially regulated
by CD5. Our results suggested that unstimulated CD5KO Th cells have significantly different
metabolic profiles. Several metabolites and metabolic genes are upregulated in unstimulated
CD5KO Th cells, and both glycolysis and mitochondrial respiration are also upregulated. We
found that this may be phenotypically linked to activation status, as more memory T cells were
present in the unstimulated CD5KO Th cell population in comparison to naïve Th cells.
To address how CD5 regulates metabolism, there are some key findings from our
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research that are worth pursuing to further elucidate the exact mechanisms of the CD5 coreceptor on Th metabolism. In analyzing T cell and serum metabolomics, we found 17
metabolites that were differentially regulated in both T cell and CD5KO mouse serum. These
results suggest that CD5KO Th cells take up more of certain metabolites and utilize them for
metabolic function [92]. These results suggest that removal of CD5 may mediate changes in the
serum metabolome via Th cell metabolism. However, we cannot firmly conclude this as our
CD5KO mouse model is completely devoid of CD5 expression, and given that other immune
cells, such as B1 B cells and dendritic cells, also normally express CD5. This necessitates further
examination in establishing the cause of CD5KO mouse serum changes. Further studies
involving a T cell-specific CD5KO mouse or adoptive T cell transfer into T cell-deficient mice
would provide further insight in determining if this phenotype is T cell-dependent.
When we performed bioinformatic pathway analysis using our RNA-Seq data, we found
16 significant pathways that may be affected by the loss of CD5. Specifically, we saw an
increase of glucose-6-phosphate and an increase in the transcription of galactose mutarotase
(GALM). This enzyme one of the enzymes responsible for converting galactose for glucose,
suggesting that CD5 may be linked to galactose usage in CD4+ T cells. No other enzymes in the
galactose-to-glucose pathway were upregulated, suggesting the need to validate whether
galactose is being utilized rather than glucose in the absence of CD5. This could be
accomplished by measuring Th cell metabolism in the presence of galactose rather than glucose
to validate whether the increased presence of glucose-6-phosphate is due to increased galactose
conversion. We also had a significant hit for the aminoacyl-tRNA biosynthesis pathway.
Evidence has suggested that codon bias exists in naïve and activated T cells [257]. Given our
evidence that suggests a higher number of CD5KO T cells have a memory-like phenotype and
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increased amino acids involved in tRNA synthesis, we suggest that future studies include using
tRNA-Seq to determine if there is codon bias due to activation status or CD5 removal.
While we primarily focused on three metabolic pathways in our bioinformatic analysis,
we also noticed that the MAPK pathway was significantly involved in CD5KO Th cells.
Previous studies have shown that there may be a connection between CD5 and the
PI3K/AKT/mTOR pathway [108], and our study also suggests this. Expression of MAPK was
upregulated (FC 0.34, FDR 0.0456), as well as CDK1 (FC 1.26, FDR 0.0389), CDK6 (FC 0.96,
FDR 0.0493), CDC28 protein kinase subunit 1b (FC 0.83, FDR 0.0411), hormonally upregulated
Neu-associated kinase (FC 3.42, FDR 0.0116), JAK3 (FC 0.63, FDR 0.0225), KSR1 (FC 0.84,
FDR 0.0421), and Nek2 (FC 1.35, FDR 0.0158). These genes are associated with regulating T
cell signaling and function[258-263]. PASK, a metabolic regulator, had a higher fold change in
CD5KO T cells (FC 1.03, FDR 0.0645) [264]. We also found that PKC (protein kinase C) and
CamK (calmodulin-dependent kinase) were upregulated in CD5KO CD4+ T cells (data not
shown). PKC affects calcium signaling, which plays a role in regulating metabolism, suggesting
that the loss of CD5 may be linked to increased metabolism through calcium modulation. CamK
indirectly affects the transcription of other genes, such as GAPDH, PGK1, ALDOA, which we
found were also upregulated. Given that these genes are involved in glycolysis, this suggests that
the increase of CamK transcription may be linked to the loss of CD5 and the subsequent changes
in metabolism. Further studies involving MAPK signaling and CD5 metabolism would be
beneficial to validate these conclusions. This could be accomplished by using PhosphoFlow to
measure expression of MAPK pathway kinases to determine kinase involvement in CD5
expression. Silencing or knocking out these genes in CD5KO Th cells and measuring their
metabolic profile to analyze their effects on Th cell metabolism in the absence of CD5.
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While we did not find a significant pathway that involved fatty acid oxidation, it is
important to note that in CD4+ T cells, we found that many fatty acid metabolites and fatty acid
oxidation metabolic genes are lower in CD5KO mice, suggesting that CD5 may be linked to
decreases in fatty acid oxidation. Investigating fatty acid oxidation in CD5KO Th cells could be
accomplished by using the Seahorse XF Palmitate Oxidation Stress Test Kit (Agilent) and
expression of fatty acid transporters such as the FATP family to determine the role of fatty acids
in Th cells [265]. Confirmation of surface-expressed transporters that were previously validated
using qPCR is also important in future studies on CD5KO Th cells.
Metabolic profiling of CD5KO T cells revealed that unstimulated Th cells have an
increased glycolytic rate and increased mitochondrial spare respiratory capacity. CD5KO Th
cells also had a slight increase in glucose uptake, indicating that CD5 is linked to functional
metabolic changes in Th cells. However, it is possible that the metabolic differences we have
seen may also be due to activation state or subset polarization in unstimulated CD4+ T cells. We
saw a significant difference in naïve and memory subsets between CD5WT and CD5KO CD4+ T
cells. Previous studies have suggested that the removal of CD5 polarizes CD4+ T cells toward a
Treg phenotype; while we did not see a significant CD4+CD25+ T cell difference between
CD5WT and CD5KO unstimulated T cells, others have seen an increased presence of Tregs
among CD5KO CD4+ T cells [110]. While performing metabolic assays and qPCR illustrated a
similar trend between naïve and unstimulated CD5KO CD4+ T cells, further studies would be
necessary to determine how the removal of CD5 changes for naïve, activated, Treg, and memory
subsets. This could be accomplished using specific T cell subset isolation kits or FACs sorting to
selectively measure metabolism in these T cell groups.
Although not discussed in our published manuscript about T cell metabolism and the
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CD5 co-receptor, we have also been studying the microbiome and behavior of CD5KO mice. It
has been demonstrated that removal of PD-1 alters T cell metabolism, which results in systemic
consequences that result in altered animal behavior [26,92]. We have observed that CD5KO mice
appear to be more anxious or aggressive in comparison to C57/Bl6 mice (unpublished data,
[266]).

Attempts to reproduce these results achieved mixed results, suggesting that several factors

may play a role in regulating CD5KO mouse behavior. One factor that may be involved is the
gut microbiome. Studies have shown that changes in the gut microbiome can elicit changes in
behavior, as well as modulate immune system function [267,268]. Previous work also
demonstrated significant differences in the microbiome of CD5WT and CD5KO mice [266]. This
makes studying the microbiome in CD5KO mice in conjunction with behavioral analysis critical
to understanding the systemic effects of CD5 removal.
To analyze the effects of CD5 removal on behavior and the microbiome, four cohorts of
CD5WT and CD5KO mice will be required: 10 male mice of each group for initial analysis, 10
male mice of each group to test amino acid enhanced diet, 10 male mice of each group to test
microbiome changes through fecal exchange, and 10 male mice of each group to test changes
upon antibiotic treatment that eliminates the gut microbiota. Mice should be housed under a 12hour reverse light cycle, so all behavioral monitoring occurs approximately 1 hour after the dark
cycle has begun. Food consumption and mouse weight should be recorded weekly to measure
food intake and weight gain. All behavioral experiments should be performed by the same
person, mice should be handled regularly (at least five times) using gentle methods such as
cupping before behavioral tests to reduce variability between mice and reduce human-caused
anxiety [269,270]. All behavioral experiments should be performed under dim red light to avoid
resetting the mouse’s circadian rhythm. All cohorts will need to be tested for behavioral changes
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using the following methods:
Marble burying test: 30 minutes before testing clean cages are prepared with 4 cm of Cellu-nest
bedding, followed by gently overlaying 20 black glass marbles (15 mm diameter) equidistant in a
4×5 arrangement. Mice are then individually added to the cage and left for a 10-min exploration
period. The mice are then removed from the cage, returned to their original cage, and
photographs are taken of the marbles. The number of marbles buried at least two-thirds are then
counted by at least 8-10 independent reviewers. The mean of these scores was used.
Open field test: 30 minutes before testing mice are brought into the room to be acclimated.
Individual mice are placed into the open field box and allowed to explore for 10 minutes while
they are videotaped with a camera located above the center of the floor of the open field. After
spending the 10 minutes in the open field box, the mice are returned to their original cage.
Subsequently, software is used to analyze the time spent in the inner and outer regions of the box
and overall locomotor behavior.
Zero maze test: 30 minutes before testing, mice are brought into the room to be acclimated.
Individual mice are placed into the zero maze and allowed to explore for 10 minutes while they
are videotaped with a camera above the center of the floor of the zero maze. After spending the
10 minutes in the zero maze, the mice are returned to their original cage. Subsequently, software
is used to analyze the time spent in the open and closed portions of the zero maze.
Three chamber socialization test: 30 minutes before testing, mice are brought into the room to be
acclimated. Individual mice are placed in the chamber and allowed to explore and acclimate for 5
minutes. A probe mouse (a wild type mouse that is gender and age matched) is placed in one of
the chambers under a wire cup, and the experimental mouse is allowed to roam the chamber for
10 minutes. Another wire cup in a separate chamber has a set of Legos that they can explore also.
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After 10 minutes, another probe mouse replaces the set of Legos under the wire cup, and the
experimental mouse is allowed to explore the chamber for another 10 minutes. Subsequently,
software is used to analyze the time spent near the probe mice and time spent in the chambers, as
well as measuring their social behaviors.
After performing behavioral data, fecal samples should be collected from each mouse to
perform 16S sequencing using the Quick DNA Fecal/Soil Microbe 96 Kit (Zymo). Blood serum
samples should also be collected to analyze serum metabolomics. After this, the first cohort
should be euthanized and intestinal fecal material collected for free IgA analysis via ELISA and
bound IgA via flow cytometry. Initial experiments measuring free IgA demonstrated lower levels
of free IgA in CD5KO mice (data not shown), suggesting that removal of CD5 may affect IgA
production [271].
After collection of fecal samples, the second cohort of mice will start receiving an amino
acid-enhanced diet. The mouse chow formulation can be provided by Research Diets, Inc. The
formulation base, Purina Rodent Chow #5001, will be modified by increasing the amount of
glutamic acid from 4.37% to 7.5%. It would also be interesting to increase the amount of Lphenylalanine and/or aspartic acid in the diet, given that glutamic acid, L-phenylalanine, and Laspartic acid were decreased in the serum of CD5KO mice. The diet should be fed to the mice
for at least 6 weeks before performing a secondary round of behavioral tests, 16S sequencing,
serum metabolomics, and IgA quantification.
After initial analysis of behavior and gut microbiome composition, the third cohort will
be fed standard chow but fecal material will be swapped between cages. It is well known that
mice consume fecal matter from other mice and fecal transplant has been successful in changing
human microbiome populations, so by doing this, the microbiome will change over time so both
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CD5WT and CD5KO mice possess the same gut microbe composition [272]. Each week,
approximately one cup of fecal-laden bedding will be taken from each cage and mixed in a
plastic bag, then redistributed between the cages. This should be done for at least six weeks
before acquiring fresh fecal samples from mice and performing 16S sequencing to determine
microbiome composition. Upon validation of 16S sequencing that CD5WT and CD5KO mice
have similar microbiomes, behavioral testing, serum metabolomics, and IgA analysis can be
performed. One consideration for this method must be given, however. It has been demonstrated
that the maternal microbiome can influence pup neuronal development and consequently affect
behavior later in life [273]. Given the differences between CD5WT and CD5KO mouse gut
microbiome, it is possible behavioral changes may be mediated during fetal development. To test
this, CD5KO and CD5WT mice can be bred to create CD5het offspring, which can then be bred
to produce F2 CD5WT and CD5KO mice born from the same mother and the same microbiome.
By raising them together, their microbiome should be maintained and any influence from fetal
development will occur for both CD5WT and CD5KO mice, which would be helpful to
determine whether behavioral differences are CD5-related, or microbiome related.
For the final cohort, after initial testing, each group will receive a cocktail of antibiotics
to eliminate the microbiome [274]. This antibiotic cocktail will consist of 2mg/mL neomycin,
0.5mg/mL bacitracin, 1.2µg/mL pimaricin, and 0.5mg/mL vancomycin. Antibiotic regiment
must be changed every 2 days and intake and mouse weight must be monitored to ensure that
mice retain a healthy weight and dosage can be calculated. The antibiotic cocktail must be
administered for at least two weeks until morphological differences are seen in fecal matter, such
as darker color and increased caecal weight [274]. Upon confirmation of antibiotic depletion of
the microbiome, behavioral testing, serum metabolomics, and IgA profiling can be performed.
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6.2 Regulation of LLO118 and LLO56 by Altered Peptides and the Co-Receptor CD5
Two helper T cells, called LLO118 and LLO56, both recognize a protein, listeriolysin O
(LLO190-201), found on Listeria monocytogenes. These T cells have similar TCRs and TCR affinity;
however, they have vastly different functional responses [136]. In vivo analysis demonstrated that

LLO118 responded more robustly to primary antigen exposure, while LLO56 produced a better
memory response upon secondary antigen exposure [137,138]. These differing responses could be
a result of TCR avidity for the LLO peptide or the level of expression of CD5, as LLO118 has
low levels of CD5 expression, while LLO56 has high levels of CD5 expression [137]. To test
these hypotheses, we used a novel panel of mutant L. monocytogenes whose LLO190-205 peptides
are altered to produce different strengths of T cell activation in vitro.
To measure proliferation of LLO118 and LLO56 Th cells, we used CFSE, a fluorescent
dye, whose brightness is halved with each cell division. We found that the removal of CD5
affected LLO118 proliferation on day 3 but did not find significant differences at day 7.
Additional biological replicates for day 7 for both LLO118 and CD5KO LLO118 T cells are
needed, as well as data for both LLO56 and CD5KO LLO56, to completely establish how the
altered peptides and CD5 are affecting Th cell proliferation.
We have preliminarily shown that there are significant differences in IL-2 production
between CD5KO LLO118 and CD5KO LLO56 Th cells. Additional biological replicates of
CD5KO LLO118 and CD5KO LLO56 are needed for both days 3 and 7, in addition to
measuring IL-2 levels of LLO118 and LLO56 Th cells. Using a cytometric bead kit to determine
if altered peptides affect the differentiation profile of LLO118 or LLO56 Th cells would also be
essential to characterizing the effects that the altered peptide panel have on cytokine production.
Our data has shown that stimulation of LLO118 and LLO56 in vivo against the altered
peptides produced diverging responses in the T cells. As previously demonstrated, LLO118 T
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cells proliferated more than LLO56 T cells when stimulated with the wild type peptide [138].
However, the partial agonist peptides, S194 and G194, stimulated LLO118 T cells much more in
comparison to the wild type peptide. Given the data we have preliminarily obtained in vitro, it
would be critical to study CD5KO LLO118 and CD5KO LLO56 Th cells in vivo to determine
their proliferation in vivo. As CD5 is expressed on other immune cell types, such as dendritic
cells, it would be important to adoptively transfer LLO118 and LLO56 Th cells and their
CD5KO counterparts into CD5KO mice to measure their in vivo responses without the influence
of CD5 [104]. Ex-vivo studies could also be performed on these Th cells to determine differences
in cytokine production, calcium signaling, signaling proteins, or metabolism.
Calcium signaling, signaling proteins, and metabolism are crucial aspects of T cell
activation, differentiation, and function. While we attempted to study calcium signaling using
calcium microscopy, it would be useful to measure it using flow cytometry as outlined in the
publication cited here [139]. We also attempted to study intracellular signaling molecules, Nur77
and IκBα, using flow cytometry, but did not see significant differences. To better measure these
or other signaling proteins, it may be possible to enrich the T cells using FACs sorting and
perform qPCR or PhosphoFlow to determine if there are true differences in the expression of
these proteins [145]. It would also be important to characterize the metabolism of LLO118 and
LLO56 T cells when stimulated by altered peptides. As TCR signaling and calcium mobilization
affect metabolism and other downstream T cell functions, it would give crucial insights into how
altered peptides affect T cell metabolism [151]. To do this, glycolysis and mitochondrial
respiration could be measured using the Seahorse XFp and associated kits, such as the Mito
Stress Test or Glycolysis Stress Test (Agilent). It would also be useful to measure glucose uptake
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using 2-NBDG, a fluorescent glucose analog, to see if stimulation with different peptides
promotes or inhibits glucose uptake.
TCR affinity and avidity are important measurements in understanding T cell signaling.
Even though LLO118 and LLO56 TCR affinity has already been measured, it would be valuable
to reproduce those results by using a method such as bio-layer interferometry. To measure
avidity, tetramers displaying each altered peptide would need to be constructed to determine how
strongly LLO118 and LLO56 bind in multimeric interactions.
6.3 Characterization of Single-Chain Antibodies Specific for Thymidine Kinase 1
Thymidine kinase 1 (TK1) is a unique cancer biomarker as it is exclusively present on the
surface of cancer cells. Using yeast display, we were able to isolate and validate ten unique scFvs
that can bind to TK1. We found that clones C, D, and W had the most similar heavy chain CDR
regions, while clones D, E, L, and W had similar light chain CDR regions. Clones B, E, I, and K
had the most amino acid diversity among their CDRs overall. In our bioinformatic modeling of
scFv binding to TK1, it appears that the vast majority of our scFv constructs may preferentially
bind to an alpha helix on the TK1 monomer. Some clones, such as WHEELZ, were shown to
have some binding areas on a beta sheet that is more exposed on the dimeric and tetrameric
forms of TK1. Evidence suggests that the monomeric and dimeric forms of TK1 are presented on
the cancer cell surface, indicating that these scFv constructs will most likely bind to those forms
found on the cell surface [73].
We validated the binding of each scFv to human TK1 protein using flow cytometry. At
100nM concentration of TK1, each clone displayed some affinity for TK1. Of the ten clones,
WHEELZ had the most binding to TK1, followed by clones C, E, and V having high binding to
TK1. Estimating the KD using flow cytometry demonstrated that all four clones likely bind with
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a nanomolar affinity to TK1. However, given the differences seen in semi-log fit, the KD of each
clone should be more precisely estimated using surface plasmon resonance or biolayer
interferometry to determine how tightly each clone binds to TK1.
To further validate scFv binding to TK1, we began cloning each scFv into the pFusehIgG1-Fc2 plasmid (InvivoGen) to add a constant domain to each scFv. To do so, we used NotIHF, NcoI, and EcoRV (New England BioLabs) restriction sites to insert the scFv in front of the
IgG1 constant domain. We were able to build scFv-Fc constructs with WHEELZ and Clones C,
D, E, I, V, and W. Clones inserted into pFuse-hIgG1-Fc2 were transfected into 100,000 CHO-K1
cells (ATCC) in 12-well plates. The transfection employed 2ul of the X-tremeGENE™ HP DNA
Transfection Reagent (Roche) and 3µg of plasmid per well. CHO-K1 cells were cultured with
transfection reagent in Ham's F-12K (Kaighn's) Medium (Gibco) supplemented with 10% FBS
and 500µg/mL Zeocin (InvivoGen) for 4 days at 37 °C and 5% CO2. Media was then changed to
CDM4CHO serum-free media (Cytivia) supplemented with 20% Cell Boost 4 (Cytivia),
500µg/mL Zeocin, and 1X protease inhibitor (ApexBio). Cells were cultured for 48-96 hours in
serum-free media which was harvested for antibody purification.
Antibody purification will be performed using the MagINDEX™ rProtein A Magnetic
Agarose according to the manufacturer’s instructions. After purification, Amicon Ultra 0.5mL
Centrifugal Filter Units (Millipore Sigma) will be used to concentrate the antibody by
centrifugation at 2000×g for 30 minutes at 4 °C. The Pierce™ BCA Protein Assay (Thermo
Scientific) will be used to quantify antibody concentration and antibody presence will be
confirmed via Coomassie-stained polyacrylamide gel. Once antibody presence has been
confirmed, we will test the scFv-Fc constructs for binding to TK1 using a dot blot assay. TK1
will be blotted onto a nitrocellulose membrane and incubated with the scFv-Fc, followed by an
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anti-human IgG antibody conjugated to HRP. Dot blots will be developed on film to visualize
binding of the scFv-Fcs to TK1.
Further validation of scFv-Fc binding to TK1 will include using flow cytometry to
analyze scFv-Fc binding to TK1+ cancer cell lines. Cancer cell lines used in this study will
include NCI-H460 (ATCC© HTB-177™), HT-29, and A549 (ATCC® CCL-185™) cell lines, all
of which express high levels of TK1. We will use an antibody-dependent cytotoxicity (ADCC)
assay to determine how well each scFv-Fc facilitates cancer cell death. To do this, human
PBMCs will be isolated from human blood using lymphocyte separation media and co-cultured
with the cancer cell lines described previously. scFv-Fc will be added and allowed to incubate
with the cells for 8 hours and 24 hours. After incubation, the WST-1 assay will be used to
measure cell viability.
If these scFvs have difficulty binding to surface-expressed TK1, the scFvs could be
shortened into a single-domain antibody format (sdAb) that would only utilize the heavy chain of
the scFv. A previous study using sdAb formats has proven successful in binding to and killing
TK1, so this could be a viable avenue to purse. Additionally, the scFvs could be modified using
site-directed mutagenic PCR to insert specific point mutations that may increase their binding to
other areas of TK1 or increase their binding affinity.
6.4 Genomics Education
There are many benefits that genomics brings to educating students at any academic
level. We found numerous studies that support the finding that genomic education facilitates
student interest and develops student confidence [206,256]. We found that genomic education can
also foster research ideas that increase understanding about genomics and recruit more students
to study science and prepare for scientific careers [192,231]. Studies have also shown that
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genomics can be scaled to teach many students and still provide meaningful learning experiences
through personal investment [201,202,204]. Hands-on learning experiences that utilize genomic
research are also a useful tool that can be utilized for many platforms [193,223,231]. Backward
education design is also a helpful education strategy to fill in existing gaps in genomic
knowledge and enhance retention and learning [249]. Many easily accessible online tools, such as
the Apple Genomic Project or the Genomic Analogy Model for Educators (GAME), are of
valuable educational benefit in designing genomic educational strategies [195]. Together, this
demonstrates that there are many educational tools and strategies that can enhance and promote
learning of genomic principles. We recommended that the incorporation of genomics education
be included in basic biology classes at the high school and college level in connection with
human and medical genetics, since genomics is dependent upon a strong genetic understanding
[188].

For graduate-level education, we suggested that educational institutions consider requiring

applying students to have taken a genomics-focused or genomics-related course in order to
provide a foundational genomic knowledge for incoming students. Genetic counseling programs
currently struggle with providing training slots and supervision; therefore, we suggested that
funding from either external or internal sources be considered to alleviate the strain on genetic
counseling educators [233].
However, some challenges and barriers remain that must be addressed. Cost and time
commitments are often a challenge in providing meaningful genomic education experiences
[233].

Healthcare professionals often have gaps in genomic knowledge, which can be neglected

due to competing priorities and time constraints [245]. We suggested that genomic education
material become more readily accessible through online formats such as email or computerbased modules to facilitate continuing genomic education for practicing healthcare providers

129

[250,251].

Lack of educational foundation and limited resources can hinder genomic education in

different sectors [205]. Genomics complexity and misconceptions perpetuated by society or the
media can compound genomic education in the public space [253]. Education for the public will
require the most extensive efforts in providing accessible and pertinent genomic information
[205].

As many people have suggested the need for public infrastructure and leadership over

genomic education, we suggested that a public organization such as the Global Genomics
Nursing Alliance (G2NA) be organized by a government entity such as the Science Education
Division of the National Institute of Health to fill these educational gaps [213]. We also suggest
that, with the increased use of direct-to-consumer genetic testing, these companies be required to
provide online educational modules to increase public genomic education and improve public
healthcare decisions [252]. Most importantly, genomics is rapidly expanding with new
information being learned each day. Thus, it is critical to improve genomic education on every
level to help people understand the benefits of genomics discoveries in understanding our
ancestry, health, and traits [184-186].
Effective genomics education is vital to advance our understanding of the rapidly
developing field of genomics that influences our understanding of health, ancestry, and traits.
Despite the challenges and barriers in implementing genomic education, there are vast benefits
for academic, professional, and public education. Effective genomic education would not only
advance genomic research, but also provide enhanced learning experiences, knowledge, and
confidence for students. It is also evident that genomic education of teachers, physicians, and
health care professionals should be a priority as it improves their knowledge, confidence, and
ability to help communicate critical genomic information simply and accurately to students,
patients, and the public. As genomics becomes more widespread and commonplace in society,
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genomics education becomes increasingly vital for genomic technologies to be utilized
appropriately. On the academic platform, ranging from high school to graduate or medical
school, future studies involving genomics integration into biology courses would be immensely
helpful in training the next generation of professionals. In the professional realm, we suggest that
educational research in improving physician or nurse confidence in providing genomic testing
information to patients would improve patient care and healthcare practices. For public
education, we suggest that more training of science policy in journalism is needed to provide
thorough coverage and discussion about scientific topics, thereby providing more complete
information to the public. We also suggest that research into developing an educational
infrastructure for genomics education would be helpful in providing information to the public
from which they could make well-educated decisions about genomics.
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1388 S. 605 W, Orem, UT 84058
208-541-5848
kvwhitley17@gmail.com

Curriculum Vitae
Academic Preparation and Training Academic Preparation and Training
June 2016-August 2022 (expected)

PhD in Microbiology and Molecular Biology
Brigham Young University, Provo, UT
Supervised by Dr. K. Scott Weber
Graduate research: Understanding the role of the T cell co-receptor CD5
GPA: 4.0

August 2015-June 2016

MS in Microbiology and Molecular Biology (transferred to PhD)
Brigham Young University, Provo, UT
Supervised by Dr. K. Scott Weber
Graduate research: Isolating TK1-specific antibodies for cancer immunotherapy

September 2014-April 2015

Adjunct Professor
Brigham Young University-Idaho, Rexburg, ID
Bio 264 Lab – Human Anatomy and Physiology

September 2009-July 2014

B.S. in Biology, Emphasis in Human Biology
Brigham Young University-Idaho, Rexburg, ID
Undergraduate research: Gene therapy targeting ovarian cancer
GPA: 3.99

Professional Teaching Experience Professional Teaching Experience
Jan. 2021-April 2021
Assistant Jan. 2020-April 2020
Jan 2019-April 2019

MMBio 463 – Immunology Teaching
Brigham Young University, Provo, UT
Professor: K. Scott Weber
• Prepared review sessions for the class before each test to review materials learned
• Planned individual meetings with struggling students to tailor their needs
• Organized student poster and oral presentations and recruited faculty and graduate
students to help assess student understanding of various immunological diseases
• Taught students about immunology principles such as immune cell types, B and T cell
signaling and activation, cytokine and chemokine production, inflammatory responses,
immune regulation, the complement system, receptor formation and antigen presentation,
autoimmunity, immunodeficiencies, cancer, and immunology experimental methods
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Sept. 2017-Dec. 2017
Assistant Sept. 2016-Dec. 2016

MMBio 522 - Flow Cytometry Teaching
Brigham Young University, Provo, UT
Professor: K. Scott Weber
• Trained students how to use three different flow cytometers: the BD Accuri,
Thermofisher Attune, and Beckman-Coulter Cytoflex
• Instructed students on flow cytometry principles such as compensation, voltage
gating, software setup and analysis, cytometric panel construction, troubleshooting,
sample preparation, and how to use FlowJo
• Revised software practice sets to enhance clarity for student understanding

Jan. 2016-April 2016

MMBio 465 - Virology Teaching Assistant
Brigham Young University, Provo, UT
Professor: Brad Berges
• Held review sessions for students, prepared quizzes to solidify students’ knowledge about
virology principles, and assisted students with scientific writing about current virology
issues
• Graded and reviewed exams with students to improve their understanding of the concepts
missed on the exam
• Instructed students on basic principles of virology, including viral structure, replication,
viral-immune interface, viral diseases, treatment and prevention of viral infections,
vaccine development, gene therapy, and experimental tools for studying viruses

Sept. 2014-April 2015

Anatomy and Physiology Adjunct Professor
Brigham Young University-Idaho, Biology Department, Rexburg, ID
• Applied understanding of human anatomy and previous work experience to teach concepts
on systemic anatomical structure, specifically the skeletal, muscular, nervous, and
sensory systems
• Planned class materials such as presentations and practice tests to aid student learning,
understanding, and retention of the concepts taught
• Prepared quizzes and exams to assess students’ knowledge of anatomical concepts

Jan. 2014-July 2014

TA and Dissection Lead for Biology 460: Human Anatomy
Brigham Young University-Idaho, Biology Department, Rexburg, ID
Professor: Sidney Palmer
• Applied knowledge of human anatomy to teach advanced anatomical concepts based on
regional structure and function
• Instructed and supervised students in cadaver dissection and organized peer instruction
and study groups
• Communicated with head professor to develop lesson plans and learning outcomes and
coordinate teaching and testing schedules
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Mentorship Mentorship
Justin Crandall – 2016 Microbiology and Molecular Biology BYU graduate, currently working in biotech industry
Steven Ogden – 2019 Molecular Biology BYU graduate, currently Practice Manager at Lakeview Family Medicine, Orem, UT
Daniel Thompson – 2017 Microbiology BYU graduate, 2021 Molecular Biology BYU PhD graduate
Hyung Joon Kim – 2017 Microbiology and Molecular Biology BYU graduate
Tia Thomas – 2018 Neuroscience BYU graduate, currently a law student at Colombia Law School in New York, NY
John Hancock – 2015 Cell Biology BYU graduate, currently pursuing an MD/PhD at University of Utah Medical School
Nolan Beatty – 2017 Molecular Biology BYU graduate, currently pursuing an MD at the University of South Florida
Rachel Johnson – 2019 Microbiology and Molecular Biology BYU graduate
Brie Kingrey – 2018 Molecular Biology BYU graduate, 2021 BYU Law graduate
Jake Robins – 2019 Microbiology BYU graduate, currently working as a medical assistant at University of Utah Health
Kelsey Bennion – 2019 Microbiology and Molecular Biology BYU graduate, currently pursuing a PhD in Cancer Biology at Emory
University
Charles Teames – 2019 Cell Biology BYU graduate, currently pursuing an MD at University of Utah Medical School
Josie Tueller – 2019 Microbiology BYU Master’s graduate, currently working for TCRCure in Durham, North Carolina
Wyatt Magoffin – 2021 Neuroscience BYU graduate
Alexa Tall – 2020 Molecular Biology BYU graduate, currently a clinical research coordinator at Huntsman Cancer Institute
Jessica Townsend – 2020 Microbiology BYU graduate, attending Baylor College of Medicine’s Physician Assistant Program
Topher Haynie – 2020 Molecular Biology BYU graduate, pursuing a Master’s degree at Brigham Young University
Carlos Moreno – 2019 Biology BYU-Idaho graduate, pursuing a PhD at Brigham Young University
Kyle Reaveley – 2022 Microbiology graduate, medical student at Noorda College of Osteopathic Medicine
Isabella Wallwitz – 2022 Microbiology graduate
Joshua Teasdale – 2022 Microbiology graduate
Joshua Bennett - current undergraduate in the lab

Awards and Fellowships Awards and

Fellowships

September 2021-August 2022

Year-Round Fellow
Simmons Center for Cancer Research at Brigham Young University, Provo, UT
Title of Proposal: Characterization of Single Chain Antibodies for Cancer
Immunotherapeutic Applications
Amount: $30,000

May 2021-August 2021

Spring/Summer Fellow
Simmons Center for Cancer Research at Brigham Young University, Provo, UT Title of
Proposal: Characterization of the T cell co-receptor CD5: a metabolic study Amount:
$9000

May 2020-August 2020

Spring/Summer Fellow
Simmons Center for Cancer Research at Brigham Young University, Provo, UT
Title of Proposal: The role of CD5 in receptor-ligand avidity in helper T cell activation
Amount: $8000
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May 2018-August 2018

Spring/Summer Fellow
Simmons Center for Cancer Research at Brigham Young University, Provo, UT Title of
Proposal: Engineering TK1-specific antibodies for immuno-therapeutic applications
Amount: $8000

May 2017-August 2017

Spring/Summer Fellow
Simmons Center for Cancer Research at Brigham Young University, Provo, UT
Title of Proposal: Engineering an Assassin: Developing a CAR-T Cell to Destroy Cancer
Amount: $7500

May 2016-August 2016

Spring/Summer Fellow
Simmons Center for Cancer Research at Brigham Young University, Provo, UT Title of
Proposal: Winning the Immunity Arms Race: Engineering Antibodies to Eliminate Cancer
Amount: $7000

September 2009-July 2014

Full-Ride Tuition Scholarship
Brigham Young University-Idaho
Amount: $1800-$2400 per semester

Laboratory Techniques and Skills Laboratory Techniques and Skills
Cellular Biology

•
•
•
•
•

Molecular Biology

Culture of splenic T cells and
bone marrow- derived
macrophages
Bacterial culturing of
E. coli and Listeria

monocytogenes

Fluorescence and light
microscopy
Cancer cell line culturing
(H460, CaOV3, A2780,
etc.)
Phage genomic analysis

•
•
•
•
•
•
•
•

Animal Care

Molecular cloning:
primer design, digestion,
and ligation
Bacterial
transformation
RNA, DNA, and plasmid
purification
DNA gel analysis and
extraction
PCR and reverse
transcription
ELIZA
Western blot
qPCR

•
•
•
•

•

Handling
Breeding
Tagging and
genotyping of
transgenics
Dissection of
spleen, lymph
nodes, bone
marrow, and
intestines
Post-orbital
injection

Analysis Software

•
•
•
•
•
•

MetaboAnalyst
Geneious
FlowJo
GraphPad
Prism
DAVID
RaptorX

Specializations

•
•
•
•

Publications Publications
March 2022

CD5 deficiency alters helper T cell metabolic function and shifts the systemic metabolome
Published in Biomedicines, invited for Special Issue: Omics Data Analysis & Integration in Complex Diseases
Authors: Kiara V. Whitley, Claudia M. Tellez Freitas, Carlos Moreno, Joshua Bennett, John Hancock,
Christopher Haynie, Brett Pickett, and K. Scott Weber
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Calcium imaging
Animal behavior
assays
Agilent
metabolic
assays
Human cadaver
dissection

January 2020

Genomics Education in the Era of Personal Genomics: Academic, Professional, and Public Considerations
Published in the International Journal of Molecular Sciences, invited for Special Issue: Feature Papers in
Molecular Genetics and Genomics
Authors: Kiara V. Whitley, Josie A. Tueller, and K. Scott Weber

October 2019

A full semester flow cytometry course improves graduate and undergraduate student confidence
Published in Biochemistry and Molecular Biology Education
Authors: Josie A. Tueller, Kiara V. Whitley, and K. Scott Weber

July 2018

Characterization of two related Erwinia myoviruses that are distant relatives of the PhiKZ-like Jumbo phages
Published in PLOS One
Authors: Daniel K. Arens, T. Scott Brady, John L. Carter, Jenny A. Pape, David M. Robinson, Kerri
A. Russell1, Lyndsay A. Staley, Jason M. Stettler, Olivia B. Tateoka, Michelle H. Townsend, Kiara
V. Whitley, Trevor M. Wienclaw, Taryn L. Williamson, Steven M. Johnson, and Julianne H. Grose

November 2017

Genome Sequences of 19 Novel Erwinia amylovora Bacteriophages
Published in American Society of Microbiology Genome Announcements
Authors: Ian N. D. Esplin, Jordan A. Berg, Ruchira Sharma, Robert C. Allen, Daniel K. Arens, Cody
R. Ashcroft, Shannon R. Bairett, Nola J. Beatty, Madeline Bickmore, Travis J. Bloomfield, T. Scott Brady,
Rachel N. Bybee, John L. Carter, Minsey C. Choi, Steven Duncan, Christopher P. Fajardo, Brayden B. Foy, David
A. Fuhriman, Paul D. Gibby, Savannah E. Grossarth, Kala Harbaugh, Natalie Harris, Jared A. Hilton, Emily
Hurst, Jonathan R. Hyde, Kayleigh Ingersoll, Caitlin M. Jacobson, Brady D. James, Todd M. Jarvis, Daniella
Jaen-Anieves, Garrett L. Jensen, Bradley K. Knabe, Jared L. Kruger, Bryan D. Merrill, Jenny A. Pape, Ashley M.
Payne Anderson, David E. Payne, Malia D. Peck, Samuel V. Pollock, Micah J. Putnam, Ethan K. Ransom, Devin
B. Ririe, David M. Robinson, Spencer L. Rogers, Kerri A. Russell, Jonathan E. Schoenhals, Christopher A.
Shurtleff, Austin R. Simister, Hunter G. Smith, Michael B. Stephenson, Lyndsay A. Staley, Jason M. Stettler,
Mallorie L. Stratton, Olivia B. Tateoka, P. J. Tatlow, Alexander S. Taylor, Suzanne E. Thompson, Michelle H.
Townsend, Trever L. Thurgood, Brittian K. Usher, Kiara V. Whitley, Andrew T. Ward, Megan E. H. Ward,
Charles J. Webb, Trevor M. Wienclaw, Taryn L. Williamson, Michael J. Wells, Cole K. Wright, Donald P.
Breakwell, Sandra Hope, Julianne H. Grose

December 2013

Adenoviral-delivered HE4-HSV-tk sensitizes ovarian cancer cells to ganciclovir
Published in Gene Therapy and Molecular Biology
Authors: Jennifer W. Rawlinson, Kiara Vaden, Joseph Hunsaker, David F. Miller, and Kenneth P. Nephew

First Author Presentations First Author Presentations
December 2021

CD5 deficiency alters helper T cell immunometabolism and shifts the systemic metabolome
Oral presentation given at 2021 American Society of Microbiology – Intermountain Branch Conference
(online)

November 2021

CD5-deficient mice have enhanced helper T cell function and a systemic metabolic shift in amino acids
Oral and poster presentations given at 2021 Autumn Immunology Conference
Characterization of Single Chain Antibodies against Thymidine Kinase 1 (TK1) for Cancer Immunotherapeutic
Applications
Oral and poster presentations given at 2021 Autumn Immunology Conference
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December 2020

the role of T cell co-receptor CD5 in T cell metabolism, the gut microbiome, and behavior
Oral presentation given at 2020 American Society of Microbiology – Intermountain Branch (online)
Awarded Best in Session

November 2019

The influence of T cell signaling strength in helper T cell response
Oral and poster presentations given at 2019 Autumn Immunology Conference

August 2019

The influence of T cell signaling strength in helper T cell response
Oral presentation given at 2019 Graduate Retreat at Brigham Young University
Awarded Best in Session

April 2019

The role of avidity in helper T cell response to infection
Poster presentation given at 2019 American Society of Microbiology – Rocky Mountain Branch Conference

April 2017

Determining the Optimal TCR: pepMHC Affinity for CD4+ T cell Primary and Memory Response
Poster presentation given at the American Society for Microbiology Intermountain Branch

January 2017

Determining the optimal TCR: pepMHC affinity for CD4+ T cell primary and memory response
Poster presentation given at 2017 Midwinter Conference of Immunologists

January 2016

Determining the optimal TCR: pMHC avidity for CD4+ T cell memory generation
Poster presentation given at 2016 Midwinter Conference of Immunologists

March 2013

Adenovirus Delivered Gene Therapy for Ovarian Cancer
Oral presentation given at BYU-Idaho Research and Creative Works Conference
Awarded 2nd Place in Oral Presentation – Biology Division

Co-Author Presentations Co-Author Presentations
November 2021

CD5 signaling inhibits T cell metabolism at the transcriptomic level
Oral and poster presentation given at the Autumn Immunology Conference
Authors: Carlos Moreno, Kiara V. Whitley, Claudia M. Tellez Freitas, K. Scott Weber, Brett E. Pickett, and
Brian Poole
Isolation and characterization of high-affinity antibodies against HPRT for immunotherapy development
Oral and poster presentation given at the Autumn Immunology Conference
Authors: Christopher Haynie, Kiara V. Whitley, Michelle Townsend, Stella Meier, Abby Johnson, Hunter Lindsay,
Kim L. O’Neill, and K. Scott Weber
The T cell co-receptor CD5 alters mouse behavior and gut microbiome composition
Poster presentation given at the BYU CURA Research Conference
Authors: Kyle S. Reaveley, Kiara V. Whitley, Claudia M. Tellez Freitas, Tyler Cox, Wyatt Magoffin, Isabella Wallwitz,
Kimble Mahler, Christopher Haynie, Alexa Tall, Joshua Teasdale, and K. Scott Weber

October 2021

CD5 signaling inhibits T cell metabolism at the transcriptomic level
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Oral presentation given at the American Society of Microbiology – Rocky Mountain Branch
Authors: Carlos Moreno, Kiara V. Whitley, Claudia M. Tellez Freitas, K. Scott Weber, Brett E. Pickett, and
Brian Poole
RNA-Seq analysis of the role of CD5 on T cell metabolic function
Poster presentation given at the American Society for Microbiology Rocky Mountain Branch Meeting (online)
Authors: Carlos Moreno, Kiara V. Whitley, and K. Scott Weber
The role of CD5 in T cell activation
Poster presentation given at the American Society for Microbiology Rocky Mountain Branch Meeting (online)
Authors: Joshua S. Bennett, Kiara V. Whitley, Claudia M. Tellez Freitas, Deborah Johnson, and K. Scott Weber
Awarded #3 ranked Poster Presentation
April 2021

The T cell co-receptor CD5 alters mouse behavior and gut microbiome composition
Poster presentation given at the Roseman University Research Symposium
Authors: Kyle Reaveley, Kiara V. Whitley, Claudia M. Tellez Freitas, Tyler Cox, Wyatt Magoffin, Isabella Wallwitz,
Kimble Mahler, Christopher Haynie, Alexa Tall, Joshua Teasdale, and K. Scott Weber

March 2021

the T cell co-receptor CD5 alters mouse behavior and gut microbiome composition
Poster presentation given at the BYU College of Life Sciences and Library Undergraduate Research Poster Competition
Authors: Kyle Reaveley, Kiara V. Whitley, Claudia M. Tellez Freitas, Tyler Cox, Wyatt Magoffin, Isabella Wallwitz,
Kimble Mahler, Christopher Haynie, Alexa Tall, Joshua Teasdale, and K. Scott Weber

December 2020

Understanding the effects of T cell co-receptor CD5 on metabolic function and the metabolome
Poster presentation given at the American Society of Microbiology Intermountain Branch Meeting (online)
Authors: Isabella Wallwitz, Kiara V. Whitley, Claudia M. Tellez Freitas, Tyler Cox, Wyatt Magoffin, Kyle Reaveley,
Kimble Mahler, Christopher Haynie, Alexa Tall, Joshua Teasdale, and K. Scott Weber
The Role of CD5 in regulating levels of T Follicular Helper cells
Poster presentation given at the American Society of Microbiology Intermountain Branch Meeting (online)
Authors: Christopher Haynie, Kiara V. Whitley, Claudia M. Tellez Freitas, and K. Scott Weber
The T cell co-receptor CD5 alters mouse behavior and gut microbiome composition
Poster presentation given at the American Society of Microbiology Intermountain Branch Meeting (online)
Authors: Kyle Reaveley, Kiara V. Whitley, Claudia M. Tellez Freitas, Tyler Cox, Wyatt Magoffin, Isabella Wallwitz, Kimble
Mahler, Christopher Haynie, Alexa Tall, Joshua Teasdale, and K. Scott Weber
Awarded Best Poster Presentation

February 2020

Role of CD5 T cell coreceptor in T cell metabolism
Poster presentation given at the Utah Conference on Undergraduate Research
Authors: Christopher Haynie, Tyler Cox, Claudia M. Tellez Freitas, Kiara V. Whitley, and K. Scott Weber

November 2019

The role of the CD5 co-receptor in T cell metabolism
Oral and poster presentation given at the Autumn Immunology Conference
Authors: Christopher Haynie, Claudia M. Tellez Freitas, Tyler Cox, Kiara V. Whitley, and K. Scott Weber
Awarded the AAI Undergraduate Award

April 2019

Flow Cytometry Education: A semester long course
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Poster presentation given at the American Society of Microbiology Rocky Mountain Branch
Authors: Josie Tueller, Kiara V. Whitley, and K. Scott Weber
March 2019

Generation and characterization of a panel of monoclonal antibodies against the tumor biomarker Thymidine Kinase 1 for
research, clinical and therapeutic applications
Presented at the American Association for Cancer Research Annual Conference
Authors: Edwin J. Velazquez, Taylor D. Brindley, Gajendra Shrestha, Rachel A. Skabelund, Corbin
M. Lee, Zachary D. Ewell, Eliza E. Bitter, Michelle H. Townsend, Kelsey B. Bennion, Kai Li Ong,
Kiara V. Whitley, Richard A. Robison, Scott K. Weber, Kim L. O'Neill.

June 2018

Mechanistically Minded: A study of the surface co-localization of salvage pathway enzymes
Poster presentation given at the National Symposium for Undergraduate Research at St. Jude Children’s Research
Hospital
Authors: Michelle Townsend, Kelsey Bennion, Evita Weagel, Edwin J. Velazquez, Kiara V. Whitley, K. Scott
Weber, and Kim O’Neill

April 2018

Macrophage toll-like receptor-chimeric antigen receptors (MOTO-CARs) as a novel adoptive cell therapy
for the treatment of solid malignancies
Poster presentation given at the American Association for Cancer Research Annual Meeting Authors: Edwin J. Velazquez,
Jake Lattin, Taylor Brindley, Zach Reinstein, Roger Chu, Lucy Liu, Evita Weagel, Michelle Townsend, Kiara V. Whitley, Eliza
Lawrence, Brandon Garcia, K. Scott Weber, Richard A. Robinson, and Kim O’Neill
Harnessing the immune system: a human engineered antibody specific to TK1
Poster presentation given at the American Association for Cancer Research Annual Meeting Authors: Kelsey Bennion, Brie
Kingrey, Michelle Townsend, Kiara V. Whitley, Edwin J. Velazquez, K. Scott Weber, and Kim O’Neill

March 2018

Development of anti-thymidine kinase 1 antibody (WHEELZ) as a potential cancer immunotherapy
Poster presentation given at the BYU College of Life Science Poster Competition
Authors: Rachel Johnson, John C. Hancock, Kiara V. Whitley, and K. Scott Weber
“ h e el z ”: A novel engineered human antibody for possible CAR T-cell therapy
W
Poster presentation given at the BYU College of Life Science Poster Competition
Authors: Kelsey Bennion, Kiara V. Whitley, Edwin J. Velazquez, Brie Kingrey, K. Scott Weber, and Kim O’Neill

February 2018

Anti-TK1 antibodies as potential antibody therapy for targeting cancer cells
Presented at the Utah Conference on Undergraduate Research
Authors: Rachel Johnson, Kiara V. Whitley, John Hancock, Josie Tueller, Steven Ogden, Hyung Joon Kim, and K.
Scott Weber

November 2017

Generation and metabolic characterization of TK-1 specific 2nd and 3rd Generation CAR Vectors
Presented at the Autumn Immunology Conference
Authors: Josie A. Tueller, Kiara V. Whitley, Edwin J. Velazquez, Evita G. Weagel, Kim L. O’Neill,
and K. Scott Weber

April 2017

Development of a TK1 specific chimeric antigen receptor T-cell for the treatment of non-small- cell lung cancer
Presented at the American Association for Cancer Research Annual Conference
Authors: Edwin J. Velazquez, Kiara Vaden, Michelle H. Townsend, Evita G. Weagel, Scott Weber, Richard A.
Robison, Kim L. O'Neill
A pre-clinical study of chimeric antigen receptor (CAR) T cells targeting Thymidine Kinase 1 (TK1) in lung cancer cell lines
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Poster presentation given at the American Society for Microbiology – Intermountain Branch
Authors: Edwin J. Velazquez, Zachary Ewell, Jake Lattin, Kiara Vaden, Michelle Townsend, Evita Weagel, K.
Scott Weber, Richard A. Robinson, and Kim O’Neill
Awarded First Place in poster presentation
February 2017

Engineering a Cancer-Specific Third Generation CAR Immunotherapy
Poster presentation at the 11th Annual Utah Conference on Undergraduate Research Authors: Josie Tueller,
Kiara Vaden, and K. Scott Weber

January 2017

Chimeric Antigen Receptor (CARs) for Thymidine Kinase 1 (TK1): A novel immunotherapy approach to fight cancer
Presented at Biomedical Engineering West Regional Conference
Authors: Edwin J. Velazquez, Kiara Vaden, Michelle Townsend, Evita G. Weagel, K. Scott Weber, Richard A.
Robison, Kim L. O’Neill

March 2016

Sequencing of an antibody specific for an epitope overexpressed on cancer cells
Presented at the Utah Conference on Undergraduate Research
Authors: Justin Crandall, Kiara Vaden, K. Scott Weber, and Kim L. O’Neill
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The following articles are a compilation of published work consisting of both first author and
co- author publications (see following pages).
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Abstract: Metabolic function plays a key role in immune cell activation, destruction of foreign
pathogens, and memory cell generation. As T cells are activated, their metabolic proﬁle is signiﬁcantly
changed due to signaling cascades mediated by the T cell receptor (TCR) and co-receptors found
on their surface. CD5 is a T cell co-receptor that regulates thymocyte selection and peripheral
T cell activation. The removal of CD5 enhances T cell activation and proliferation, but how this is
accomplished is not well understood. We examined how CD5 speciﬁcally affects CD4+ T cell
metabolic function and systemic metabolome by analyzing serum and T cell metabolites from CD5WT
and CD5KO mice. We found that CD5 removal depletes certain serum metabolites, and CD5KO T
cells have higher levels of several metabolites. Transcriptomic analysis identiﬁed several upregulated
metabolic genes in CD5KO T cells. Bioinformatic analysis identiﬁed glycolysis and the TCA cycle as
metabolic pathways promoted by CD5 removal. Functional metabolic analysis demonstrated that
CD5KO T cells have higher oxygen consumption rates (OCR) and higher extracellular acidiﬁcation
rates (ECAR). Together, these ﬁndings suggest that the loss of CD5 is linked to CD4+ T cell metabolism
changes in metabolic gene expression and metabolite concentration.
Keywords: T cell co-receptor; CD5; T cell metabolism; metabolomics; helper T cell; RNA-Seq;
bioinformatics
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1. Introduction
CD4+ helper T cells (Th) are a vital component of the immune system responsible for
directing other immune cells to eliminate pathogens and cancer [1–3]. Speciﬁcally, Th cells
facilitate CD8+ killer T cell recruitment and enhance killer T cell function against cancer
and infectious diseases [4,5]. Th cells also activate B cells via cytokines, which provide
antibodies that can target cells and foreign pathogens for destruction. Th cells are a valuable
resource for improving killer T cell response in cancer treatment and have become a focus
of immunotherapeutic research [6]. While it is increasingly clear that helper T cells serve an
important role, the exact details about which entities produce an effective Th cell response
remain unclear.
During an immune response, activated T cells undergo metabolic changes by transitioning from mitochondrial respiration to glycolysis. This signiﬁcant metabolic shift
affects T cell activation, proliferation, and function [7–9]. Naïve T cells remain relatively
quiescent and rely predominantly on mitochondrial respiration to meet basal metabolic
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needs [10,11]. As T cells become activated, the glycolytic switch causes ATP to be less
efﬁciently produced; however, critical intermediates are produced via glycolysis, such as
the pentose phosphate pathway that provides ribose for cellular growth [10,12]. T cell
activation requires signals mediated by the T cell receptor (TCR) and co-receptors on the T
cell membrane [13,14]. These signaling proteins determine the magnitude of the glycolytic
switch and affect gene expression, controlling cell proliferation and cytokine production,
all of which are required for a strong immune response [15–17]. Co-receptors on the surface of T cells also play a vital role in T cell activation by regulating the T cell response
through stimulation or inhibition [18]. Co-receptors such as PD-1 and CTLA-4 inhibit the
TCR-peptide-MHC signal, making them instrumental targets for antibody-blockade cancer
immunotherapies [19–21]. The removal of PD-1 alters T cell metabolism, which also results
in altered systemic metabolite levels and potential consequences, such as altered animal
behavior [8,22]. Together, this suggests that T cell co-receptor signaling not only changes T
cell function but can also result in signiﬁcant changes outside the immune system.
CD5 is a T cell co-receptor that negatively regulates T cell activation during T cell development in the thymus. It belongs to the group B scavenger-receptor cysteine-rich (SRCR)
superfamily and is associated with the TCR/CD3 complex [23,24]. CD5 expression levels
correlate with the strength of the signal between the TCR-self-pMHC and help ﬁne-tune the
TCR repertoire by altering TCR signaling strength during the selection process in the thymus [25,26]. Evidence suggests that CD5 can bind to CD5 on other cells, CD5 ligand (CD5L)
that is transiently found on activated splenocytes, and CD72 found on B cells [27–29]. CD5
appears to regulate T cell signaling by recruiting a signaling complex composed of adaptor
proteins, as well as positive and negative regulators of TCR signaling [30]. This is initiated
by phosphorylation of residue 429 on CD5, which serves as a docking station for these
adaptor proteins and leads to context-dependent positive or negative TCR signals [30–32].
CD5 has been shown to alter basal NF-κB signaling based on self-peptide-induced TCR
signaling strength [33]. CD5-deﬁcient T cells and anti-CD5 antibodies have been shown
to increase T cell proliferation, cytokine production, activation-induced cell death (AICD),
and modulate calcium mobilization [19,26,34]. These inhibitory functions often cause or
result in changes to T cell metabolism, suggesting that CD5 may play a role in regulating
metabolism and, like PD-1 and CTLA-4, be a potential immunotherapeutic target.
Here, we investigated whether the removal of CD5 alters T cell metabolic function and
potential systemic consequences. We measured serum and Th cell metabolomics in CD5
wild type (CD5WT) and CD5 knockout mice (CD5KO). We found that certain metabolites
were reduced in the serum of CD5KO mice and were increased inside CD5KO T cells.
Speciﬁcally, we observed that several metabolites important for glycolysis and mitochondrial respiration were upregulated in CD5KO Th cells. We performed RNA-Seq on CD5WT
and CD5KO Th cells and identiﬁed 1442 genes that were differentially expressed. We
found 774 differentially expressed genes in CD5KO Th cells involved in metabolic function,
including genes for ﬁve metabolite transporters. Bioinformatic analysis of metabolomic
and RNA-Seq data revealed that CD5 might promote speciﬁc metabolic pathways, which
consequently affects metabolite concentration and usage. We tested the metabolic function of CD5WT and CD5KO Th cells and found that the removal of CD5 promoted T cell
metabolic function by increasing their glycolytic rate and mitochondrial spare respiratory
capacity. Together, these ﬁndings suggest that the loss of CD5 is linked to Th cell metabolic
changes on a transcriptional level and has systemic metabolic consequences.
2. Materials and Methods
2.1. Mice
C57BL/6 mice (CD5WT) and C57BL/6 mice deﬁcient in CD5 (CD5KO) were used
in this study and housed in a pathogen-free facility and fed Purina Rodent Chow #5001
(LabDiet, St. Louis, MO, USA). T cells for these assays were acquired from mice aged 7–
12 weeks old. Mice were euthanized before spleen removal. All animal studies were
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approved by and performed in accordance with the BYU Institutional Animal Care and
Use Committee (protocol numbers 21-0308 and 18-0708).
2.2. T Cell Isolation
Spleens were isolated from CD5WT and CD5KO mice and homogenized into a single
cell suspension. Unstimulated CD4+ T cells were selected using positive selection CD4+
(L3T4) microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany; kit #130-117-043) according to manufacturer instructions. Naïve CD4+ T cells were isolated using the Naïve CD4+
T cell kit (Miltenyi Biotec, Bergisch Gladbach, Germany; kit #130-104-453) according to
manufacturer instructions.
2.3. Serum and T Cell Metabolomics
T cells were isolated as described above, centrifuged, and media removed, then ﬂash6
frozen and stored at −
80 ◦C. Approximately 3x10×
–5x106 T×cells were used in each sample
(each derived from a single mouse), and cell count was reported so experiments could be
adjusted accordingly. Blood (150–200 μL) was collected from CD5WT and CD5KO mice
and allowed to coagulate at room temperature for 30 min, followed by centrifugation for
C.
ten minutes at 4 ◦C. Serum was aliquoted into 50 μL and stored at 80 ◦−
Cold 90% methanol (MeOH) solution was added to each sample to give a ﬁnal concentration of 80% MeOH for each cell pellet. Samples were then incubated at − 20 ◦C for
1 h. After incubation, the samples were centrifuged at 20,000×g for 10 min at 4 ◦C. The
supernatant was then transferred from each sample tube into a labeled, fresh microcentrifuge tube. Pooled quality control samples were made by removing a fraction of collected
supernatant from each sample, and process blanks were made using only extraction solvent
and no cell culture. The samples were then dried en vacuo.
All GC-MS analyses were performed with an Agilent 7200 GC-QTOF and an Agilent
7693A automatic liquid sampler (Agilent Technologies, Santa Clara, CA, USA). Dried
samples were suspended in 40 μL of a 40 mg/mL O-methoxylamine hydrochloride (MOX)
(MP Biomedicals, Irvine, CA, USA; #155405) in dry pyridine (MilliporeSigma, Burlington,
MA, USA; #PX2012-7) and incubated for one hour at 37 ◦C in a sand bath. Twentyﬁve microliters of this solution were added to autosampler vials; 60 μL of N-methyl-Ntrimethylsilyltriﬂuoracetamide (MSTFA with 1% TMCS, Thermo Fisher Scientiﬁc, Waltham,
MA, USA; #TS48913) were added automatically via the autosampler and incubated for
30 min at 37 ◦C. After incubation, samples were vortexed, and 1 μL of the prepared sample
was injected into the gas chromatograph inlet in the split mode with the inlet temperature
held at 250 ◦C. A 5:1 split ratio was used for analysis for most metabolites. Any metabolites
that saturated the instrument at the 5:1 split were analyzed at a 50:1 split ratio. The gas
chromatograph had an initial temperature of 60 ◦ C for one minute, followed by a 10 ◦C/min
ramp to 325 ◦C and a hold time of 10 min. A 30 m Agilent Zorbax DB-5MS with a 10 m
Duraguard capillary column was employed for chromatographic separation. Helium was
used as the carrier gas at a rate of 1 mL/min. Below is a description of the two-step
derivatization process used to convert non-volatile metabolites to a volatile form amenable
to GC-MS. Data was collected using MassHunter software (Agilent Technologies, Santa
Clara, CA, USA).
For metabolomics analysis, metabolites were identiﬁed, and their peak area was
recorded using MassHunter Quant. This data was transferred to an Excel spreadsheet
(Microsoft, Redmond, WA, USA). The Metabolite identity was established using a combination of an in-house metabolite library at the University of Utah. The Metabolomics
Core was developed using pure pre-purchased standards, the NIST library, and the Fiehn
library. Analysis was performed using MetaboAnalyst (www.metaboanalyst.ca, accessed
on 1 March 2022) with the following parameters: samples were analyzed based on peak
intensity, normalized by sum, log transformation, and Pareto scaling. Altered metabolites
were identiﬁed using a p-value below 0.05 and a fold change of 1.5 [35]. MetaboAnalyst
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was also used to perform pathway analysis using the metabolites upregulated in CD5KO T
cells and downregulated in CD5KO serum as input.
2.4. RNA-Seq and qPCR
Three CD5WT and three CD5KO RNA samples (each derived from a single mouse)
were isolated for CD4+ T cells. After T cell isolation, cells were centrifuged, supernatant
removed, ﬂash-frozen in liquid nitrogen, and stored at−80 ◦C. Each sample had less than
1 × 107 T cells; the smallest number of cells used was 1 × 106 T cells. Total RNA was isolated
using the RNeasy Mini Kit (Qiagen, Hilden, Germany) and sequenced at the University
of Colorado at the Genetics Microarray Core. Cell number and RNA concentration were
reported to the University of Colorado so that experimental adjustments could be made
accordingly. RNA-Seq data were analyzed using the BYU high-performance computing
environment and processed using the ARMOR Snakemake-based automated workﬂow
within a dedicated Conda environment [36]. The Database for Annotation, Visualization,
and Integrated Discovery (DAVID) was used to categorize genes and perform pathway
analysis. qPCR primers were designed to amplify 21 metabolic genes (Table S1). Beta-actin
was used as an internal control. RNA for qPCR was isolated using the RNeasy Mini Kit
(Qiagen, Hilden, Germany) and converted to cDNA using the High-Capacity RNA-tocDNA Kit (Applied Biosystems, Waltham, MA, USA). qPCR was performed using the
Power SYBRTM Green PCR Master Mix (Thermo Fisher Scientiﬁc, Waltham, MA, USA) on
the StepOnePlus thermocycler (Applied Biosystems, Waltham, MA, USA). Conditions were
as follows: 50 ◦ C for 2 min, 95 ◦C for 10 min, 40 cycles of 95 ◦C for 15 s followed by 60 ◦ C
for 1 min, and melt curve analysis at 95 ◦C for 15 s, 60 ◦C for 15 s, and 95 ◦C for 15 s. ΔΔCт
values were calculated using the StepOne software v2.3 (Applied Biosystems, Waltham,
MA, USA).
2.5. T Cell Metabolic Assays
The extracellular acidiﬁcation rate (ECAR) and oxygen consumption rate (OCR) were
measured using an Extracellular Flux Analyzer XFp (Agilent Technologies, Santa Clara,
CA, USA). Seahorse XF RPMI Base Medium (Agilent Technologies, Santa Clara, CA, USA;
Cat#103336-100) replaced culture media; 200,000 T cells were seeded onto a Poly-D-Lysine
(Gibco, Waltham, MA, USA; #A3890401) coated Seahorse 8-well plate and pre-incubated
at 37 ◦C for 60 min in the absence of CO2. To measure mitochondrial respiration and
glycolysis, we used the XFp Mito Stress Test kit (Agilent Technologies, Santa Clara, CA,
USA; #103010-100). Cells were resuspended in XF assay media supplemented with 25 mM
glucose, 2 mM L-glutamine, and 1 mM sodium pyruvate. The OCR rate (pmoles/min) and
ECAR (mpH/min) were measured at baseline and in response to 1 μM oligomycin, 1.5 μM
ﬂuorocarbonyl cyanide phenylhydrazone (FCCP), and 0.5 μM rotenone/antimycin A. All
chemicals were purchased from Seahorse Bioscience (Agilent Technologies, Santa Clara,
CA, USA). Cell counts between wild type and knockout T cells acquired by an Olympus
automated cell counter were used to normalize the data. Calculations for individual
parameters represent the average of individuals for each assay group. Error bars were
calculated based on the individual well calculation for each parameter.
2.6. Flow Cytometry
2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-Deoxyglucose (2-NBDG) (Cayman
Chemical Company, Ann Arbor, MI, USA; #11046) glucose uptake was measured using
ﬂow cytometry. Brieﬂy, 500,000 CD4+ T cells were incubated with 2-NBDG for 20 min at
37 ◦C, 5% CO2 in R10 media consisting of 1640 RPMI, 10% fetal bovine serum (Hyclone
Laboratories Inc., Logan, UT, USA), 1% Glutamax (Gibco), and 0.5% gentamycin (Life
Technologies, Waltham, MA, USA). Fifty thousand events were recorded using the BD
Accuri ﬂow cytometer. Mitochondrial mass and membrane potential were measured using
MitoTracker Green (Thermo Fisher Scientiﬁc, Waltham, MA, USA) and MitoProbe DilC1(5)
(Thermo Fisher Scientiﬁc, Waltham, MA, USA), respectively, and stained according to the
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manufacturer’s instructions. Propidium Iodide (PI) was used to gate out dead cells. T
cells (5 ×
106 CD4+) were isolated, and 50,000 events were recorded using the BD Accuri
ﬂow cytometer. FlowJo was used to analyze the data and calculate the mean ﬂuorescence
intensity (MFI).
To measure activation state, 500,000 CD4+ T cells were labeled with the following panel:
anti-mouse CD4 FITC (eBioscience, Waltham, MA, USA; clone GK1.5), anti-mouse/human
CD44 APC (Biolegend, San Diego, CA, USA; clone IM7), and anti-mouse CD62L PE
(Miltenyi Biotec, Bergisch Gladbach, Germany). To measure subset polarization, 500,000
CD4+ T cells were labeled with the following panel: anti-mouse CD4 FITC (eBioscience,
clone GK1.5) and anti-mouse CD25 (eBioscience, clone PC61.5). Fifty thousand events were
recorded using the Beckman-Coulter Cytoﬂex ﬂow cytometer.
2.7. Statistical Analysis
Statistical analyses were performed in Graphpad PRISM version 7.0 (San Diego, CA,
USA). Analyses included unpaired Student’s t-test (metabolomics), paired t-test (functional
metabolic assays), or analysis of variance (ANOVA) for metabolomics.
3. Results
3.1. Removal of CD5 Decreases Serum Amino Acid Levels in CD5KO Mice
We wanted to quantify any changes in metabolite concentration in the serum of wildtype and CD5 knockout mice. To do so, we performed non-targeted GC-MS of the serum
metabolome of CD5WT and CD5KO mice. Subsequent data analysis revealed the detection
of 125 different metabolites in the serum comprised of amino acids, fatty acids, sugars,
nucleic acid products, and glycolysis/TCA cycle products (Figure 1A).
Of the 125 metabolites detected, 65 were conﬁrmed after calculating the coefﬁcient
of variance to determine each metabolite’s reliability (Figure 1B). Partial least-squares
discriminant analysis (PLS-DA) demonstrated that the serum metabolome of CD5KO
mice was considerably different in comparison to CD5WT mice (Figure 1C). Heatmap
analysis of the top 25 deregulated metabolites (as determined by t-test and ANOVA) also
indicated clear differences in the serum metabolome composition between CD5WT and
CD5KO mice (Figure 1D). To determine metabolite enrichment between groups, we
analyzed which metabolites had a fold change > ± 1.5 or a p-value < 0.05 (Figure 1E).
Of these metabolites, 15 metabolites had lower concentrations in CD5KO serum, while
12 had higher concentrations in CD5KO serum. A volcano plot analysis determined
which metabolites met both requirements of fold change and p-value (Figure 1F). The
volcano plot analysis identiﬁed 10 metabolites that had both a 1.5-fold change and a pvalue below 0.05 (Figure 1G). Of these metabolites, six had lower concentrations in
CD5KO serum (L-glutamic acid, L-aspartic acid, L-phenylalanine, glycine, L-serine, and
pyroglutamic acid), while four had higher concentrations in CD5KO serum (hypoxanthine,
3-hydroxybutyric acid, gluconic acid, and inosine). Together, these results suggest that CD5
systemically affects the serum metabolome.
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Figure 1. The serum metabolome of CD5KO mice is signiﬁcantly different than CD5WT mice. Serum
metabolites were measured using GC-MS and characterized using MassHunter software (Agilent)
and analyzed with the MetaboAnalyst software tool. Samples were normalized to assume a Gaussian
distribution (n = 3). (A) One hundred twenty-ﬁve different metabolites were measured, comprising
37 amino acids, 31 fatty acids, 15 sugars, 14 nucleic acids and byproducts, and 18 metabolites involved
in glycolysis or the TCA cycle. (B) Reliability of metabolites was measured using the coefﬁcient
of variance and revealed 65 reliable metabolites. (C) Partial least-squares discriminant analysis of
CD5WT and CD5KO serum metabolome. (D) Heat map representing the 25 metabolites with the
greatest relative intensity between three samples of CD5WT and CD5KO mice, as determined by
student t-tests. Blue indicates lower metabolite concentrations, while red indicates higher metabolic
concentrations. (E) Twenty-seven metabolites were substantially different, either by fold change (±1.5)
or p-value (<0.05). Of these 27 metabolites, 15 metabolites were diminished in CD5KO serum, while
12 metabolites were increased in CD5KO serum. Ten metabolites that were not statistically different
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(p > 0.05) had a fold change of ±1.5 (L-lysine, ornithine, 2-hydroxybenzoic acid, uric acid, uracil, Lproline, L-alanine, D-mannose, palmitoleic acid, and D-fructose). Eight metabolites were signiﬁcantly
different (p ≤ 0.05) but not 1.5-fold different (nonanoic acid, myo-inositol, benzoic acid, fumaric acid,
D-malic acid, capric acid, and urea). (F) Volcano graph highlighting signiﬁcant metabolites based on
p-value (y-axis) and fold change (x-axis) on a logarithmic scale. Parameters for signiﬁcance in the
Volcano graph were set at a p-value < 0.05 and a fold change of ±1.5 or higher. (G) Analysis identiﬁed
ten metabolites that are signiﬁcantly different between CD5WT and CD5KO mouse serum. Of these
ten metabolites, six metabolites (L-glutamic acid, L-aspartic acid, glycine, L-serine, pyroglutamic
acid, and L-phenylalanine) were signiﬁcantly decreased in the serum of CD5KO mice in comparison
to CD5WT. Four metabolites (Hypoxanthine, 3-hydroxybutric acid, gluconic acid, and inosine) were
signiﬁcantly increased in the serum of CD5KO mice in comparison to CD5WT. Metabolites with a
negative fold change were lower in CD5KO serum, while metabolites with a positive fold change
were higher in CD5KO serum.

3.2. CD5KO Th Cells Have Elevated Levels of Many Metabolites
To determine whether serum metabolome differences were reﬂective of the metabolome
in unstimulated Th cells, we performed non-targeted GC-MS on T cells from CD5WT and
CD5KO mice. Data analysis revealed that 108 different metabolites were detected in Th
cells (Figure 2A).
Of the 108 metabolites detected, 60 were conﬁrmed after calculating the coefﬁcient
of variance to determine each metabolite’s reliability (Figure 2B). Partial least-squares discriminant analysis (PLS-DA) demonstrated that the T cell metabolome of CD5KO mice was
considerably different from CD5WT mice (Figure 2C). Heatmap analysis of the top 25 deregulated metabolites (as determined by t-test and ANOVA) also indicated that CD5KO T
cells had higher levels of several metabolites (Figure 2D). To determine metabolite enrichment between groups, we analyzed which metabolites had a fold change greater than
0.05. This analysis revealed 44 metabolites that had a substantial fold
±1.5 or a p-value ≤
change and/or a p-value below 0.05 (Figure 2E). Of these metabolites, 30 metabolites had
higher concentrations in CD5KO T cells, while 14 had lower concentrations in CD5KO
T cells. Twenty-nine metabolites had both a 1.5-fold
change and a p-value below 0.05 and
±
included nine amino acids (Figure 2F), seven fatty acids (Figure 2G), and thirteen other
metabolites (Figure 2H), many of which are important metabolites in glycolysis and the
TCA cycle. Of the nine signiﬁcantly different amino acids, eight had higher concentrations in CD5KO T cells (L-glutamic acid, L-phenylalanine, L-aspartic acid, asparagine,
2-aminoadipic acid, L-threonine, L-proline, and ornithine), while one (taurine) was lower
in CD5KO T cells. Of the seven signiﬁcantly different fatty acids, two had higher concentrations in CD5KO T cells (O-phosphoethanolamine and glycerol-3 phosphate), while ﬁve
had lower concentrations in CD5KO T cells (lauric acid, nonanoic acid, 1-monomyristin,
1-palmitoylglycerol, and 1-steroylglycerol), illustrating that fatty acid oxidation may be
lower in CD5KO T cells. Of the thirteen other signiﬁcant metabolites, two had lower concentrations in CD5KO T cells (phosphate and oxalic acid). The other eleven metabolites that
had higher concentrations in CD5KO T cells included fumaric acid, uracil, nicotinamide,
glucose-6-phosphate, citric acid, ribitol, D-glucose, hypoxanthine, 3-hydroxybutric acid,
D-malic acid, and myo-inositol.
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Figure 2. Increased intracellular metabolites were found in CD5KO unstimulated Th cells. T cell
metabolites were measured using GC-MS and characterized using MassHunter software (Agilent)
and analyzed with the MetaboAnalyst software tool. Samples were normalized to assume a Gaussian
distribution (n = 4). (A) Metabolites measured (n = 108), comprising 33 amino acids, 26 fatty acids,
14 sugars, 12 nucleic acids and byproducts, and 16 metabolites involved in glycolysis or the TCA
cycle. (B) Reliability of metabolites was measured using the coefﬁcient of variance and revealed
60 reliable metabolites. (C) Partial least-squares discriminant analysis of CD5WT and CD5KO T
cell metabolome. (D) Heat map representing the 25 metabolites with the greatest relative intensity
between four samples of CD5WT and CD5KO T cells, as determined by student t-tests. Blue indicates
lower metabolite concentrations, while red indicates higher metabolic concentrations. (E) Fortyfour metabolites were signiﬁcantly different, either by fold change (±1.5) or p-value (<0.05); thirty
metabolites were upregulated in CD5KO T cells, while fourteen metabolites were downregulated in
CD5KO T cells. (F–H) Twenty-nine metabolites were statistically different in both fold change (±1.5)
and p-value (<0.05). This included (F) nine amino acids (eight upregulated and one downregulated),
(G) seven fatty acids (two upregulated and ﬁve downregulated), and (H) thirteen other metabolites
(eleven upregulated and two downregulated). Metabolites with a negative fold change were lower in
CD5KO T cells, while metabolites with a positive fold change were higher in CD5KO T cells.
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3.3. RNA-Seq Identiﬁed Several Genes Involved in Metabolism That Are Upregulated in CD5KO
Th Cells
To understand how the loss of CD5 is linked to metabolic gene expression in unstimulated Th cells, we performed RNA-sequencing to analyze the transcriptome of CD5WT and
CD5KO Th cells. Of the 13,977 genes identiﬁed, 1442 genes were shown to be differentially
expressed in CD5WT and CD5KO Th cells (Figure 3A).

Figure 3. RNA-Seq illustrated several metabolic genes that may be regulated by CD5 in unstimulated
Th cells. (A) Volcano plot illustrating differentially expressed genes. Of the 1442 differentially
expressed genes, we identified 936 genes that were upregulated in CD5KO T cells, while 506 genes
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were downregulated in CD5KO T cells (bar graph). (B) Using the Functional Annotation Tool in
DAVID, all differentially expressed genes were mapped into broad categories, 14 of which were
statistically signiﬁcant (Benjamini value < 0.05). Three categories of interest are highlighted in red
text. (C–E) Genes were classiﬁed into three metabolic categories: glycolysis, fatty acid oxidation,
and amino acid metabolism. Transcripts with a negative fold change had decreased expression in
CD5KO T cells, while transcripts with a positive fold change had higher expression in CD5KO T cells.
(C) Of the eleven transcripts assigned to glycolysis, nine were upregulated in CD5KO T cells and
two were downregulated. (D) Of the seven transcripts assigned to fatty acid oxidation, four were
upregulated in CD5KO T cells and three were downregulated. (E) Of the ten transcripts assigned
to amino acid metabolism, nine were upregulated in CD5KO T cells and one was downregulated.
(F) Five metabolite transporters were signiﬁcantly upregulated in CD5KO T cells: Slc1a4 (ASCT1),
Slc5a3 (SMIT), Slc7a10 (ASC1), Slc43a1 (LAT3), and Slc25a13 (CITRIN). Log2 fold change (FC) is
shown next to each transporter.

Of those 1442 genes, 936 genes were upregulated in CD5KO Th cells, while 506 genes
were downregulated in CD5KO Th cells. Using the Functional Annotation Tool on DAVID,
all genes were organized into different functional categories (Figure 3B). Of the 14 pathways
listed, three categories were of interest: signaling, metabolic process, and immune system
process. Of the 774 genes in the metabolic process category, 501 genes were upregulated in
CD5KO Th cells. Of these genes, we categorized metabolic genes of interest into three categories: glycolysis, fatty acid oxidation, and amino acid metabolism (Figure 3C–E, Table S2).
Of the eleven transcripts assigned to glycolysis, nine (ENO1b, GAPDH, GALM, PDK3,
TPI1, PGAM1, GCG, PGK1, and ALDOC) were upregulated in CD5KO T cells. Of the seven
transcripts assigned to fatty acid oxidation, four (ECHDC2, DECR1, PPA1, and ACLY) were
upregulated in CD5KO T cells, while three transcripts (ACSF2, ACSS1, and ACSS2) were
downregulated in CD5KO T cells. Of the ten transcripts assigned to amino acid metabolism,
nine (ODC1, ASNS, BCAT1, GSTT3, GOT1, GOT2, FAH, GLDC, and SCCPDH) were upregulated in CD5KO T cells. In addition, ﬁve metabolite transporters were signiﬁcantly
upregulated in CD5KO Th cells (Figure 3F). Four metabolite transporters are expressed
on the cell surface—SLC1a4 (glutamate/neutral amino acid), SLC5a3 (inositol), SLC7a10
(D-serine/neutral amino acid), and SLC43a1 (phenylalanine/large neutral amino acid).
One is expressed on the mitochondrial surface—SLC25a13 (glutamate). All the transporters
in metabolites that we found were elevated in CD5KO Th cells (Figure 2F) or depleted in
CD5KO serum (Figure 1G). These results suggest that CD5 is linked to Th cell metabolism
changes through the transcriptional expression of metabolic genes and transporters.
3.4. Metabolomic and Transcriptomic Pathway Analysis Revealed That CD5 May Be Linked to
Speciﬁc Metabolic Pathways
To determine if the loss of CD5 involves speciﬁc metabolic pathways on a metabolomic
and/or transcriptomic level, we performed bioinformatic analysis of all signiﬁcant metabolites using MetaboAnalyst 5.0 (www.metaboanalyst.ca, accessed on 1 March 2022). We
included metabolites that are decreased in CD5KO serum, given that intracellular metabolite increase may be caused by metabolite removal from the serum [22]. Using the Pathway Analysis tool, we found eight pathways that were statistically signiﬁcant with a pvalue < 0.05 (Figure 4A,B).
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Figure 4. Bioinformatic pathway analysis demonstrated that CD5 affects important metabolic
pathways in unstimulated Th cells. (A–E) Pathway analysis was performed using MetaboAnalyst 5.0
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to determine pathway impact and signiﬁcance based on our metabolomics data. (A) Signiﬁcant
pathways were plotted against p-value (−log10) and pathway impact factor. (B) Eight pathways were
statistically signiﬁcant by p-value (<0.05), while four pathways were statistically signiﬁcant by false
discovery rate (FDR, <0.05). (C–E) Based on FDR signiﬁcance, we selected and mapped the top three
pathways using KEGG as reference. Metabolites highlighted in orange represent metabolites that
were decreased in CD5KO T cells or higher in CD5KO mouse serum, metabolites highlighted in
green represent metabolites that were increased in CD5KO T cells or lower in CD5KO mouse serum,
and metabolites highlighted in blue represent intermediate metabolites. (C) In the aminoacyl-tRNA
biosynthesis pathway, 13 signiﬁcant metabolites were involved. (D) In the arginine biosynthesis
pathway, ﬁve signiﬁcant metabolites were linked to this pathway. (E) In the alanine, aspartate,
and glutamine metabolism pathway, ﬁve signiﬁcant metabolites were included (glutamate, citrate,
fumarate, aspartate, and asparagine). (F,G) DAVID was used to analyze pathway enrichment based
on our RNA-Seq data. Sixteen KEGG pathways were statistically signiﬁcant. Of these 16 pathways,
we focused on three pathways directly involved in metabolism (biosynthesis of amino acids, glycolysis/gluconeogenesis, and carbon metabolism). Based on these three pathways, we combined
our metabolomic and RNA-Seq data to demonstrate metabolite and gene involvement in glycolysis
(F) and the TCA cycle (G). Metabolites highlighted in orange represent metabolites downregulated
in CD5KO T cells, metabolites highlighted in green represent metabolites upregulated in CD5KO
T cells or downregulated in CD5KO mouse serum, and metabolites highlighted in blue represent
intermediate metabolites. Metabolic enzymes that were signiﬁcantly upregulated in CD5KO T cells
are highlighted in yellow. Bright blue boxes indicate upregulated metabolite transporters in CD5KO
T cells. Dark blue boxes indicate other pathways that may be involved.

Of these eight pathways, four were statistically significant with an FDR < 0.05 (Figure 4B).
Given these results, we analyzed the top three metabolic pathways and mapped where
our signiﬁcant metabolites were involved in these pathways using KEGG as the reference. The top three pathways included the alanine, aspartate, and glutamate pathway,
the arginine biosynthesis pathway, and the aminoacyl-tRNA biosynthesis pathway. In the
aminoacyl-tRNA biosynthesis pathway, we found ten upregulated metabolites and three
downregulated metabolites that could be used for tRNA synthesis (Figure 4C). This suggests that CD5 may be linked to DNA translation and amino acid sensing. In the arginine
biosynthesis pathway, four upregulated metabolites were involved: ornithine, glutamate,
aspartate, and fumarate (Figure 4D). Four of these metabolites feed directly into the urea
cycle (ornithine and aspartate) or are a byproduct (fumarate and urea) of the urea cycle.
Glutamate affects the urea cycle more indirectly as it is used to produce ammonia, from
which is formed L-citrulline, which enters the urea cycle. In the alanine, aspartate, and
glutamate pathway, upregulated metabolites included aspartate, L-asparagine, fumarate,
and glutamate (Figure 4E). Interestingly, four of the ﬁve metabolites feed into the TCA cycle.
These results suggest that CD5 may be linked to metabolic pathways that are signiﬁcant for
T cell activation and function.
We also desired to determine whether our RNA-Seq data could help us understand
how CD5 may be linked to metabolism on a transcriptomic level. To do this, we used the
Functional Annotation Tool in DAVID to map pathways involved with signiﬁcant genes
from our RNA-Seq data. Sixteen pathways were statistically signiﬁcant (Table S3). Of
these 16 pathways, three were directly involved with metabolism: biosynthesis of amino
acids, carbon metabolism, and glycolysis/gluconeogenesis. Using KEGG as a reference, we
found that many of the upregulated genes were involved in glycolysis and mitochondrial
respiration. In glycolysis, eight genes for glycolytic enzymes were upregulated (Figure 4F).
Interestingly, every enzyme involved in the conversion of fructose-1-6-bisphosphate to
phosphoenolpyruvate was upregulated in CD5KO Th cells. We also found that the enzyme
that converts galactose to glucose-6-phosphate (galactose mutarotase) was upregulated.
Of genes involved in mitochondrial respiration or amino acid metabolism, six genes were
upregulated (Figure 4G). Glutamic-oxaloacetic transaminase 1 and 2 (GOT1 and GOT2) are
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primarily responsible for the reversible conversion of glutamate to aspartate, glutamate to αketoglutarate, and aspartate to oxaloacetate; together, this is known as the malate-aspartate
shuttle [37]. Given that we saw an upregulation of aspartate, glutamate, and malate in
CD5KO Th cells, this suggests that CD5 may inﬂuence the malate-aspartate shuttle on a
transcriptomic level. We also saw an upregulation of branched-chain amino acid
transaminase 1 (BCAT1), which converts leucine, isoleucine, and valine into substrates that
produce glutamate as a byproduct. Interestingly, we saw decreased amounts of isoleucine
and valine in CD5KO T cells (Figure 2E), suggesting that increased transcription of BCAT1
may provide increased amounts of glutamate available for use in CD5KO CD4+ T cell
metabolism. We also saw an upregulation in succinate dehydrogenase complex iron sulfur
subunit B (SDHB), which is a subunit of succinate dehydrogenase that converts succinate
to fumarate and is part of Complex II in the electron transport chain [38]. We also saw an
upregulation of the aldehyde dehydrogenase 7 family member A1 gene (ALDH7A1),
which converts acetaldehyde to acetate, which can be converted to acetyl-CoA and be used
in the TCA cycle. Together, this pathway analysis suggests that the loss of CD5 is linked to
metabolic gene expression, which, in turn, may modulate metabolite availability.
3.5. Quantitative PCR Validates That CD5 Removal Is Linked to Transcriptional Upregulation of
Metabolic Genes
To validate the results of our RNA-Seq data, we performed quantitative PCR to
calculate the expression of metabolism-related genes between CD5WT and CD5KO unstimulated Th cells. We analyzed 21 candidate genes based on our RNA-Seq and bioinformatic
pathway data analysis (Figure 5).
Of the 21 metabolic genes measured, only 4 genes (Eno1b, Pgk1, Sdhb, and GOT2) did
not conclusively show substantially higher fold change in CD5KO T cells in comparison to
CD5WT. Interestingly, of the nine genes involved in glycolysis (Figure 5A), GCG (glucagon)
had the highest fold change and corresponded to our RNA-Seq data (Figure 5D). Many
of the signiﬁcant genes involved in glycolysis were validated (ALDOA, ALDOC, GALM,
GAPDH, PGAM1, and TPI1), indicating that CD5 plays a transcriptional role in regulating
unstimulated Th cell glycolysis (Figure 4F). Of the seven genes involved in amino acid
metabolism or the TCA cycle (Figure 5B), ASNS (asparagine synthetase) had the highest
fold change and mirrored results seen in RNA-Seq (Figure 5E). Surprisingly, only one of
the three metabolic genes involved in the TCA cycle, ALDH7a1, was validated. However,
we observed that all genes involved with amino acid metabolism (BCAT1, FAH, GOT1and
ASNS) were upregulated. These results indicate that CD5 is involved in the transcriptional
regulation of genes involved with L-glutamic acid (BCAT1, GOT1, and ASNS) [39,40],
phenylalanine (FAH) [41], and asparagine (ASNS) [39], which we saw upregulated in
CD5KO T cells (Figure 2F). FAH is also responsible for forming fumaric acid (which was
upregulated in CD5KO T cells), which is used in the TCA cycle [42]. Therefore, this
suggests that CD5 may be involved in regulating the TCA cycle by controlling metabolite
concentration mediated by other genes. Of the metabolite transporters we validated, all
but SLC25a13 had an average 2-fold increase in transcription or more (Figure 5C). Similar
changes in fold change were seen in our RNA-Seq data (Figure 5F). Given that many fold
change measurements seen in RNA-Seq in comparison to qPCR were not the same, this is
likely due to sample processing differences between the two methods. These results indicate
that CD5 is linked to the upregulation of T cell metabolic genes involved in metabolite
transporters, glycolysis, the TCA cycle, and amino acid metabolism.
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Figure 5. Comparative qPCR validated several upregulated metabolic genes in unstimulated CD5KO
Th cells. (A–C) Twenty-one metabolic genes were selected for validation. Fold change was measured
using CD5WT as reference and β-actin as the endogenous control (n = 3). Fold changes were calculated
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using the formula 2−ΔΔCт. (A) Of the nine genes involved in glycolysis, all but two (Eno1b and
Pgk1) exhibited an average fold change of 1.5 or higher. (B) Of the seven genes involved in the
TCA cycle or amino acid metabolism, all but two genes (Got2 and Sdhb) demonstrated an average
fold change above 1.5. (C) Of the ﬁve metabolite transporters we measured, all but SLC25a13
(mitochondrial glutamate) had at least an average 2-fold change. Pale yellow = average less than
1.0-fold change, yellow = average 1.0-fold change or higher, pale orange = average 1.5-fold change
or higher, dark orange = average 2.0-fold change or higher, red = average 3.0-fold change or higher,
dark red = average 5.0 = fold change or higher. (D–F) Comparison of qPCR average fold change and
RNA-Seq fold change of metabolic genes involved in glycolysis (D), amino acid metabolism or the
TCA cycle (E), and metabolite transporters (F). Red patterned bars represent qPCR fold change, dark
blue patterned bars represent RNA-Seq fold change. Only two genes (Gcg and Eno1b) had drastically
different fold changes.

3.6. CD5KO Th Cells Have Different Metabolic Proﬁles Compared to CD5WT Th Cells
To determine if CD5 functionally affects T cell metabolism, we measured the glycolytic
proﬁle and mitochondrial respiration of unstimulated CD5WT and CD5KO Th cells using
the Mito Stress Test (Agilent, Figure 6A–G).
Unstimulated CD5KO T cells had an increased oxygen consumption rate (OCR) in
comparison to CD5WT T cells (Figure 6A). The basal rate of CD5KO T cells, the last
measurement before the addition of oligomycin, was signiﬁcantly higher than CD5WT T
cells (Figure 6B), as well as the maximal rate, the ﬁrst measurement after FCCP injection
(Figure 6C). The spare respiratory capacity (SRC), which is the OCR difference between the
maximal and basal rates, was also signiﬁcantly higher in CD5KO T cells than CD5WT T
cells (Figure 6D). Similar differences were seen in published work described by Milam et al.,
where CD5lo cells had higher basal and maximal rates, as well as higher SRC [43]. Together,
these results suggest that the removal of CD5 is linked to increases in Th cell mitochondrial
respiration. We also measured mitochondrial mass and membrane potential to see if
mitochondrial structure or physiology played a major role in these metabolic changes. We
saw no statistical difference between CD5WT and CD5KO T cells, suggesting mitochondrial
dynamics may not play a signiﬁcant role in regulating CD5KO T cell metabolism (Figure S1).
Unstimulated CD5KO T cells also had an increased extracellular acidiﬁcation rate in
comparison to CD5WT T cells (Figure 6E). The basal rate and maximal rate were also
signiﬁcantly higher in CD5KO T cells (Figure 6F,G). We also performed ﬂow cytometric
analysis of glucose uptake in unstimulated Th cells using the ﬂuorescent glucose analog
2-NBDG (Figure 6H). CD5KO T cells have a slightly higher uptake of glucose in comparison
to CD5WT T cells. These results suggest that the removal of CD5 on unstimulated Th cells
is linked to glycolysis and mitochondrial respiration and may alter the metabolic proﬁle of
unstimulated Th cells.
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Figure 6. Removal of CD5 functionally increased glycolysis and mitochondrial respiration in unstimulated Th cells. (A,E) Using a standard Seahorse protocol, approximately 200,000 CD4+ T cells
were seeded into a poly-d-lysine coated 8-well XFp plate and analyzed for metabolic function using
stepwise injections of oligomycin, carbonyl cyanide p-(triﬂuoromethoxy) phenylhydrazone (FCCP),
and rotenone plus antimycin A. Three wells were plated for each mouse, and the average was taken for
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each analysis. Both measurements for glycolysis and mitochondrial respiration were acquired from
each individual sample. (A–D) Oxygen consumption rate (OCR) was used as a readout to measure
mitochondrial respiration via the Agilent Seahorse Mito Stress Test (n = 6). (B) Basal OCR, the readout
before the oligomycin injection, was measured. Each plot point represents the average of three
wells; p = 0.0088 by paired student t-test. (C) Maximal OCR, the ﬁrst readout after FCCP injection,
was measured. Each plot point represents the average of three wells; p = 0.004 by paired student ttest. (D) Spare respiratory capacity (SRC), the difference between maximal and basal rate, was
measured. Each plot point represents the average of three wells; p = 0.0047 by paired student t-test.
(E–G) Extracellular acidiﬁcation rate (ECAR) was used as a readout to measure the glycolytic rate
via the Agilent Seahorse Mito Stress Test (n = 6). (E) Basal ECAR, the readout before the oligomycin
injection, was measured. Each plot point represents the average of three wells; p = 0.0163 by paired
student t-test. (G) Maximal ECAR, the ﬁrst readout after FCCP injection, was measured. Each
plot point represents the average of three wells; p = 0.0203 by paired student t-test. (H) 2-NBDG, a
ﬂuorescent glucose analog, was used to monitor glucose uptake in CD5WT and CD5KO unstimulated
Th cells (n = 5); p = 0.0184 by paired student t-test. (* p < 0.05; ** p < 0.01).

3.7. Unstimulated CD5KO CD4+ T Cells Have Phenotypic Differences in Comparison to CD5WT
CD4+ T Cells
We used ﬂow cytometry to phenotype CD5WT and CD5KO CD4+ T cells to see if there
were any phenotypic differences in activation state or Th subset polarization (Figure 7).
We found that unstimulated CD5KO CD4+ T cells had higher levels of CD44 in
comparison to CD5WT CD4+ T cells (Figure 7A). We also found that there were higher
numbers of naïve T cells within the CD5WT CD4+ T cell population; however, we saw
higher numbers of memory T cells in the CD5KO CD4+ T cell population (Figure 7B,C).
While we did not see a signiﬁcant increase in CD4+CD25+ T cells in the CD5KO T cell
population, the CD5KO CD4+ T cells may have altered T cell subset phenotypes. To
determine if our results suggest metabolic differences based on activation state or subset
phenotype, we measured naïve T cell metabolism using the Mito Stress Test (Figure S2a).
We also measured gene expression of naïve CD5WT and CD5KO CD4+ T cells using qPCR
(Figure S2b). Both experiments demonstrated similar trends seen in unstimulated CD4+ T
cells, but there was no statistical signiﬁcance between naïve CD5WT and CD5KO CD4+
T cells.
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Figure 7. Unstimulated CD5KO CD4+ T cells were phenotypically different from CD5WT CD4+ T cells. (A) CD4+ T cells
were stained with CD44, CD62L, and CD25 to determine activation state and subset polarization. (B) Gating strategy to
determine naïve and memory populations between CD5WT
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and CD5KO CD4+ T cells. (C) Naïve (CD44 low, CD62L high) and memory (CD44 high, CD62L low)
populations were measured within CD4+ T cells. ** p-value < 0.01.

4. Discussion
CD5 is a T cell co-receptor that plays a critical role during early T cell development
by negatively regulating TCR signaling strength with the self-peptide-MHC complex.
Evidence of CD5 importance in T cell signaling was evident in CD5KO thymocytes and
CD5KO naïve T cells, which are hyperresponsive to TCR stimulation and produce higher
cytokine levels [26,44]. Given how T cell signaling and metabolism are intricately connected,
we hypothesized that the negative regulation of CD5 alters T cell metabolism. In this
report, we have shown that the removal of CD5 drastically changes T cell metabolism
through transcriptional mechanisms. We found that the serum metabolome composition
in CD5KO mice was signiﬁcantly different compared to CD5WT mice. Speciﬁcally, we
saw a signiﬁcant decrease in the levels of six different amino acids or derivatives and a
signiﬁcant increase in four metabolites. We have also shown that Th cells lacking CD5 had
increased levels of several key metabolites. In analyzing T cell and serum metabolomics,
we found 17 metabolites that were differentially regulated in both T cell and CD5KO mouse
serum. Eleven metabolites were higher in CD5KO T cells but lower in CD5KO mouse
serum (fumaric acid, uracil, ornithine, L-phenylalanine, L-proline, L-serine, L-aspartic acid,
L-glutamic acid, pyroglutamic acid, D-malic acid, and myo-inositol). Two metabolites,
capric acid and nonanoic acid, were lower in CD5KO T cells but higher in CD5KO mouse
serum. Interestingly, three metabolites, D-fructose, 3-hydroxybutric acid, and inosine, were
both higher in CD5KO T cells and CD5KO serum. These results suggest that CD5KO Th
cells take up more of certain metabolites and utilize them for metabolic function [22]. Given
these drastic changes involved in both CD5KO mouse serum and CD4+ T cell metabolome,
these results suggest that removal of CD5 may mediate changes in the serum metabolome
via Th cell metabolism.
However, we cannot ﬁrmly conclude this as our CD5KO mouse model is completely
devoid of CD5 expression, and given that other immune cells, such as B1 B cells and
dendritic cells, also normally express CD5. Recent ﬁndings have shown that CD5 expression
on B1 B cells drastically changes their ability to ﬁght infection [45]. Dendritic cells that lack
CD5 expression have also been shown to enhance CD4+ and CD8+ T cell activation and
produce better anti-tumor responses [46]. These factors necessitate further examination
in establishing the cause of CD5KO mouse serum changes. Further studies involving a
T cell-speciﬁc CD5KO mouse or adoptive T cell transfer into T cell-deﬁcient mice would
provide further insight in determining if this phenotype is T cell-dependent.
Of the signiﬁcant metabolites found differentially regulated in CD5KO Th cells and
serum, we found eight signiﬁcant pathways that these metabolites may affect. Of the
20 amino acids that are used for tRNA synthesis, we found that 13 of these amino acids are
differentially regulated in CD5KO CD4+ T cells. Five metabolites (ornithine, L-glutamic
acid, L-aspartic acid, fumaric acid, and urea) are involved in the arginine biosynthesis
pathway. While we did not see increased levels of arginine, two metabolites involved
in this pathway, (L-glutamic acid and ornithine) are particularly critical for the synthesis
of polyamines needed in active T cells for differentiation and proliferation [47]. Five
metabolites (L-glutamic acid, L-aspartic acid, L-asparagine, citric acid, and fumaric acid)
were signiﬁcant in the alanine, aspartate, and glutamate metabolism pathway. Since we
have also seen increases in glucose-6-phosphate, myo-inositol, and D-fructose, these results
suggest that CD5 may be linked to glucose breakdown and TCA cycle regulation [48].
Together, this evidence suggests that the removal of CD5 increases metabolite concentration
that could be used for speciﬁc metabolic pathways important for T cell function.
We performed bioinformatic pathway analysis using our RNA-Seq data and found
16 signiﬁcant pathways that may be affected by the loss of CD5. We showed that CD5 might
directly impact glycolysis and the TCA cycle via increased metabolite concentration or
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transcriptionally regulated metabolic genes. Speciﬁcally, we saw an increase of glucose-6phosphate and an increase in the transcription of galactose mutarotase (GALM), suggesting
that CD5 may be linked to galactose usage in CD4+ T cells. As we did not ﬁnd upregulation
of other enzymes involved in the galactose-to-glucose pathway, future functional validation
of this conclusion would require measuring T cell metabolism in the presence of galactose
to assure that the increased presence of glucose-6-phosphate is due to increased galactose
conversion.
While we primarily focused on three metabolic pathways in our bioinformatic analysis,
we also noticed that the MAPK pathway was signiﬁcantly involved in CD4+ CD5KO T
cells. Previous studies have shown that there may be a connection between CD5 and the
PI3K/AKT/mTOR pathway [49], and our study also suggests this. Brieﬂy, we found that
PKC (protein kinase C) and CamK (calmodulin-dependent kinase) were upregulated in
CD5KO CD4+ T cells (data not shown). PKC affects calcium signaling, which plays a
role in regulating metabolism, suggesting that the loss of CD5 may be linked to increased
metabolism through calcium modulation. CamK indirectly affects the transcription of
other genes, such as GAPDH, PGK1, ALDOA, which we found were also upregulated.
Given that these genes are involved in glycolysis, this suggests that the increase of CamK
transcription may be linked to the loss of CD5 and the subsequent changes in metabolism.
Further studies involving MAPK signaling and CD5 metabolism would be beneﬁcial to
validate these conclusions.
While we did not ﬁnd a signiﬁcant pathway that involved fatty acid oxidation, it is
important to note that in CD4+ T cells, we found that many fatty acid metabolites and fatty
acid oxidation metabolic genes are lower in CD5KO mice, suggesting that CD5 may be
linked to decreases in fatty acid oxidation. This is especially interesting given that PD-1
knockout T cells rely more on fatty acid oxidation [8]. Future studies investigating fatty
acid oxidation in CD5KO CD4+ T cells are necessary to determine the role of fatty acids in
Th cells.
Validation of metabolic gene expression revealed that several metabolic genes involved
in glycolysis, the TCA cycle, amino acid metabolism, and metabolite transportation were
upregulated in CD5KO unstimulated Th cells. Of the 21 metabolic genes analyzed, all but
four genes demonstrated at least an average 1.5-fold increase in CD5KO T cells in comparison to CD5WT T cells. Seven genes involved in glycolysis were validated; however, only
one directly involved in the TCA cycle was validated. Despite this, we saw upregulation in
four genes involved with amino acid metabolism, which conﬁrmed some of our previous
metabolomics results. Of these genes, BCAT1 has also been shown to convert glutamate to
α-ketoglutarate [40] and FAH converts fumaroacetate to fumaric acid [42], indicating that
CD5 is linked to transcriptional regulation of amino acid production needed for the TCA
cycle. We also validated that all signiﬁcant metabolite transporters were upregulated in
CD5KO T cells using qPCR, indicating that CD5 is also linked to transcriptional regulation
of metabolite transporters to increase the uptake of metabolites. Further conﬁrmation of
surface-expressed metabolite transporters is important for future studies on CD5KO CD4+
T cells.
Metabolic proﬁling of CD5KO T cells revealed that unstimulated Th cells have an
increased glycolytic rate and increased mitochondrial spare respiratory capacity. CD5KO
Th cells also had a slight increase in glucose uptake, indicating that CD5 is linked to
functional metabolic changes in Th cells. Increased metabolic regulation has the potential
to metabolically prime the T cell to function better under stressful conditions, such as a
nutrient-deprived tumor microenvironment [50]. However, it is possible that the metabolic
differences we have seen may also be due to activation state or subset polarization in
unstimulated CD4+ T cells. We saw a signiﬁcant difference in naïve and memory subsets
between CD5WT and CD5KO CD4+ T cells. Previous studies have suggested that the
removal of CD5 polarizes CD4+ T cells toward a Treg phenotype; while we did not see
a signiﬁcant CD4+CD25+ T cell difference between CD5WT and CD5KO unstimulated T
cells, others have seen an increased presence of Tregs among CD5KO CD4+ T cells [51].
While performing metabolic assays and qPCR illustrated a similar trend between naïve and
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unstimulated CD5KO CD4+ T cells, further studies would be necessary to determine how
the removal of CD5 changes for naïve, activated, Treg, and memory subsets.
Because of these T cell metabolic changes, CD5 has the potential to impact health and
disease, such as chronic infection and cancer immunotherapy [52]. Inhibitory signaling
from co-receptors such as PD-1 has been shown to aggravate T cell exhaustion during
infection because of metabolic changes initiated by the co-receptor [53]. CD5 has also been
shown to promote infection by the hepatitis C virus, indicating that the blockade of CD5
may be beneﬁcial in treating certain chronic infections [54]. Inhibitory co-receptors such
as PD-1 and CTLA-4 have become prominent targets for immune checkpoint inhibition in
cancer immunotherapy, allowing for T cells to be activated in cancerous environments [55].
Effects of PD-1 blockade have demonstrated changes in amino acid concentration in T cells,
much like we have demonstrated with the removal of CD5 [22]. Blockade of CD5 also
demonstrated increases in both CD4+ and CD8+ T cell responses to cancer, indicating that
its inhibitory effects can be halted by antibody blockade [27,34]. Together, this evidence
suggests that CD5 may be a potential immunotherapeutic target for antibody blockade
to increase T cell activation and allow T cells a better metabolic advantage in a glucosedepleted tumor microenvironment.
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Abstract: Since the completion of the Human Genome Project in 2003, genomic sequencing has
become a prominent tool used by diverse disciplines in modern science. In the past 20 years, the
cost of genomic sequencing has decreased exponentially, making it affordable and accessible.
Bioinformatic and biological studies have produced significant scientific breakthroughs using the
wealth of genomic information now available. Alongside the scientific benefit of genomics,
companies offer direct-to-consumer genetic testing which provide health, trait, and ancestry
information to the public. A key area that must be addressed is education about what conclusions
can be made from this genomic information and integrating genomic education with foundational
genetic principles already taught in academic settings. The promise of personal genomics providing
disease treatment is exciting, but many challenges remain to validate genomic predictions and
diagnostic correlations. Ethical and societal concerns must also be addressed regarding how
personal genomic information is used. This genomics revolution provides a powerful opportunity
to educate students, clinicians, and the public on scientific and ethical issues in a personal way to
increase learning. In this review, we discuss the influence of personal genomics in society and focus
on the importance and benefits of genomics education in the classroom, clinics, and the public and
explore the potential consequences of personal genomic education.
Keywords: personal genomics; Human Genome; sequencing; genetic testing; bioethics; genomics
education; science education
1. Introduction
Genomics has become a central pillar driving modern scientific research and discovery.
Beginning with the Human Genome Project that was initiated in 1990 and completed in 2003, the
study of genomics has rapidly evolved in the last 30 years. Today, it is possible to rapidly sequence
an organism’s genome and determine critical insights into many areas including health, ancestry, and
traits [1]. The vast amount of genomic information obtained over the last decade has provided crucial
insights into various health issues, which have significantly improved diagnosis and treatment for
many diseases [2]. For example, personal genomics data is now used to distinguish different cancers,
such as Burkitt’s lymphoma and diffuse B-cell lymphoma, and enables prediction of cancer sensitivity
to drugs and treatment selection [3]. Additionally, genomics data has been used in the clinic to help
monitor the likelihood of graft rejection by measuring gene expression in peripheral lymphocytes [4].
Important advancements in genomics have expanded to other organisms, such as bacteriophages
which are currently being characterized and developed for agricultural treatments such as fire blight
Int. J. Mol. Sci. 2020, 21, 768; doi:10.3390/ijms21030768
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[5]. The use of genomics to characterize bacteriophages allows their genomes to be analyzed for
bacterial specificity and to identify genes that may be beneficial or harmful in targeting specific
bacterial populations [6]. In addition, genomics has played a key role in ushering in new fields of
research such as the microbiome, providing many important basic science insights as well as potential
treatments for many diseases [7]. For example, patients with Clostridium difficile infection have
significantly benefited from microbiome transplants from healthy donors, thereby providing an
effective treatment for a highly morbid infection [8]. Genomics provides information regarding the
healthy donor’s microbiome profile for healthcare providers to know the characteristics and
composition of the transplant bacterial community [9]. These rapid advancements have been enabled
by the arrival of next-generation sequencing in 2006, which inspired a technological wave of new
methods and applications that have revolutionized DNA sequencing [1]. With many highthroughput sequencing methods now readily available, the cost and time to obtain genomic data has
decreased significantly. The Human Genome Project took 13 years and cost $95,263,072, whereas
today some companies charge less than $1000 to sequence your entire genome in 24 hours [10].
Despite the exciting technical advances in genomics, many societal, ethical, and scientific
concerns remain. The significant decrease in cost has made genomic sequencing more accessible to
businesses outside of academic and clinical research, leading to the development of direct-toconsumer genomic profiling [11]. Some studies have shown that direct-to-consumer genomic
profiling has been beneficial in identifying and preventing disease [12]. However, many health care
professionals remain concerned about direct-to-consumer genomic profiling, as results may lack
clinical validity, can be misinterpreted by patients, and can psychologically impact some patients’
well-being [11,13,14]. For these reasons, genetic counselors are trained to interpret results and
provide education to patients to help them make informed healthcare decisions, yet many people are
unlikely to utilize genetic counselors and opt to interpret their results on their own or see a physician
instead [15]. However, many healthcare professionals that are not specialized in genomics, such as
primary care physicians, feel unprepared to answer patient questions about their genomic profile
[16–18]. This rapidly moving field is uncovering societal challenges in how to properly incorporate
and utilize genomics as a part of our understanding of health and disease and medical practice.
The dramatic increase of public interest for genomic profiling from 29% to 37% between 2008 to
2011 also presents potential ethical issues [19]. The Genetic Information Nondiscrimination Act of
2008 (GINA) prevents employment and health insurance discrimination based on genetic
information; however, ethical and privacy concerns remain, primarily regarding data access [14].
Recently, law enforcement and public attention has focused on using genealogical genomic profiling
to find relatives and ancestors via direct-to-consumer genetic testing [20]. Famously, the Golden State
Killer was recently apprehended after police used genomic information obtained through
GEDmatch, a genealogy company, to trace the killer through familial genomic profiling [21].
Currently, the Federal Bureau of Investigation is addressing guidelines for using genealogy, stating
that investigations only utilize this source of information if CODIS reveals no matches and only using
public databases which inform the users of this possible forensic use [22]. More recently, the Pentagon
advised all military personnel against direct-to-consumer genetic testing [23]. The GINA does not
apply to military personnel, therefore, the discovery of unknown genetic markers or inaccurate
results which affect military physical requirements could jeopardize the member’s service, as well as
potentially affect military security through exposure of genetic information [24]. While personal
genomics is a valuable tool for police to identify and locate suspects, it raises privacy concerns for the
public and military and requires public discussion and education about the use of genomic
information [25].
As genomics remains an emerging discipline, much work still needs to be accomplished for the
genomic therapeutic potential of precision medicine to be fully realized. Most genome-wide
association studies (GWAS) have data from subjects of European descent, limiting the interpretation
of and increasing uncertainty of disease risk for non-European subjects [26]. Cancer biomarkers such
as BRCA1/2 are significant indicators of breast cancer; however, many BRCA1/2 mutations and
unknown genetic variants are poorly defined, making disease risk uncertain and disease assessment
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and diagnosis complicated [2,27]. Unfortunately, these complications in data interpretation create
considerable issues, such as significant risk of misdiagnosis, psychological impacts on patient and
relatives, unnecessary medical procedures, and decreased confidence in proper diagnosis and
treatment [28]. Consequently, a lack of genomic understanding regarding how to interpret genomic
test results is an important need for genomic education about what can and cannot be concluded
from personal genomic information. As genomics is a critical branch of genetics, it is equally
important that a concrete understanding of genetics preludes and accompanies genomic education.
Beyond its potential in ancestry identification, law enforcement, and health care, this personal
genomics revolution provides a powerful opportunity to educate students, clinicians, and the public
on relevant scientific and ethical issues. Effective genomic education enables healthcare professionals,
students, and the general public to understand the benefits of genomic discoveries with important
applications in ancestry, health, traits, and forensics [29–31]. In this review, we discuss recent
literature on personal genomics education in academic, professional, and public settings and examine
the benefits for enhanced student learning in the classroom and potential consequences of personal
genomic education.
2. Academic Genomics Education
2.1. High School Education
High school is one of the earliest academic institutions where students are introduced to
genomics. As genomic information becomes more common, it is imperative that molecular and
genomics education begin early to not only provide background to future health professionals, but
to familiarize all citizens with the limits and possibilities of genomic information in healthcare and
beyond [32]. Genomic education in high school is also important because high school biology is
frequently not only the initial, but also the final formal exposure to genomics for many Americans
[33]. Many high school students have the interest, maturity, and intelligence to learn and understand
genomics, yet few studies involving high school students and genomic education have been
conducted in the past five years (Table 1) [34–44].
Table 1. Publications in the last five years on high school students and genomics education.
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Each of these studies incorporated teaching genomic principles to high school students. Of the
nine studies identified, three utilized genomic online tools to teach concepts [36,37,39]. Many of the
tools utilized in these studies, such as the NCBI database and next generation sequencing, are critical
for genomic studies in college. Utilizing these technologies in high school classrooms can facilitate
interest in and preparation for careers focused on genomics [34].
One interesting study utilized media representation of genomics to teach students to think
critically of media portrayal and framing of science topics [44]. With media being readily available, it
is essential for students to develop critical thinking and reasoning skills so they can identify
misconceptions in the media regarding science topics [45]. Teaching genomics to high school students
can also help public perception and understanding [38]. Athanasiadis and colleagues held an
educational symposium for students and teachers across Denmark which garnered positive media
attention as the symposium was extensively broadcast on primetime news and published online.
These studies demonstrate the importance and influence of media in teaching genomics.
Of the nine studies described in Table 1, seven studies surveyed student learning (indicated by
asterisk next to paper title in Table 1). Of the seven studies, six of the studies demonstrated that
student knowledge and interest increased as the model was implemented, indicating these learning
models have the potential to improve genomics education. Students felt that learning genomics
helped prepare them for future academic study [37] and created a more positive learning experience
[40]. Thus, these publications indicate that incorporation of genomic education can be beneficial for
high school student learning [38,39,44].
It is also important to recognize the need for teacher education and curriculum development
specific for this new field of genomics. Without training and updated curriculum, teachers can be
uncomfortable or hesitant to implement new teaching techniques. Programs such as Teaching the
Genome Generation (TtGG) are enabling teachers to become more confident in genomic education as
the programs teaches them hands-on laboratory skills that they can use to teach students real-life case
scenarios [41]. It is interesting to note that teaching style can also impact learning experiences [40]. A
recent study identified the importance of assessing student knowledge and tailoring lessons based
on student knowledge gaps in order to positively deepen student knowledge and attitudes towards
genomic information [44]. By helping to open educational doors for teachers, they can be better
prepared and equipped to engage their students in learning genomic principles. Programs like TtGG
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can also provide collaboration opportunities for teachers to discuss and potentially improve genomic
curriculum [41]. A recent study found that of 11 selected textbooks, 73.8% of the genomic content
only discussed classic single gene diseases, such as sickle cell anemia, indicating that many high
school textbooks likely need updating to include multifactorial or complex conditions such as cancer
or diabetes [33]. Understanding that many common diseases are controlled by numerous factors,
including genetics and the environment, could be pivotal for preparing students with knowledge
needed for a future filled with genomic applications [33]. Thus, these studies indicate that not only
teaching genomics to high school students is important but educating teachers and modernizing
curriculum is also vital to facilitate student learning.
2.2. Undergraduate and Graduate Education
Teaching undergraduate and graduate students is another key academic focal point of genomic
education. Over the last twenty years, studies involving genomic education of college students has
steadily increased (Figure 1). Of the 99 personal genomics studies we identified in the past 19 years,
nearly half of the studies were published in the last four years, indicating that genomic education is
being implemented at an increased rate in the college setting. Interestingly, many studies performed
earlier in the decade focused on teaching upper-level junior and senior life science majors [46,47], but
more recently introductory biology courses have begun to incorporate genomics into their class
curriculum [48,49].

Figure 1. Number of college genomic education publications since 2000: Ninety-nine studies from
2000 to 2019 were surveyed. Of the 99 published studies, 4 were published between 2000 and 2004, 11
were published between 2005 and 2009, 33 were published between 2010 and 2014, and 55 were
published in the last five years (2015 to present).

College genomic education is also targeting a variety of student majors (Figure 2). Many of the
studies we surveyed did not specify their class’s major composition or the class composition spanned
multiple disciplines [50]; however, 32 of the studies focused on the genomic education of life sciences
majors, primarily focusing on biology and biochemistry majors [51,52]. It is immensely important
that genomics education be emphasized for life science majors, as many of them will pursue
healthcare careers and play an important role in disseminating genomic information to their patients
[53]. Surprisingly, only a few studies focused specifically on non-science majors. It is possible that
studies we surveyed that did not specify their class target audience or composition had an impact on
non-science majors taking the class. Educating non-science majors in genomics will be an important
avenue to educate students who do not specialize in a science major and prepare them to understand
and recognize the importance and influence of genomics in society [54].
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Figure 2. Targeted or reported college student major composition of undergraduate/graduate classes.
Of the 99 personal genomics studies we surveyed, we analyzed the target student audience or the
reported class major composition. We found that 44 of the studies spanned multiple majors or did not
specify their target student audience, 32 of the studies were focused on life science students, 15 on
nursing students, 2 on pre-medicine students, 3 on non-science majors, and 4 on other disciplines.

Remarkably, 15 of the studies were focused on examining genomic education for nursing
students. According to many studies, there is an increasing need for nursing students to be educated
in genomics as their knowledge of and attitude toward genomics is poor, and many do not feel
prepared to use genomics in the clinic [55–57]. Nurses are also crucial healthcare providers that,
alongside physicians, are part of the frontline in providing genomic education to patients [58]. Studies
have shown that providing genomic courses for nursing students improves student confidence and
genomic literacy [59,60]. Nurses are a critical part of the healthcare workforce, and therefore it is
important for nursing classes to incorporate genomics into their curriculum [59].
Of the studies surveyed, there were notable learning models and resources that have been
successfully used to teach college-level genomics, particularly to life sciences majors. Course-based
undergraduate research experiences (CUREs) are a major method of undergraduate genomic
education [61]. CUREs are designed to provide learning and hands-on research experience to
undergraduate students [62]. In surveying the literature, three studies about genomic CUREs stood
out. Olson et al. published a genomic CURE designed to screen gene expression in Drosophila [63].
With over 250 co-authors, this study demonstrated significant success in involving a large
introductory class size in research-based genomic learning. This study also positively impacted
student learning and significantly increased the number of undergraduate students that continued
to pursue a STEM degree. Reeves et al. studied the conservation of the methionine pathway in yeast
to teach genomics to students in a CURE-based setting [51]. Five semesters of teaching this course
revealed that many students significantly increased their knowledge base and research skills.
Importantly, underrepresented minority students had larger knowledge gains than other groups,
indicating a positive movement toward cultivating successful professionals to bring diversity to their
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field [64]. Bhatt and Challa designed an introductory course which taught genomic principles
through hands-on experience with CRISPR-Cas9, which has become one of the most important
genome-editing tools in modern science [65]. The study utilized zebrafish to analyze genetic
mutations with their corresponding phenotype and allowed students to design and test CRISPR-Cas9
templates in order to disrupt certain zebrafish genes. Additionally, this CURE demonstrated student
knowledge increases, and students also reported that they gained transferrable skills and insights
applicable outside of the CURE. Given these observations, CUREs are a vital educational means for
teaching genomics to college students.
One of the most widespread CURE programs is the Genomics Education Partnership (GEP). The
GEP consists of over one hundred universities who are collaborating to bring genomic learning to
their classrooms through research-based methods. Students who participate in GEP projects actively
learn how to perform genome annotation of Drosophila and produce gene profiles of specific portions
of different Drosophila genes [66]. Students who have worked on GEP projects have reported
increased knowledge gains and value their learning experience and contribution to science [67]. GEP
projects are also very accessible to most universities as only computers are needed and are versatile
since projects can be short and be accomplished by many students in comparison to a typical
research-based class [66]. These studies have demonstrated that GEP is a valuable teaching resource
for undergraduate genomic education [67].
Science Education Alliance Phage Hunters Advancing Genomics and Evolutionary Science
(SEA-PHAGES), also called Phage Hunters, is another CURE program which has been instrumental
in teaching undergraduates about genomics [68]. Phage Hunters was designed to be a year-long
course for beginning undergraduates where bacteriophages are isolated from soil samples,
sequenced, and characterized the following semester for putative gene function [69]. Seventy-three
universities have implemented beginning courses of Phage Hunters and have demonstrated that
Phage Hunters increases student learning, interest, and pursuit of academic education in STEM
majors [49,69,70]. Some universities have modified the Phage Hunters course so that the second
semester of gene characterization is included into other biology classes and have demonstrated equal
academic value and success [49]. In addition to the benefits of student learning, students often
become authors on scientific publications of bacteriophage characterization, thereby improving their
academic portfolio as well [6]. These studies demonstrate that Phage Hunters is a valuable CURE
which can be implemented in large undergraduate classes and be advantageous for teaching
genomics.
A valuable way to teach genomics to college students and significantly improve interest and
engagement is to personalize the data they are analyzing. We highlight two genomics education
studies performed at Brigham Young University. The first study examined the effects of giving
students personal genomics kits and found that just the anticipation of getting personal data in the
future improved student learning and interest in their related course material as compared with
students who were analyzing genomics data from an unidentified individual [46]. Students who were
going to receive personal genomic results spent more time studying for their lecture-based molecular
biology, genomics, or immunology courses, which increased their confidence to interpret the results
they would receive as well as better understand the risks and benefits of using direct-to-consumer
genetic testing. The second study examined the effects of giving students microbiome kits and found
that students who analyzed their personal microbiome were more engaged in learning and had a
more positive attitude towards the class as a whole as compared with students analyzing microbiome
data from an unidentified individual [47]. Students who analyzed their own microbiome data also
reported they visited more websites and sources to learn about the microbiome, indicating that
receiving personal microbiome kits increased their interest in learning. Additionally, students who
received microbiome kits felt the course was more applicable to them than those who analyzed
microbiome data from an unidentified individual. While these studies did not directly involve
students performing research like in CUREs, it is important to note that students analyzing personal
genomics or microbiome data spent more time studying the topic and their interest increased in
comparison to control groups who only received data from an unidentified individual [46,47]. These
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studies indicate that providing genomics data that is personal to you is a valuable tool for increasing
student interest and engagement and educating undergraduate and graduate students in genomics
topics.
2.3. Medical School Education
Genomics is becoming an integral part of medicine and physicians must be prepared to
understand and communicate complex genomic information to patients and the public in a simple
and accurate manner [71]. This critical need for genomics in medical school has already been
incorporated into many medical student training programs [72]. The Association of Professors of
Human and Medical Genetics has developed a core curriculum for medical students, which focuses
on understanding genomic variance, disease phenotype, genomic technologies, and direct-toconsumer testing [72]. Despite this, there has been debate about the most effective educational models
with which to teach genomics to medical students [73]. Use of personal genomics in medical school
has had mixed results. One study found that student interest did not increase and that many students
did not think personal genomics was useful [74]. In contrast, another study found that genomics
enhanced learning and provided a positive learning experience [75]. Interestingly, the difference
between these two studies was the addition of personal genomic testing to the genomics course.
Students who did personal genomic testing had significantly higher test scores and self-reported that
their conceptual knowledge in genomics had significantly increased [75]. These studies suggest that
including personal genomics testing into medical school classrooms may be beneficial in increasing
student knowledge and interest about genomics.
The Anatomy to Genomics (ATG) Start Genetics medical school initiative is another promising
method for teaching medical students about genomics [76]. The ATG initiative incorporates first-year
anatomy with genomics to teach students about genomic sequencing application and strengthen their
understanding in anatomy. As part of the initial study at Lewis Katz School of Medicine at Temple
University, DNA samples were taken from the liver, skin, cardiac, and skeletal tissue. Seven different
cadavers were dissected, DNA samples were analyzed, and students were asked to research single
nucleotide polymorphisms (SNPs) (Figure 3). This ATG program allowed students to draw
conclusions about the cadaver’s traits and disease phenotype regarding its genomic profile. Another
group performed a similar study on a cadaver who had been diagnosed with idiopathic pulmonary
fibrosis [77]. Interestingly, the genomic characterization of the cadaver revealed that the individual
could have died from nonspecific interstitial pneumonia rather than idiopathic pulmonary fibrosis
as had been suspected by the attending physician. The students found that the cadaver had a SNP
(rs35705950) in the promotor region of the mucin glycoprotein MUC5B, which is associated with risk
of developing idiopathic pulmonary fibrosis, but the SNP had never been linked to nonspecific
interstitial pneumonia. These findings confirm that the SNP in MUC5B promotor is related to the
development of lung disease and that the cadaver was genetically predisposed to lung disease.
Together, these studies demonstrate that a combined anatomy and genomics approach is
advantageous to student learning and furthering clinical research.
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Figure 3. Workflow of first-year medical anatomy lab and genomics. Cadavers are dissected by
students and traits about the cadaver are observed and recorded. DNA samples are isolated from
various organs, including the heart and liver. Samples are sequenced and professors assign SNPs to
different student groups who characterize the SNPs and associate them with cadaver traits. The
students present their research in a 15-minute PowerPoint presentation [76].

2.4. Education for Genetic Counselor Students
The need for genetic counselors has never been more important with the rise of genomic
technologies and healthcare services available to the public [78]. There has been a significant increase
in demand for genetic counselors due to the genomics revolution; however, lack of funding,
counseling supervision, and training slots has created a nationwide shortage of genetic counselors
[79]. Genetic counseling programs are designed to educate students to fill a professional role in
providing genomic-related medical advice to patients and medical practitioners [80]. With
specialized training and certification, it is extremely important that up-to-date genomics and
counseling education be emphasized in genetic counseling training programs [81]. Genetic
counseling instructors were surveyed about the incorporation of genomics into genetic counseling
training and found that the majority felt genomics was important to include and that most topics
were currently included or being established [82].
Some institutions such as Stanford University are focusing on experiential learning utilizing
”rotations’ for genetic counseling students to teach variant interpretation using a case-based system
[83]. Three distinct ”rotations” were created, focusing on different settings of genetic counselors, i.e.,
clinical, research, or laboratory-based rotations. Students reported that these rotations were
particularly useful in preparing them for their chosen discipline. Another study conducted at the
University of North Carolina at Greensboro and Duke University found that teaching clinical
application of genomics testing should be emphasized [81]. Students in this study reported that while
genomics testing curriculum prepared them to pass the ABGC board exam, 50% of students felt
unprepared to fill the role of providing genomic testing interpretation on a clinical scale. These
studies emphasize the need to analyze genetic counseling student training and perhaps incorporate
more access to clinical or hands-on experiences to improve genetic counselor preparation [81,83].
3. Genomics Education for Clinical Professionals and the Public
Advancements in genomic education on the academic level have rapidly expanded over the past
decade; however, educating healthcare professionals that are currently practicing and the public is
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equally critical and must be addressed [84]. Current health professionals need to be educated as they
administer developing genomic technologies in the healthcare industry as they may have been
trained before the genomics era, and the public needs to be educated as the influence of genomics is
becoming more personal and frequent [50,85]. Here we will discuss recent strategies and challenges
in the education of practicing nurses, practicing physicians, and the public.
3.1. Nurse Genomic Education
Nurses are a pivotal part of the healthcare workforce in implementing genomics into everyday
patient care as they lead changes in healthcare and ethical practices and interact frequently with
patients [86]. However, many nurses lack understanding of genomic principles, resulting in
healthcare deficits that can be improved through genomic technologies [87]. Eighteen countries were
recently surveyed on existing genomic education and three countries (United Kingdom, Japan, and
the United States) have genomics integrated into nursing student classes and competencies, but only
Israel requires all practicing nurses to take a mandatory 28 h course in order to remain certified to
practice [58]. Other studies have measured genomic competence, knowledge, and attitudes and
found that genomic integration into nursing practice is currently lacking, but education programs
improved competency [88]. These studies indicate genomic competency desperately needs to be
incorporated into continued nursing education.
Nursing professionals have begun developing initiatives to address genomic educational needs.
In 2012, the Genomic Nursing State of the Science Initiative established a blueprint to improve
genomic nursing education through development of infrastructure and research to guide genomic
healthcare [89]. More recently, the Global Genomics Nursing Alliance (G2NA) was established in
2017 to focus genomic education and advancement in the general nursing population [58]. Their
efforts focus on improving teaching resource accessibility and increasing collaboration between
nurses around the world [86]. These efforts mark the beginning of increasing genomic competency
throughout the nursing profession.
3.2. Genomic Education for Practicing Physicians
Physicians are often the first healthcare professional with whom patients want to discuss genetic
test results; however, many practicing physicians who have not been trained in genomics in medical
school do not feel prepared to use or interpret genetic test results [90,91]. It has been shown that
physicians are more likely to utilize genomic technologies if they have institutional guidelines,
patient interest, and clinical validity, but most importantly the knowledge and confidence needed to
successfully administer tests and understand results [92]. In response to this need for genomic
education for physicians, many options have become available to begin filling gaps in physician
knowledge. Two major organizations have been formed to support genomic education for
physicians, The Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCCPEG) and the Genetics in Primary Care Institute (GPCI).
The ISCC-PEG was formed in 2013 and designed to be a collaborative network in which
physicians can address educational gaps to subsequently improve genomic knowledge and increase
the use of genomics in practice [93]. The ISCC-PEG also provided a framework with which physicians
can use to critically analyze genomic competency called ”entrustable professional activities” or EPAs
(Figure 4). Each EPA outlines principles which can guide the physician’s learning so they can
understand genomics and execute these principles [94]. These principles can provide a critical
foundation of genomics knowledge for physicians to utilize genomic technologies. The GCPI was
established in 2011 as an electronic resource aimed at increasing genomic education and knowledge
among physicians [72]. The website provides webinars on various genomics topics and resources for
educating physicians. Together, these two organizations provide significant resources to aid
physician genomic education and incorporation of genomic technologies into mainstream medicine.
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Figure 4. Five ”entrustable professional activities” or EPAs necessary for physician instrumentation
of genomics in the medical field and areas of focus for analyzing physician genomic competency
adapted from [93]. These EPAs include family history, genomic testing, somatic genomics, and
microbial genomics which all play a vital role in improving patient treatment.

Outside of these two organizations, other resources and models for physician genomic education
are available. A recent study revealed that active learning modules used in training physicians not
only improved genomic knowledge and confidence, but also increased retention of principles and
subsequent changes in physician practice [95]. Educators in this study also utilized principles of
backward design to identify gaps in genomic knowledge and structured the training to test genomic
competency in those areas, which helped improve the educational outcomes [96]. Aside from inperson training, many other resources sites, data repositories, interprofessional education, and even
emails are being used to disseminate genomic information to physicians, indicating that
incorporation of genomic education into medical practice is becoming a reality [97,98].
3.3. Public Education
The public is perhaps one of the most difficult demographics to educate about genomics due to
varying backgrounds, learning capacities, and attitudes about science [50]. However, educating the
public about genomics is critical because genomics is becoming more mainstream and affects their
personal lives; therefore, they need genomics education in order to make educated decisions about
healthcare for themselves and their families [80,99]. Currently, many obstacles make educating the
public about genomics challenging, including the media and educational infrastructure [50].
There are many websites dedicated to providing foundational genomic understanding, such as
Genetic Alliance, Scitable, and the PHG Foundation [100]. The media can be a useful tool for
researching genomics; however, like many other science topics, the internet also provides misleading
or unhelpful information [43]. Often, people find information about genomics through news
headlines, which presents a dilemma primarily centered on journalism [45]. News journalists are
trained to write very differently from scientists as they generate engaging headlines or article
introductions that often lack the context needed to accurately understand the genomic issue at hand
[100]. Additionally, the audience may not finish reading or only skim through the article, which can
perpetuate confusion and misconceptions about genomic studies [101]. To combat this challenge,
more training of science policy in journalism is needed to provide thorough coverage and discussion
about scientific topics, thereby providing more complete information to the public [102].
Educational infrastructure is another main concern of public genomic education. In a recent
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study, genomic researchers and advisors were interviewed about educating the public and found
that much debate revolves around who is responsible for teaching the public about genomics, who
the target audience is, and how the subject should be approached [50]. This study also revealed that
there is a need for some entity to lead and centralize public genomic education, as well as develop an
educational framework with which to educate the public. If a centralized organization can address
these challenges, public genomic education can become more effective and beneficially help the
public make decisions about their healthcare regarding genomics.

4. Benefits, Challenges, and Potential Strategies of Genomic Education
In this review, we have discussed genomic education on academic, professional, and public
platforms. There are substantial benefits and challenges in implementing genomic education in all
these areas (Table 2).
Table 2. Benefits and challenges in incorporating genomic education into academic, professional, and
public settings.

Benefits of Genomic Education
Improves knowledge, interest, and
engagement
Creates positive learning that can be scaled to
many

Challenges of Genomic Education
Gap in knowledge among healthcare
professionals
Cost, time commitment, competing priorities

Drives and strengthens genomic research
Allows personal investment to drive learning

Complexity of subject material
Misconceptions from media

Increases retainment of STEM college majors
and enhances career skills and capabilities
Develops confidence in knowledge of and
communication skills about genomics

Genomic science still developing, making
implementation challenging
Lack of infrastructure or resources for
professional development

As previously described, there are many benefits that genomics brings to educating students at
any academic level. Numerous studies support the finding that genomic education facilitates student
interest and develops student confidence [52,103]. Genomic education can also foster research ideas
that increase our understanding about genomics and recruit more students to study science and
prepare for scientific careers [37,77]. Studies have also shown that genomics can be scaled to teach
many students and still provide meaningful learning experiences [49]. It is also important to note that
the personal aspect of genomics can improve interest and engagement of learning by increasing
personal investment in the learning material [46,47]. However, some challenges and barriers remain
that must be addressed (Table 2). Cost and time commitments are often a challenge in providing
meaningful genomic education experiences [79]. Healthcare professionals often have gaps in genomic
knowledge, which can be neglected due to competing priorities and time constraints [92]. Lack of
educational foundation and limited resources can hinder genomic education in different sectors [50].
Genomics complexity and misconceptions perpetuated by society or the media can compound
genomic education in the public space [100]. Most importantly, genomics is rapidly expanding with
new information being learned each day. Thus, it is critical to improve genomic education at the
academic, professional, and public platforms to reach as many people as possible and to realize the
benefits of genomics discoveries in understanding our ancestry, health, and traits (Figure 5) [29–31].
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Figure 5. Summary of the importance of and needs for genomic education across various academic,
professional, and public platforms.

Despite the benefits and challenges of genomic education, it is critically important that
educational dissemination and teaching strategies be addressed. Many educational approaches have
been presented in this review, and here we summarize some educational guidelines which have been
shown to improve genomic learning across various platforms as well as propose suggestions to
address genomic education obstacles (Table 3).
Table 3. Strategies and suggestions for genomics education in academia, professional, and public settings.
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Many of these strategies and suggestions can easily be applied across multiple platforms; for
example, many academic platforms can incorporate personal learning experiences by having
students acquire and analyze their own genomic data [46,47]. Hands-on learning experiences that
utilize genomic research are also a useful tool that can be utilized for many platforms [41,68,77].
Backward education design is also a helpful education strategy to fill in existing gaps in genomic
knowledge and enhance retention and learning [96]. Many easily accessible online tools, such as the
Apple Genomic Project or the Genomic Analogy Model for Educators (GAME), are of valuable
educational benefit in designing genomic educational strategies [40]. Together, this demonstrates that
there are many educational tools and strategies that can enhance and promote learning of genomic
principles.
We also have a few suggestions that educators, companies, and governments could utilize to
promote genomic education. We recommend that the incorporation of genomics education be
included in basic biology classes at the high school and college level in connection with human and
medical genetics, since genomics is dependent upon a strong genetic understanding [33]. In regard
to medical, graduate, and genetic counseling education, we suggest that educational institutions
consider requiring applying students to have taken a genomics-focused or genomics-related course
in order to provide a foundational genomic knowledge for incoming students. Genetic counseling
programs currently struggle with providing training slots and supervision, therefore, we suggest that
funding from either external or internal sources be considered to alleviate the strain on genetic
counseling educators [79]. Physicians and healthcare professionals have competing interests and time
constraints, so we suggest that genomic education material become more readily accessible through
online formats such as email or computer-based modules in order to facilitate continuing genomic
education for practicing healthcare providers [97,98]. Education for the public requires the most
extensive efforts in providing accessible and pertinent genomic information [50]. As many people
have suggested the need for public infrastructure and leadership over genomic education, we suggest
that a public organization such as the Global Genomics Nursing Alliance (G2NA) be organized by a
government entity such as the Science Education Division of the National Institute of Health to fill
these educational gaps [58]. We also suggest that, with the increased use of direct-to-consumer
genetic testing, these companies be required to provide online educational modules to increase public
genomic education and improve public healthcare decisions [99]. In conclusion, these suggestions
should provide avenues for multiple platforms for integrating and strengthening genomic education
at academic and non-academic levels.
5. Conclusions
Effective genomics education is vital to advance our understanding of the rapidly developing
field of genomics that influences our understanding of health, ancestry, and traits. Despite the
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challenges and barriers in implementing genomic education, there are vast benefits for academic,
professional, and public education (Figure 4). Effective genomic education would not only advance
genomic research, but also provide enhanced learning experiences, knowledge, and confidence for
students. It is also evident that genomic education of teachers, physicians, and health care
professionals should be a priority as it improves their knowledge, confidence, and ability to help
communicate critical genomic information simply and accurately to students, patients, and the
public. As genomics becomes more widespread and commonplace in society, genomics education
becomes increasingly vital for genomic technologies to be utilized appropriately.
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Abstract
Flow cytometry is a versatile and high throughput technique for rapid and
efficient biological testing. It requires a high level of conceptual, technical,
and analytical skills to properly design experiments, effectively operate flow cytometry machines, and analyze the data. A lack of training and development of any
of these three skills can result in underutilization and improper use of flow
cytometric machines that can impede research progress. Often students develop
these conceptual, technical, and analysis skills from trial and error, but many students either do not use this powerful flow cytometry technology, use it improperly
or ineffectively, or give up using it without proper training and support. Here we
report on a course which teaches flow cytometry skills to undergraduate and graduate students. The design of this course is unique in that it teaches conceptual,
technical, and analytical skills related to flow cytometry in a full semester format.
Undergraduate and graduate students reported significant increases in their confidence levels over the course of the semester. Here we provide our findings and
resources for others who may want to implement a similar course.
KEYWOR DS
confidence, flow cytometry, full semester, graduate, undergraduate

1

| INTRODUCTI ON

Flow cytometry is a technique that can be used to
simultaneously quantify multiple markers on a single cell
and analyze thousands of cells in a matter of seconds.1–3 It is
remarkably powerful and useful for many different disciplines.4 The field itself is rapidly expanding and there is an
important need for effective training.2 Numerous novel applications of flow cytometry are being identified and developed,
increasing the versatility of its use.5 Academic interest of both
faculty and students in using this technology has risen,
increasing the need for student training so this technology
and innovative uses can be understood and utilized.
To effectively utilize flow cytometry in academic
settings, undergraduate and graduate students need to

be competent in understanding proper experimental setup
and design, executing effective machine usage and data
acquisition, and performing appropriate data analysis.6,7
Lack of education in flow cytometry conceptual, technical,
and analytical skills often leads to student learning by trial
and error, which can result in expensive machine repair or
waste of costly resources.8 We have also seen that lack of
education on the university level has resulted in underutilization of flow cytometric machinery. These two issues
highlight the need for more education in flow cytometry
in academic settings where students are actively involved
in learning how to perform research.
In addition to improving research efficiency and productivity, flow cytometry education can also provide a
useful skill set to students for future career opportunities

© 2019 International Union of Biochemistry and Molecular Biology
Biochem Mol Biol Educ. 2019;1–9.
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in academics or industry.9 Very few articles have been
published outlining flow cytometry education efforts.
Here we provide a brief summary of the published articles describing flow cytometry education efforts in a
classroom setting (Table 1).
Education research can provide evidence based reports
of better ways to teach specific topics.10,11 Many have
called for more of this evidence-based educational research
and better alignment of teaching with successful practices.12 Personal investment in the material and use of
novel technologies can be very useful for learning.13–15
There are important lessons from evidence-based research
in flow cytometry, especially in the development of applicable instruction and student participation yielding better
learning. Fuller et al. reported the success of two short flow
cytometry courses targeted to different audiences.16 The
first reported on students which had direct applications for
flow cytometry in their research, so the 3-day course
focused mainly on technical skills and data interpretation.
The second course consisted of a three-hour tutorial for
undergraduate pathology students which focused on establishing a more basic understanding of flow cytometry
through active learning. By utilizing real flow cytometry
data in a computer learning center, the researchers were
able to see student engagement and improved skills in
both their 3-day and 3-hour courses.16 Ott et al. report
about a course with an in-depth study of immunological
tools, including half of a semester focused on flow cytometry. By delving deeper into flow cytometry, the students were able to develop expertise and were exposed
to numerous applications.17 The undergraduate students
reported increases in confidence across the board and
had high satisfaction with the half semester flow cytometry course.
Others have described the successful use of flow cytometry as a tool in a laboratory course. Flow cytometry

TABLE 1

does not have to be a technique only used in large
research projects; it can be very effective for classroom
education of students about biotechnology techniques.18
Boothby et al. emphasized flow cytometry as a tool to
visualize phagocytosis in a teaching laboratory setting.19
A similar article teaches about the value of advancing
technology by comparing microbial cell counting with
a hemocytometer to the accuracy and speed of a flow
cytometer.20 Even high school students can gain skills from
the flow cytometry educational experiences as reported by
the leaders of a summer biotechnology internship program,
again showing that a diverse range of students can benefit
from learning this technology.21
Flow cytometry education can also help students feel
more comfortable and encourage undergraduate research.
However, a solid understanding of the physical technology, the biological principles, and the data processing is
necessary for students to effectively gather data with a flow
cytometer.22 One previous publication detailing the effectiveness of an 8 week course cites student feedback that
due to the complexity of the topic they wanted the course
to be an entire semester.17
Here we seek to address the need for a more comprehensive and expanded flow cytometry course by outlining
a successful semester-long course. This article aims to help
science educators as no full semester course has been previously presented in the literature. This course provides
hands- on experience, in-depth conceptual understanding,
and development of proficiency for students. This class is
also designed to make students aware of the possibilities of
the technology, address limitations such as the initial price
investment, and provide ideas for helping students wrestle
with highly technical data and machine complexity. This
article focuses primarily on course content and student
confidence, while future studies will focus on measuring
student proficiency.

A brief review of existing flow cytometry education articles

Audience/purpose

Time

Takeaway

References

Undergraduate students and
research trainees

Three hour tutorial and a 3-day
program

An active and collaborative
approach aids learning

Fuller et al.16

Undergraduate teaching lab to
learn about phagocytosis

Five to six hours (one module)

Applying flow cytometry can be the
ideal method in a classroom

Boothby et al.19

Undergraduate teaching lab about
microbial growth curves

Three weeks (one lab module)

Comparison of various methods
benefits students

Forget et al.20

Undergraduate teaching lab about
immunology (T cells)

One quantitative exercise

New generation flow cytometers are
an excellent classroom tool

Stoyan et al.18

Undergraduate teaching lab for
immunology skills

Half semester

Students are interested and engaged
in flow cytometry skills

Ott and Carson17

High School students laboratory
experience

One month summer apprenticeship

Younger students can benefit from
access to the technique

Lewis et al.21
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2 | MATE RI AL S AND METHODS
2.1 | Subjects
This report uses data from a flow cytometry course
offered at Brigham Young University (MMBio 522, Flow
Cytometry) in the Fall of 2018. The course is designed
for graduate students and for undergraduates who are
heavily involved with research. The target student typically has a research project that uses or will need to use
flow cytometry, making the class highly applicable for
the students. In recent years, the course has also become
a class commonly taken by brand new graduate students
who have not chosen a lab yet, leading to a wider variability in student abilities, interest, and skills. The
course has also expanded and evolved to include and
support students in fields beyond biology, specifically
chemistry and engineering. The course currently supports training for 24 students.

2.2 |

Course outl ine

This two credit course is intended to teach students how
to design and run flow cytometry experiments tailored to
the two instruments in the Research Instrumentation
Core Facility (RIC) at the Brigham Young University
College of Life Sciences: the BD Accuri C6+, which has
two lasers and can measure six parameters, and the
Beckman Coulter Cytoflex, which has four lasers and can
measure 13 parameters. The course consists of hour-long
biweekly lectures or labs designed to teach conceptual, technical and analytical skills, which build upon each other,
increasing in difficulty level (Figure 1a). These skills are
practiced and assessed throughout the course with variable
associated point values (Figure 1b, Table 2, and Figure S1).
Table 2 and Figure S1 can provide an outline for others
interested in a developing a similar course.
The following main sections of the course help students gain a theoretical and technical understanding
of how flow cytometry works and then to apply that
knowledge in hands-on experiments and data analysis
(Figure S1).
• Conceptual quizzes: The students read one to two chapters from “Flow Cytometry: First Principles” by Givan
to prepare for class. Quizzes are comprised of seven
questions which cover material from the previous class
to assess understanding of concepts taught in lecture
and three questions about the reading assignment in
order to assess lecture preparation.
• Computer lab assignments (Figure 2): The course utilizes a student computer laboratory in which each
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FI G U R E 1 Progression of complexity in the course. The course
is organized to allow skills to build upon each other. (a) This depicts
the conceptual framework for the course, where learning conceptual
skills builds the foundation for learning technical skills followed by
analytical skills, culminating with student skill tests and individual
application presentations. (b) This outlines the assessment pattern in
the course. Students have multiple opportunities to practice and
demonstrate competency in these skills sets

computer is equipped with software from two flow
cytometric machines, the BD Accuri C6+ and the
Beckman Coulter Cytoflex, in order to provide data
analysis practice. FlowJo data analysis software is also
used in a month-long academic license for data analysis in a couple of the labs. Integrating technology into
courses can be very useful for student engagement and
future success in the technique.23,24
• Hands-on machine training: This course provides technical cytometric machine training in the RIC at Brigham Young University with help from the director
and technicians. Two cytometric machines are available in the RIC: A BD Accuri C6+ that can measure
six parameters and a Beckman Coulter Cytoflex that
can measure 13 parameters.
• Sample preparation training: Preparation of flow cytometry samples (e.g., isolation of T cells and staining with
antibodies) is demonstrated to the students followed with
practice by the students. This exercise helps students
familiarize themselves with sample preparation work
and benefit by improving technique. The example demonstration is done with mouse splenocytes (Figure S2).
• Current applications: Students choose an article with a
flow cytometry application of interest and present the
technique to the class. Quizzes are given to assess basic
understanding of the techniques presented. Recent
research shows benefits to learning when students read
current literature.25
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TABLE 2

General course outline objectives and student hourly load

Weekly schedule

Objectives and skills

Student hourly load

Weeks 1–6
Conceptual focus

Students will learn the basic conceptual and analytical principles of 2 hours/week in the classroom
flow cytometry. Students must be able to:
2–5 hours/week outside of the classroom
• Understand what components comprise a flow cytometer and the
studying the reading assignments and
purpose of each component
preparing for quizzes at the beginning
of each classroom period
• Comprehend the dynamics of light and fluorescence utilized in
flow cytometry
• Identify applications of flow cytometry in biological research
• Navigate the basic functions involved in flow cytometry analysis
software
• Implement the principles taught and apply them to experimental
design and sample data analysis

Weeks 7–10
Technical focus

Students will learn technical aspects and principles of flow cytometry.
Students must be able to:
• Prepare flow cytometry samples
• Understand flow cytometer specifications and the impact on
experimental design and set up
• Run flow cytometry software and understand how to operate flow
cytometry machinery
• Analyze data obtained from their flow cytometry experiments

2 hours/week in the research
implementation core (RIC)
2+ hours/week outside of the classroom
preparing samples

Weeks 11–14
Analytical/
application
focus

Students will learn applications of flow cytometry and integrate their
conceptual learning with technical experience. Students must be
able to:
• Demonstrate their understanding of flow cytometry by presenting
on a current flow cytometry application to the professor and
students in a clear and concise matter
• Prepare their own flow cytometry samples and independently
operate the flow cytometer to analyze their prepared samples
• Analyze sample data independently

2 hours/week in the classroom or RIC
2–5+ hours/week outside of the
classroom preparing samples and
presentation

2.2.1 | Machines an d progr ams
This course used FlowJo analysis software on an academic
license as well as BD Accuri C6+ and Cytoflex data software. The student BD Accuri and the Cytoflex machines
were used for technical skill practice. As seen above, there
are diverse assessment types used to accomplish the aims
of the course. Similarly, using multiple learning tools is a
benefit of this class. The readings and lectures provide a
base understanding for students, while the technical portion of the class allows for hands on supervised learning.
Students also give presentations about current applications
which doubles as an assessment for the individual and a
learning activity for their peers. By utilizing multiple
methods for information delivery, this course caters to a
broader audience of students.

2.3 |

Surv ey inst rument

For this study, students were given a 10-question survey
1 week into the semester and 1 week before the end of
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published survey used by Ott et al. in their class evaluating flow cytometry and ELISA laboratory modules. The
survey was granted exempt status by the Brigham Young
University IRB (#E18387). Students were asked to rate
their perceived knowledge and skill level on a scale of
1–5, with 1, strongly disagree; 2, disagree; 3, neither agree
or disagree; 4, agree; and 5, strongly agree.

2.4 |

Dat a anal ysis

Data analysis was performed on responses from students
who had completed both the pre- and postsurveys. The
surveys were anonymous but labeled with a student
number to allow for pairwise linking of the results. A
five-point Likert scale was used to access student attitudes and data comparisons between groups were performed using a Wilcoxon ranked test. Results were
analyzed as paired responses from the pre- and post-test.
A Bonferroni correction for multiple testing was applied,
adjusting the threshold for significance to α = .017 for
Figure 3 and α = .005 for Figure 4. Statistics were per-
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FIGURE 2

Example of computer lab assignment. This section of the assignment was designed to test the student's knowledge in
analyzing data in the BD Accuri C6+ software package. Questions focused on enhancing flow cytometry principles such as color
compensation, gating, making graphs, and population identification. Similar questions were asked across multiple data sets to reinforce
student knowledge and skill acquisition by analyzing different data

3 | RESU LTS
These students were all self-selecting students enrolled in
the Flow Cytometry Course at Brigham Young University
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during fall semester of 2018. Fourteen students completed the pre- and postsurveys. Only students who completed both the pre- and postsurveys were included in
this data analysis.

TUELLER ET AL.

Students report a significant increase in confidence
from the presurvey to the postsurvey with relation to
these skills targeted in the course (Figure 3). This method
TABLE 3

Ten question survey administered to students

Students rated their perceived knowledge and skill level from
“strongly disagree” to “strongly agree” (Score 1 through 5).
I am able to:

Skill

1. Describe in basic terms how a flow
cytometer works

Conceptual

2. Design properly controlled flow cytometry
Analytical
experiments to address research questions
and troubleshoot as needs arise
3. Explain how flow cytometry data is
generated and presented in histogram or
dot plots

Conceptual

4. Understand how the fluidics and optics
systems enable multicolor analysis of a
single cell

Conceptual

5. Identify current applications of flow
cytometry

Conceptual

6. Compensate fluorescence cross talk on a
flow cytometer

Technical

7. Analyze and interpret flow cytometry data

Analytical

8. Stain membrane bound antigens for flow
cytometric analysis

Technical

9. Quantify cell viability on a flow cytometer

Technical

10. Design and run a multicolor flow
cytometry experiment

Analytical

Note. Assessment of student attitudes was measured by agreement with
statements on a five-point Likert scale (1, strongly disagree; 2, disagree;
3, neither agree or disagree; 4, agree; 5, strongly agree), and results are
displayed as the mean. Question numbers here are referred to in subsequent
figures by Q1, Q2, and so on.

FIGURE 3

of data assignment emphasizes the specific goals of the
course. The increase in student confidence scores is consistently improved across the three types of questions (conceptual, technical, and analytical). It is interesting to note that
students had higher presurvey confidence in conceptual
skills, yet the increase in the postsurvey confidence levels
for the conceptual questions is similar to those seen with
the technical and analytical. The analytical and technical
skills can be classified as more difficult skills to master and
students entered with less confidence in these topics.
Upon examination of individual questions, some other
trends appear. In Figure 4a (conceptual questions), Question
1 asked about the most basic knowledge of flow cytometry,
and students rated themselves relatively highly. Many students coming into this course have some knowledge of flow
cytometry via exposure in a research laboratory setting, or
even use of a student flow cytometer which requires a twohour training to operate. The other conceptual questions
(Questions 3–5; histograms, fluidics, and applications) have
similar responses and increases, where students report high
confidence in these skills at the end of the course.
When looking at the technical questions (Figure 4b),
Question 6 shows the lowest average starting score. This
question referred to compensation, an advanced flow cytometry technique which many of the students did not have
any exposure to before the course. The two other technical
skills (Questions 8 and 9; cell staining, and viability analysis) show similar increases to most other skills. The analytical questions (Figure 4c) include the actual design of proper
controls, data interpretation and multicolor experiment
design (Questions 2, 7, and 10). Students report medium
levels of confidence in these difficult skills in the presurvey
and had similar increases in the postsurvey.
This survey did not reveal any differences in confidence
levels between undergraduate and graduate students or

Self-assessment by skills. Questions from the 10 question survey, grouped by skill type as indicated in Table 3. These
represent the mean responses for each set of skills before and after the course. Students report a significant gain of confidence in the skills in
each category. Grey represents responses from the survey given at start of the course (presurvey) and black represents responses from the
survey given at the end of the course (postsurvey). The threshold for significance was set at α = .017, according to the Bonferroni
adjustment. (** = p < .017, *** = p < .001)
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7

F I G U R E 4 Individual question
analysis of changes in student pre and
post survey responses. Questions are
grouped into (a) conceptual,
(b) technical, and (c) analytical
questions. Results are displayed as
mean and assessed using a Mann–
Whitney U test. Grey represents
responses from the survey given at start
of the course (presurvey) and black
represents responses from the survey
given at the end of the course
(postsurvey). The threshold for
significance was set at α = .005,
according to the Bonferroni adjustment.
(** = p < .005, *** = p < .001)

male or female students (data not shown). This may be due
to the course effectiveness for many types of students or
small sample size. It should be noted that these results represent a self-assessment of skills, so they measure student
confidence and not actual ability. This course is designed as
a launching ground for students to do their own research
projects, so confidence and willingness are a necessary first
step. Future studies are planned to formally examine student proficiency at the end of the course.

4 | DISCUSSION
Flow cytometry skills are increasingly important in
today's competitive job and research market.9 Creating
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opportunities to learn marketable skills is a major goal for
many university programs.26 While others have reported
educational opportunities for exposure to flow cytometry,
this report outlines a comprehensive semester long course
dedicated to teaching flow cytometry skills. Students
reported significant increases in their confidence level in
relation to essential flow cytometry skills. Building complex skills on top of simple skills can be an effective way to
teach and this course outline may prove useful for other
educators wishing to implement similar programs.
This course seeks to help students become independent users of flow cytometers, but that can be variable
depending on the students' abilities and motivation. As
mentioned previously, a wide range of students have
taken this course. For some students, flow cytometry is
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an immediately necessary skill for their research, while
others are merely interested in future career options. This
wide array of students may require additional customization of the course, possibly adding additional technical
and specific training for those wanting to become proficient at more complex applications. Alternatively, this
course could narrow or split in focus, as seen in Fuller
et al.16 and focus on the specific needs of the various
groups.
Early iterations of the course did not include any
sample preparation training, but students provided feedback that this was proving to be a barrier for student use.
Many students wanted to learn flow cytometry skills
before investing in the costly reagents in order to assess if
the flow cytometer would fit with their project. Other students had very little wet lab background, so preparing
cells on their own and without instruction was an intimidating prospect. After student feedback, a cell staining
element was incorporated for the first time and was
received well.
This year also provided a unique challenge after two
Attune machines were swapped for one Cytoflex
machine. While this allowed for more complex multicolor experiments, it limited the technical practice time
for each student on the machine with more parameters.
Despite this challenge, students reported that they had
increased confidence in their conceptual, technical, and
analytical skills and proficiency. Interestingly, students
also reported a desire to have more focus on technical
skills. This may reflect a practical approach to learning,
but it may also signal a possible barrier to future expansion with a limited number of flow cytometry machines.
This specific course was complicated by a downsize in
the number of machines available for course use, and
that may be reflected in students' answers. In the future,
this could be addressed by having students work with
teaching assistants or technicians on the machines during times they signed up for outside of the regularly
scheduled class time. Students were generally satisfied
with the addition of a day to practice cell preparation
which is useful for future teaching of this course.
One shortcoming to note is that the confidence levels
reported by students may or may not translate to true
proficiency. This could be due to the assessment not adequately measuring the gain in student skills or the skills
evaluated may not be the ones needed to predict competence in completing independent flow cytometry experiments. While all students did pass a proficiency test at
the end of the semester administered by the course teaching assistants, this does not necessarily lead to successful
data collection and analysis, especially when considering
that students may not use these skills regularly and may
forget them. The goal of this course is to provide a
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background for students to design their own experiments,
but they may need to review these technical and analytical points in order to be successful in the future.
In a thematic analysis of student comments, it was
apparent that students had high interest in gaining a conceptual understanding of flow cytometry. That was the
most common answer category in response to the question, “What are you looking to gain from this course?”
This may be because students did not have a framework
for what kinds of technical or analytical skills they may
need. However, near the end of the course, students were
most satisfied with their knowledge in conceptual and
analytical skills. They were less satisfied with the technical skills gained, perhaps reflecting an inadequate
amount of time operating the machines to internalize the
technical skills.
Traditional flow cytometry training has often been
informal, short, and largely self-directed. However, this is
a complex technique with many subtleties that need to
be learned to be an effective user. For some users, a short
training is sufficient for their purposes, but for others, a
deeper understanding could yield efficient and interesting research. This course could be a welcome addition for
universities looking to expand the range of skills for their
students, and for instrument cores aiming to maximize
student usage and research productivity. This article aims
to give educators a basis for their own course development. Additional variations of this course may include a
lecture class with an accompanying laboratory class to
emphasize and help students internalize technical skills,
or a unit in other related courses. By promoting student
skills, this course could aid student research productivity
and increase marketability, while providing a unique and
valuable educational experience.
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Bacteriophages are a major force in the evolution of bacteria due to their sheer abundance
as well as their ability to infect and kill their hosts and to transfer genetic material. Bacteriophages that infect the Enterobacteriaceae family are of particular interest because this bacterial family contains dangerous animal and plant pathogens. Herein we report the isolation
and characterization of two jumbo myovirus Erwinia phages, RisingSun and Joad, collected
from apple trees. These two genomes are nearly identical with Joad harboring two additional
putative gene products. Despite mass spectrometry data that support the putative annotation, 43% of their gene products have no significant BLASTP hit. These phages are also
more closely related to Pseudomonas and Vibrio phages than to published Enterobacteriaceae phages. Of the 140 gene products with a BLASTP hit, 81% and 63% of the closest hits
correspond to gene products from Pseudomonas and Vibrio phages, respectively. This
relatedness may reflect their ecological niche, rather than the evolutionary history of their
host. Despite the presence of over 800 Enterobacteriaceae phages on NCBI, the uniqueness of these two phages highlights the diversity of Enterobacteriaceae phages still to be
discovered.

Introduction
The existence of bacteriophages has been known since the early 1900’s when Frederick Twort
and Felix d’Herelle independently isolated phage [1]. Phages are now considered the most
abundant source of biomass on the planet [2] and contribute heavily to the evolution of bacteria because of their ability to infect and lyse different bacterial strains as well as their ability to
transfer genetic information [3, 4]. Due to this transfer of genetic information, phages have
been shown to be required for the pathogenicity of several bacterial strains, such as pathogenic
V. cholerae, C. diphtheriae, and E. coli strains [5–7]. This incredible bacterial host specificity
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has led to many attempts to use them as diagnostic and therapeutic agents [8]. d’Herelle was
one of the first to put this into practice by using phage to treat and cure patients with Bacillus
based dysentery [9].
Enterobacteriaceae is one of the most highly studied bacterial families with over 50 accepted
genera. These genera include several well-known animal pathogens such as Enterobacter,
Escherichia, Klebsiella, Salmonella, Shigella, and Yersinia, as well as plant pathogens such as
Erwinia and Dickeya (for a recent discussion on the classification of this family see [10]). This
family is a major health concern in the United States with the Centers for Disease Control and
Prevention (CDC) citing carbapenem resistant and extended spectrum �-lactamase (ESBL)
producing Enterobacteriaceae as “urgent” and “serious” threats [11]. Plant pathogens are also
of great concern, with Erwinia infections causing over $100 million in agricultural loss per
year [12]. Studying the evolution of this family of bacteria, including the phages that infect
them, is critical to controlling many health and agricultural concerns.
Over 800 phages that infect members of the Enterobacteriaceae family have been isolated,
sequenced, and deposited in NCBI. Most of these phages infect genera with common animal
pathogens including Escherichia, Salmonella, Shigella, and Klebsiella. Phages of the plant pathogens have also been recently deposited, including those that infect Erwinia amylovora, the
causative agent of fire blight [13]. When infected, fire Blight causes the leaves of the Rosaceae
plants to dry and shrivel up, giving the appearance of being scorched. Another similar wilting
disease infecting the Cucurbita genus, which includes squash and pumpkin, is caused by Erwinia tracheiphila. It has been reported to cause millions of dollars of agricultural loss in the
northeastern United States [14]. Therefore, the study of Erwinia phages may aid in understanding and treating multiple devastating agricultural diseases. Currently, 45 Erwinia specific
phages have been isolated and deposited on NCBI, 25 of which were discovered by our group.
Herein we report the isolation and characterization of two of these Erwinia phages,
vB_EamM_RisingSun (RisingSun) and vB_EamM_Joad (Joad). These phages have only very
distant relationships to other published phages and are highly similar to one another, with
Joad containing two additional genes. BLASTP hits to putative annotated ORFs indicate that
much of their genomes are composed of novel proteins with no BLASTP hit, while many of
those having BLASTP hits harbor closer relationships to Pseudomonas and Vibrio phages as
opposed to Enterobacteriaceae phages.

Methods

Phage isolation, sequencing and host range
Both Joad and RisingSun were isolated from apple blossom samples collected in Payson, Utah.
Blossoms were crushed with a mortar and pestle and the resulting debris was added to an
exponential culture of Erwinia amylovora ATCC 29780 [15, 16]. The enrichment culture was
harvested by centrifugation 48 hours later, filtered with at 0.45 μM filter, and used to infect a
fresh culture of bacteria. Three plaque purifications were performed, after which a high titer
lysate was made in liquid broth. Phage DNA was extracted from this lysate using the Phage
DNA Isolation Kit (Norgen Biotek Corporation), and was sequenced, assembled, and annotated as previously described [15]. Host range was performed by spotting 5 uL of lysate onto
0.5 mL of bacteria imbedded in LB top agar. Positive spots were verified by plaque assay. Bacterial strains used included Erwinia amylovora ATCC 29780, Erwinia amylovora EA110 [16],
Pantoea agglomerans E325 [17], Pantoea vegans C9-1 [18], Dickeya chrysanthemi ATCC 11663
[19], the common clinical strain Pseudomonas aeruginosa Boston 41501 ATCC 27853 [20],
Pseudomonas chlororaphis ATCC13985 [21], Vibrio cholerae ATCC 14035 (originally deposited by Standards Lab., London) [22], Salmonella enterica typhimurium LT2 (a generous gift
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from John Roth, UCDavis), Enterobacter cloacae ATCC 13047(deposited by the CDC) [23],
and E. coli BW25113 [24].

Electron microscopy
Samples were prepared for transmission electron microscopy by placing 20 uL of high-titer
phage lysate on a 200-mesh copper carbon type-B electron microscope grid for two to five
minutes. Excess lysate was wicked away and the grid was then stained for one minute using 2%
phosphotungstic acid. The grid was then briefly dipped into distilled water and excess liquid
was wicked away. Phages were imaged at the BYU Microscopy Center. The phages were measured for capsid width as well as tail length and width using ImageJ software [25].

Mass spectrometry
Samples were prepared according to the methods of Guttman et al. [26]. Briefly, (all concentrations are final concentrations) fresh lysates were diluted with TNE (50 mM Tris pH 8.0, 100
mM NaCl, 1 mM EDTA) buffer and RapiGest SF reagent (Waters Corp.) was added to 0.1%
before 5 min of boiling. Next, samples were incubated at 37˚C for 30 min in the presence of 1
mM TCEP (Tris (2-carboxyethyl) phosphine). Iodoacetamide (0.5 mg/ml) was used to carboxymethylate the samples for 30 min at 370 C. Carboxymethylation was neutralized with 2 mM
TCEP. Using a trypsin:protein ratio of 1:50 samples were digested overnight at 370 C. Next,
250 mM HCl was used to degrade the RapiGest for 1 hr at 370 C. Samples were then centrifuged for 30 min at 40 C and 14000 rpm. In new tubes, peptides were extracted from the soluble fractions by desalting using Aspire RP30 desalting columns (Thermo Scientific).
High pressure liquid chromatography (HPLC) coupled with tandem mass spectroscopy
(LC-MS/MS) using nano-spray ionization was used to analyze the trypsin-digested peptides
according to the method of McCormack et al. [27]. Experiments were performed on a TripleTOF 5600 hybrid mass spectrometer (ABSCIEX) interfaced with nano-scale reversed-phase
HPLC (Tempo) using a 10 cm-100 μm ID glass capillary packed with 5-μm C18 ZorbaxTM
beads (Agilent Technologies, Santa Clara, CA). The peptides were eluted from the C18 packed
capillary tubes into the mass spectrometer using a linear gradient of Acetonitrile (ACN) (5–
60% generated from two buffers: buffer A with 98% H2O, 2% ACN, 0.2% formic acid, and
0.005% TFA, and buffer B with 100% ACN, 0.2% formic acid, and 0.005% TFA) at a flow rate
of 250 μl/min for 1 hr.
MS/MS data were acquired in a data-dependent manner in which the MS1 data were
acquired for 250 ms at m/z of 400 to 1250 Da and the MS/MS data were acquired from m/z of
50 to 2,000 Da. For independent data acquisition (IDA) parameters of MS1-TOF for 250 milliseconds, followed by 50 MS2 events of 25 milliseconds each were used. The IDA criteria were
set at over 200 counts threshold, charge state of plus 2–4 with 4 seconds exclusion window.
Finally, the collected data were analyzed using MASCOT1(Matrix Sciences) and Protein
Pilot
4.0 (ABSCIEX) for peptide identifications.

Analysis of RisingSun and Joad phage genomes
Gepard [28] was used to create three dot plots, one with whole genome sequences, one with
major capsid protein (MCP) sequences, and one with terminase sequences. Putative major
capsid proteins and terminase proteins from phage Joad were used in BLASTP [29–31] analysis to find related phages [2, 32, 33]. Accession numbers that were used are: whole genome
accession numbers (Joad [MF459647], RisingSun [MF459646], Pseudomonas phage EL
[NC_007623.1], Pseudomonas phage OBP [NC_016571.1], Vibrio phage pTD1 [AP017972.1],
Vibrio phage VP4B [KC131130.1], Pseudomonas phage phiKZ [AF399011.1]), MCP accession
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numbers (Joad [ASU03832.1], RisingSun [ASU03587.1], Pseudomonas phage EL [YP_418111.1],
Vibrio phage pTD1 [BAW98274.1], Vibrio phage VP4B [AGB07257.1], Pseudomonas phage OBP
[YP_004958031.1], Pseudomonas phage phiKZ [AAL83021.1]) and terminase accession numbers
(Joad [ASU03673.1], RisingSun [ASU03430.1] Pseudomonas phage EL [YP_418044.1], Vibrio
phage pTD1 [BAW98365.1], Vibrio phage VP4B [AGB07167.1],Pseudomonas phage OBP
[YP_004957913.1], Pseudomonas phage phiKZ [NP_803591.1]). Kalign [34–38] was used to determine average nucleotide identity (ANI) of the phage genomes.

Motif analysis and identification
The Center for Phage Technology Galaxy Server (https://cpt.tamu.edu/galaxy-pub/) and
MEME [39] were used to scan the phage genome for significant motifs with an e-value less
than 10−7. The Galaxy Server was able to scan the entire genome at once. FIMO [40] was used
to search the phage genome for motifs found in the Galaxy results that passed our significance
threshold (q value <0.01) and determined the exact positions of the motif(s) in the entire
genome. We then used DNA Master [41] and Phamerator [42] to analyze the genes neighboring the motifs to determine putative transcription patterns.

Results and discussion

Phage isolation and sequencing
Joad and RisingSun were isolated from apple tree samples that appeared to be infected with
fire blight. DNA analysis suggests Joad and RisingSun are Jumbo phages [43] with genome
sizes of 235374 bp and 235108 bp respectively (a summary of their genomes is provided in
Table 1). A search for tRNA’s using tRNA ScanSE [44] returned no tRNA results. No rigorous
testing for lysogeny formation has been performed, but their clear plaque morphology and
ease in obtaining higher titers suggest they may be lytic phages. This conclusion is supported
by a BLASTP analysis of the putative Major Capsid Protein (MCP) from Joad, which has only
close BLASTP hits to phage and none to bacterial genomes. In a recent analysis of phage, Casjens et al. found that MCP’s from temperate phages generally have BLASTP hits that are >70%
identity in bacterial genomes [45].

Phage morphology
Transmission electron microscopy (TEM) analysis revealed the large nature of these phages.
From three independent TEM images of RisingSun (Fig 1), the average capsid width was 143.2
+/- 6.0 nm, tail width was 23.2 +/- 2.4 nm, and tail length was 206.8 +-3.6 nm, consistent with
the large genome size reported above. The measurements from the single Joad image obtained
were within the standard deviation of RisingSun measurements. The viral morphology, icosahedral capsids attached to long contractile tails, is consistent with these phages belonging to
the jumbo myoviridae bacteriophages [32].
Table 1. General characteristics of Erwinia amylovora phages Joad and RisingSun.
Phage Name

Fold Coverage

Joad

GenBank
Accession #
MF459647

ORFs

tRNAs

GC%

522.2

Genome
Length (bps)
235374

RisingSun

MF459646

245

none

48.29

138.6

235108

243

none

48.32

https://doi.org/10.1371/journal.pone.0200202.t001
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Fig 1. Transmission electron microscopy revealed (A) RisingSun and (B) Joad as Myoviridae.
https://doi.org/10.1371/journal.pone.0200202.g001

Genomic analysis
Whole genome dot plot comparisons (Fig 2A) were performed using the whole genome
sequences of Joad, RisingSun, and any phages that were retrieved from a BLASTP analysis of
their putative major capsid (MCP) and terminase proteins. The dot plot reveals two distinct
clusters of phages, and low relatedness between singletons (unique phages unrelated to others
in the group). Clusters are defined here similarly to other studies, as two or more phages with
sequence similarity over at least half of the genome [2]. Joad and RisingSun constitute one
cluster with Pseudomonas phage EL being a distant relation in the gray area of cluster boundary, while the second cluster is comprised of two Vibrio phages, VP4B and pTD1. Whole
genome Average Nucleotide Identity (ANI) data shown in Table 2A support the clusters identified in Fig 2A with a 96% identity match between Joad and RisingSun. These two phages also
had 46% similarity compared to EL and only 36% similarity compared to OBP and phiKZ,
while low similarity is seen between Joad and the singleton phages. A 75% identity match is
also observed within the vibrio phage cluster of VP4B and pTD1. ANI data show that Joad and
RisingSun differ in genome size by 266 nucleotides, Joad having the larger genome, in an otherwise highly similar genome (~96.6% nucleotide identity). In addition to the distinct clusters,
Fig 2A shows a distant relationship between Joad and EL, indicative of divergent evolution
and lateral gene transfer that has occurred.
A dot plot of the Major Capsid Protein (MCP) and terminase amino acid sequences (Fig 2B
& 2C) and percent identity data (Table 2B) support this distant relationship between Joad and
EL. Table 2B shows a 57% identity between the MCP amino acid sequences of the two phages,
whereas Vibrio phages pTD1 and VP4B MCP amino acid sequences are highly similar at nearly
90% amino acid identity. The terminase dot plot, Fig 2C, and percent identity data in Table 2C
continue to support a distant relationship between Joad and EL.
Both the dot plot and ANI indicate that the Joad cluster is markedly different from the Vibrio cluster and EL phage consistent with the weak similarity of the MCP and terminase amino
sequences. Comparing Joad to OBP and phiKZ, which have similar terminase proteins, shows
little relation and confirms the distinctiveness of Joad. Since terminase conservation has been
shown to reflect phage packaging mechanisms [46] the terminase similarity to phiKZ, although
distant (~28% identity) suggests these phages package DNA by a headful mechanism [47].
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Fig 2. Dot plot comparisons for whole genome nucleotide sequences, MCP amino acid sequences, and terminase
amino acid sequences of seven phages. Blue horizontal and vertical lines were added to show genome boundaries.
Erwinia phages: Joad, RisingSun (RS). Vibrio phages: pTD1, VP4B. Pseudomonas phages: EL, OBP, phiKZ. A)
Nucleotide dot plot shows genome similarity between seven phage genomes. Two distinct clusters are shown, the Joad
and RS cluster and the Vibrio phage cluster. B) Dot plot comparison for MCP amino acid sequences of seven phages.
The clusters are shown between Joad and RS and between Vibrio phages pTD1 and VP4B. C) Dot plot comparison for
terminase amino acid sequences of seven phages. Two clusters are formed between Joad and RS and between Vibrio
phages pTD1 and VP4B.
https://doi.org/10.1371/journal.pone.0200202.g002

This analysis is consistent with analysis of our whole-genome phage sequencing raw results for
RisingSun analyzed by Phageterm [48] which also suggested a headful packaging mechanism.

Whole-proteome comparison of Joad and RisingSun
Phamerator [42] was used to produce full-genome comparison maps for both Joad and RisingSun which were modified for simplicity (Fig 3). Consistent with the mild differences seen in
ANI analysis, the genomes encode nearly identical gene products (colored with similar coloring based on the Phamerator default values of greater than 32.5% identity by BLASTP and less
than 1e-50 e-value from ClustalO), with many having 100% identity. The most obvious difference is the two genes present in Joad that are not present in RisingSun, of which gene product
Table 2. Joad and RisingSun are a unique cluster of phages when compared to others using whole genomes, MCP amino acid sequences, and terminase amino acid
sequences. 2A) Similarity of seven phage genomes according to Average Nucleotide Identity (ANI). 2B) Percent identity of major capsid proteins (MCP) amongst seven
phages. 2C) Percent identity of terminase proteins amongst seven phages. Percent identity was determined by BLASTP analysis.
2A

ANI of Whole genome
Joad

Rising Sun

EL

pTD1

VP4B

OBP

phiKZ

Joad

100

RisingSun

96.61

100

EL

45.83

45.73

100

pTD1

38.24

37.86

35.21

100

VP4B

38.8

38.41

35.67

75.14

100

OBP

36.53

36.17

33.7

37.08

41.11

100

phiKZ

36.25

35.94

33.5

37.04

41.2

46.98

100

2B

Identity of MCP gene products
EL

pTD1

VP4B

OBP

phiKZ

Joad

Rising Sun

Joad

100

RisingSun

100

EL

57.22

57.22

pTD1

40.78

40.78

21.98

100

VP4B

40.48

40.48

38.27

89.74

100

OBP

30.71

30.71

31.18

33.61

34.90

100

phiKZ

23.58

23.58

21.98

21.60

22.19

25.29

100

2C

Terminase gene products
EL

pTD1

VP4B

OBP

phiKZ

Joad

100

Rising Sun

100

Joad

100

RisingSun

99.63

100

EL

56.43

56.43

100

pTD1

53.63

53.63

50.42

VP4B

53.96

53.96

50.08

95.75

100

OBP

48.49

48.49

48.31

47.59

47.97

100

phiKZ

27.71

27.71

27.29

31.54

32.24

28.73

100

https://doi.org/10.1371/journal.pone.0200202.t002
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Fig 3. Whole genome comparison map between the phages Joad and RisingSun adapted from Phamerator [42].
Boxes on top of the genome ruler are genes expressed on the forward strand, while boxes under the genome ruler are
genes expressed on the reverse strand. The colored boxes categorize homologous proteins. The purple between the two
genomes represents high nucleotide similarity, while the white between the two nucleotides represents nucleotide
variation. Annotated functions were collected through BLAST and Phamerator searches. Abbreviations include:
Discoidin (Coagulation factor also known as F5/8 type C domain known as the discoidin (DS) domain family); GroEL
(GroEL-like type 1 chaperonin protein); PhoH (Phosphate starvation protein PhoH); ZipA (cell division protein
ZipA).
https://doi.org/10.1371/journal.pone.0200202.g003

122 had a BLASTP hit to an HNH endonuclease and the other encodes a protein with
unknown function. Not every gene with a BLASTP or Phamerator hit is labeled on this map as
many have an unknown function or are indiscriminant structural proteins. Proteins of significance are discussed in the following section “Interesting proteins”, for which Fig 3 will serve as
a reference.

Interesting proteins and host range
Joad and RisingSun appear to be two very similar Jumbo phages [43] with only distant relationship to other phages. Due to the fact that these phages are so similar, we will be specifically
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referring to the genes, gene functions, and gene products of RisingSun. Of the 243 putative
gene products in the RisingSun genome ~43% have no known function and do not have any
significant BLASTP hits (e-value of 10−7 or less). This large proportion of proteins with no
BLASTP hit (~43%) represents proteins that have not been previously found in nature [49,
50]. This finding, combined with their nucleotide dissimilarity discussed above, further sets
RisingSun and Joad apart. The remaining gene products are represented as those with BLASTP
hits but no known function (NKF) (~24%) and those with BLASTP hits and putative or
known functions (~33%) (Fig 4A). Of the ~33% of gene products with known functions, ~36%
of them are unspecified structural proteins and another ~12% represent major capsid and tail
fiber proteins. The remaining gene products with putative function are primarily putative
enzymes, namely those involved with DNA and RNA synthesis including an NAD-dependent
DNA ligase (gp108), RNA polymerase beta subunit (gp29), and a helix-turn-helix XRE-family
domain among others (gp180) (Fig 4B).
The RisingSun gene products that have BLASTP hits are mainly homologous to other
phage gene products. Specifically, of the 140 gene products with BLASTP hits, 81% correspond
to Pseudomonas phage gene products. Gene products from phages EL, OBP, and phiKZ match
74%, 53%, and 24% of NKF/putative function gene products, respectively, while other Pseudomonas phages match 37%. Vibrio phages also showed a marked similarity to the RisingSun
proteome with 63% of gene products with a BLASTP hit from a Vibrio phage gene product.
Phages VP4B and pTD1 match 58% and 60%, respectively, and other Vibrio phages match
24% of NKF/putative function gene products. Due to the high similarity of gene products with
a BLASTP hit, we further analyzed the entire proteome of RisingSun in comparison to the
Pseudomonas and Vibrio phages EL, OBP, VP4B and pTD1.

Fig 4. RisingSun and Joad are unique phages whose proteomes contain novel proteins. A) Distribution of proteins
in RisingSun based upon BLASTP hits that are novel, have no known function, and putative function. B) Putative gene
ontology in RisingSun. C) Percentage of RisingSun gene products with BLASTP hits to proteins in other phages/
organisms.
https://doi.org/10.1371/journal.pone.0200202.g004
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Despite the lack of strong nucleotide similarity (see Table 2), an analysis of total RisingSun
gene homologs reveals 42% of RisingSun genes have homologs in Pseudomonas phage EL, 30%
have homologs in Pseudomonas phage OBP, 33% in Vibrio phage VP4B and 35% in Vibrio
phage pTD1 (see S1 Table for specific gene product homologs). In contrast RisingSun has only
14% of its gene products in common with phiKZ (Fig 4C). Note that these numbers are based
off of annotation of gene products and could be different based on annotation. Given that
other phage classifications systems have grouped related phage by 40% or greater proteome
conservation, Pseudomonas phages EL and OBP as well as VP4B and pTD1 are distant members of a more evolutionarily diverse supercluster, with EL being the closest member to the
Joad Cluster. The conserved gene products of this supercluster (totaling 63 gene products) are
primarily structural genes (24 gene products) and include the MCP, portal, terminase and tail
proteins. Nineteen of the remaining conserved gene products have putative functions in DNA
replication and recombination, one appears to be involved in cell lysis (a phage related lysozyme). This leaves 19 of the 63 conserved gene products (~30%) that have no putative function.
Due to this relationship, we tested the ability of phage Joad to infect Pseudomonas aeruginosa
as well as several Enterobacteriaceae strains (Table 3). Although clear spots could be seen on
Erwinia amylovora, Pantoea vegans and Pseudomonas aeruginosa Boston 41501 by spot test, no
plaques were observed on Pseudomonas aeruginosa when assayed by plaque assay suggesting
the spot test resulted from a toxin product in the Joad lysate. Joad did not appear to infect several other Enterobacteriaceae tested (including a Pantoea agglomerans strain, a Vibrio cholerae
strain, an E. coli strain, a Dickeya strain, a Salmonella strain and an Enterobacter strain). As
noted by the infectivity Pantoea vegans but not Pantoea agglomerans strain, this host range is
no wise comprehensive since several other species or even strains within a species may be a
host of Joad.
The RisingSun proteome also showed similarity to a range of other phage and bacteria. The
most prominent group being a highly related Erwinia phage family, which consists of phages
Deimos-Minion, Simmy50, SpecialG, and Ea35-70. This family matched to 21% of all RisingSun gene products, while gene products from other Erwinia phages corresponded to a total of
23% of gene products. Other phages infecting Cronobacter and Ralstonia bacteria among others matched 26% of the gene products, while 37% of total RisingSun gene products had a
BLASTP hit to various bacteria including Pseudomonas aeruginosa (Fig 4C). While several of
these less common matches had the lowest e-value from a particular BLAST, in a handful of
Table 3. Host range of phage Joad suggests narrow specificity towards Erwinia amylovora and the closely related
Pantoea vegans bacteria. The bacteria tested is provided along with the plaque forming units from three independent
assays.
Bacteria tested

Plaque forming units/mL (Pfu/mL)

Erwinia amylovora ATCC 29780

108

Erwinia amylovora EA110

108

Pantoea vegans C9-1

108

Pantoea agglomerans E325

0

Dickeya chrysanthemi ATCC 11663

0

Salmonella enterica serovar typhimurium LT2

0

E. coli BW25113

0

Enterobacter cloacae ATCC 13047

0

Pseudomonas aeruginosa Boston 41501

0

Pseudomonas chlororaphis ATCC13985

0

Vibrio cholerae ATCC 14035

0

https://doi.org/10.1371/journal.pone.0200202.t003
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Fig 5. Predicted gp164 RisingSun functional protein modeling using RaptorX [51, 52]. A) This model reflects
RisingSun gene product 164 aligned to the protein DNA adenine methylase [Bilophila sp. 4_1_30]: WP_009733305.1.
Both proteins have similar folds, indicating that they may share the same function. B) This model reflects RisingSun
gene product 85 aligned to the protein RNA polymerase beta subunit [Erwinia phage vB_EamM_RAY]: ANH51783.1.
The protein folds diverge drastically, indicating that the two proteins may not share a similar function.
https://doi.org/10.1371/journal.pone.0200202.g005

cases they were for the most part orders of magnitude higher than the Pseudomonas and Vibrio
phages discussed above.
Due to the distant nature of many of the BLASTP hits, we analyzed several protein putative
functions by comparing their predicted folds to those of their BLASTP hits using RaptorX (Fig
5). Of the 50 RisingSun gene products with a putative function of interest, 26 shared similar
folds to at least one of their respective BLASTP hits, suggesting that they share that putative
function (S2 Table). Ten of these 26 proteins matched those from bacteria other than Erwinia
while nine matched those from non-Erwinia phages. This leaves over half of these proteins
originating from a source other than Erwinia or its phages. The remaining 24 proteins do not
have enough sequence homology to suggest further conserved function.

Mass spectrometry
As shown in Table 4, we were able to confirm the accuracy of our genome annotation via mass
spectrometry identification of protein fragments within the viral lysate of RisingSun. Mass
spectrometry was able to identify nine structural proteins, three proteins with other putative
functions, five novel proteins, and 14 hypothetical proteins within the phage lysate. The two
proteins that had the most significant coverage and retrieval were gp68 and gp83. The gp83
product is the likely major capsid protein from BLASTP analysis, whereas gp68 has homology
(E-value: 3.10e-07) to pfam12699 phiKZ-like internal head proteins. Besides phage structural
proteins, three proteins with putative function were identified; a putative transglycosylase
(gp231) that may aid in breaking down the Erwinia cell wall, a putative UvsX-like protein
that is likely to function in DNA recombination (gp218), and a tubulin-like protein (gp17).
Although a majority (84%) of the peptides identified by mass spectrometry belong to putative
hypothetical proteins having homologs in NCBI, five completely novel proteins were identified
that have never before been reported (that lack a BLASTP hit with an E-value <10−7). These
proteins demonstrate the distant nature of this phage when compared to known phages, as
43% of the proteins annotated were novel. Proteins that are under-represented in the mass
spectrometry data may indicate either lower expression levels, or proteins whose expression
occur in the host but are not present in the virion.
In work by Lecoutere et. al. the team performed ESI-MS/MS on Pseudomonas phages
phiKZ and EL [53]. Upon comparing the gene products, they and we have retrieved several
different gp have been in common. Of the structural proteins retrieved in RisingSun, gene
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products 1, 2, 63, 66, and 68 had corresponding proteins retrieved by Lecoutere. Gene products 200 and 204 do not have matches to phage EL according to BLASTP while gp83 and
gp196 do have matches but were not retrieved in the other analysis. Gene product 231 with a
putative transglycosylase function was also retrieved by both labs while gp17 and 218 were
retrieved in our lab. In the hypothetical protein grouping gp131 and 185 did not have matches
to phage EL while gp28, 212, and 216 were only retrieved by our group. The rest of the proteins
in this group namely gp5, 59, 64, 65, 73, 189, 207, 233, and 243 were obtained by both labs.
Table 4. RisingSun gene products with peptides detected by LC/MS/MS of a crude phage lysate.
RisingSun gp #

Putative Protein Function

Retrieval #*

%Cov/%Cov(95)

Peptides(95%)

Phage Structural Proteins
gp83

major capsid protein

1

75.1/54.88

48

gp68

internal head protein

2

62.65/40.96

80

gp200

virion structural protein

12

36.36/26.22

5

gp204

virion structural protein

13

35.56/25.7

6

gp2

tail tube protein

17

61,41/18.79

4

gp63

phage capsid and scaffold

26

34.33/6.54

2

gp1

tail sheath protein

43

24.12/1.26

1

gp196

virion structural protein

57

52.94/6.23

1

gp66

internal head protein

73

27.61*

0

Other Putative Functions
gp231

transglycosylase

44

53.06/4.76

1

gp218

UsvX recombination protein-like

84

20

0

gp17

tubulin-like protein

62

41.43/4.36

1

*

Novel Hypothetical Proteins (no BLASTP hit E-value of <10−7)
gp163

9

64.81/37.96

7

gp206

60

29.38/9.00

1

gp71

54

47.54/3.93

1

gp150

72

11.45*

0

gp72

11

37.77/20.11

10

Hypothetical Phage Proteins
gp28

14

34.19/11.65

5

gp5

15

51.69/13.84

6

gp189

16

40.26/14.29

5

gp59

18

50/8.59

3

gp243

20

46.08/6.14

2

gp185

25

38.59/9.00

2

gp233

27

29.56/4.56

2

gp65

32

18.5/4.62

1

gp216

33

29.08/1.59*

1

gp73

40

37.26/3.79

1

gp207

51

18.21/5.84

1

55

41.87/5.19

1

gp64

67

43.49/4.75

1

gp212

71

21.25*

0

gp131

SPFH domain containing protein

*

The gene product number (RisingSun gp #), putative protein function (from BLASTP homolog or conserved domain CD), retrieval number, percent of the protein
covered by peptide matches is provided (the percentage is given for both total and 95 percent confidence peptides), and number of 95% peptides is given. *The retrieval
numbers missing correspond to bacterial or human (such as keratin) proteins present in the crude lysate. No reverse peptides of RisingSun were detected. The asterisks
(*) indicates low confidence proteins due to total coverage of less than 30%.
https://doi.org/10.1371/journal.pone.0200202.t004
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Motif analysis shows putative structural protein conservation. Finding conserved
motifs in phage genomes may provide insight into transcriptional regulons, and therefore a
deeper understanding of phage lifecycle and proteomics due to the frequent co-regulation of
related genes [54]. RisingSun was analyzed for motifs using The Center for Phage Technology
Galaxy Server [55], a software that allows you to search an entire genome at once. After covering the entire genome only one motif passed our e-value significance threshold of 10−7. We
then ran this motif through FIMO [40], a program that allows the search of an entire genome
for a specific motif. We looked for occurrences of the motif represented by a logogram in (Fig
6A), which passed a q-value significance threshold of 0.01. Only 5 repetitions of this motif
occurred and all in a relatively small area near the end of the genome (Fig 6B).

Fig 6. Locations of one motif discovered in five different structural genes. A) Exact location of motif sites, p and qvalues, sequence of motifs (conserved nucleotides shown in red), and putative gene function. Logogram shows motif
sequence and larger letters represent frequent conservation. B) Arrows show approximate location of motif site. Genes
were analyzed from the RisingSun annotation and thus locations are shown in the RisingSun phamerator map.
https://doi.org/10.1371/journal.pone.0200202.g006
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Identifying genes neighboring these motifs may identify co-regulated genes with related
function. Fig 6. is a portion of the Joad and RisingSun genome map showing the motif locations
within a span of 10 genes. Five gene products, namely gp204, gp203, gp200, gp199 and gp196
contain the motifs suggesting gene products 196–205 may be co-regulated. One of the gene
products (gp205) in this region is completely novel (no BLASTP hit), and nine (gp204, gp203,
gp202, gp201, gp200, gp199, gp198, gp197 and gp196) are putative virion/structural proteins
based on annotation of related phage BLASTP hits. Despite the novelty of one of the genes, the
evidence that this conserved motif brings suggests that genes gp196-205 are indeed structural
proteins or are involved in virion assembly and that all are transcribed together. These results,
however, are hypothetical and wet lab experiments are necessary for confirmation.

Conclusions
Herein we report the discovery and characterization of two newly isolated Erwinia phages,
Joad and RisingSun, bringing the apparent total number of Erwinia phages on NCBI as of writing of this article to 45 reported full genome sequences. Joad and RisingSun, at over 200kbp,
are two highly related Jumbo phages of the Myoviridae family, only distantly related to Pseudomonas phages EL and OBP and even more distantly related to Vibrio phages VP4B and pTD1
(Fig 2A). All six of these phages are most likely distant phiKZ-like phages as previously determined for EL and OBP [56, 57]. Dot Plot, ANI and BLASTP analysis all suggest the unique
nature of Joad and RisingSun phages but also brings to attention that these phages have closest
similarity to phages that infect bacteria outside of the Enterobacteriales order of bacteria. A
BLASTP analysis of the putative proteome reveals BLASTP hits for ~57% of the proteins, however 33% are proteins of unknown function. The remaining putative gene products with no
BLASTP hits (43%) represent proteins that have not been previously found in nature. These
join the bounty of phage gene products [49, 50] with unknown structural folds and function.
Both Pseudomonas and Vibrio phages had higher similarity to Joad and RisingSun than any
of the >800 Enterobacteriaceae phages on NCBI, despite all three of their respective hosts phylogenetically only having the class Gammaproteobacteria in common [58]. Of the 140 gene
products with a BLASTP hit, 81% and 63% of the closest hits corresponded to gene products
from Pseudomonas and Vibrio phages, respectively. Given that Pseudomonas bacteria are
found on apple blossoms [59–64] it is reasonable to posit that extensive exposure to this strain
has allowed for lateral gene transfer between phages, with possible tail fiber exchange for host
recognition [65–69]. However, recent work by Adeolu and colleagues has indicated that the
Enterobacteriales order is more nuanced than previously thought and that classification methods may need to be rethought [10]. In addition to a standard 16S rRNA based phylogenetic
tree for the order Enterobacteriales, Adeolu and colleagues constructed three more trees based
on 1548 core proteins, 53 ribosomal proteins, or four multi-locus sequence analysis proteins.
After analyzing 179 species within this order they propose forming seven families, one of
which is an Erwinia-Pantoea clade [10]. This classification is supported by our findings that
these phages are quite distinct from other Enterobacteriaceae phages and can infect a Pantoea
vegans strain. A reclassification of this magnitude highlights the complex evolution, and hence
classification, of bacteria and the phage that infect them. Because phages are a major source of
bacterial evolution, through the control of bacterial number as well as lateral gene transfer,
understanding their complexity is vital. Joad and RisingSun join the 43 other Erwinia phages
available on NCBI and provide insight into this evolutionary complexity, highlighting the similarity between Erwinia and the Pseudomonads. The relationship of these phages with more
distant bacteria may reflect both an ecological niche as well as true diversity within the
Enterobacteriales.
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Supporting information
S1 Table. A list of RisingSun (MF459646) gene products that are in common with Pseudomonas phages EL (NC_007623) and OBP (NC_016571) as well as Vibrio phages pTD1
(AP017972) and VP4B(KC131130). BLASTP was used to determine the gene products in
common, using the e-value cutoff of 1e-7. Putative functions and the gene product number are
provided from the annotation of phage RisingSun (from both BLASTP hits and conserved
domains retrieved). The symbol “x” indicates no homolog was found. Bolded gp# indicates
that the putative function was taken from the phage of that column.
(DOCX)
S2 Table. Predicted protein fold of putative RisingSun functional proteins as compared to
BLASTP functional hits. Putative gene products identified for RisingSun were compared to
their respective BLASTP hit with known function using RaptorX. Each alignment was given
an average template modeling score (TM) between 0 and 1. According to Sheng Wang et al., if
the TM is greater than 0.6, there is a 90% chance that two proteins share a similar fold. However, if the TM is less than 0.4, then the two proteins are not similar. When considering 50
genes with a putative protein function of interest, 26 proteins demonstrated similar folding to
at least one of their respective BLASTP hit. Three proteins demonstrated similar folding to two
BLASTP hits, for a given pair the structures were compared using RaptorX. In each of the
three cases the protein structures matched each other having TM values above 0.6.
(DOCX)
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Genome Sequences of 19 Novel Erwinia amylovora
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ABSTRACT Erwinia amylovora is the causal agent of ﬁre blight, a devastating disease affecting some plants of the Rosaceae family. We isolated bacteriophages from
samples collected from infected apple and pear trees along the Wasatch Front in
Utah. We announce 19 high-quality complete genome sequences of E. amylovora
bacteriophages.

E

rwinia amylovora is a Gram-negative facultative anaerobic rod-shaped bacterium
and the causative agent of ﬁre blight (1), a disease that affects some members of the
plant family Rosaceae and causes the infected areas of the plant to appear burnt (2, 3).
E. amylovora is a member of the Enterobacteriaceae family, which includes many wellcharacterized pathogenic bacteria such as Salmonella enterica and Escherichia coli. Thus,
understanding the evolution of this plant pathogen and the bacteriophages that infect it
may provide insight into the evolution of the Enterobacteriaceae family, including other
pathogenic strains.
Herein, we announce the genome sequences of 19 novel E. amylovora bacteriophages, vB_EamP_Frozen, vB_EamP_Gutmeister, vB_EamP_Rexella, vB_EamM_DeimosMinion, vB_EamM_RAY, vB_EamM_Simmy50, vB_EamM_Special G, vB_EamM_Caitlin,
vB_EamM_ChrisDB, vB_EamM_EarlPhillipIV, vB_EamM_Huxley, vB_EamM_Kwan, vB_EamM_
Machina, vB_EamM_Parshik, vB_EamM_Phobos, vB_EamM_Stratton, vB_EamM_Joad,
vB_EamM_RisingSun, and vB_EamM_Yoloswag. Samples were collected from apple and
pear trees bearing symptoms of ﬁre blight infection that were found along the Wasatch
Front of Utah. Phages were ampliﬁed via enrichment culture of these samples, and
resulting phages were then plaque puriﬁed by a minimum of three passages. All phages
reported in this announcement infect the Erwinia amylovora ATCC 29780 strain.
Genomic DNA was extracted using the Phage DNA isolation kit (Norgen Biotek
Corporation) and sequenced using 454 pyrosequencing (454 Life Sciences, Roche
Diagnostics) or Illumina HiSeq 2500 sequencing (Illumina, 250-bp reads). Contigs were
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TABLE 1 Properties of 19 novel Erwinia amylovora bacteriophage genomes

Phage name
vB_EamP_Gutmeister
vB_EamP_Frozen
vB_EamP_Rexella
vB_EamM_Deimos-Minion
vB_EamM_RAY
vB_EamM_Special G
vB_EamM_Simmy50
vB_EamM_Caitlin
vB_EamM_ChrisDB
vB_EamM_EarlPhillipIV
vB_EamM_Huxley
vB_EamM_Kwan
vB_EamM_Machina
vB_EamM_Parshik
vB_EamM_Phobos
vB_EamM_Stratton
vB_EamM_Yoloswag
vB_EamM_RisingSun
vB_EamM_Joad

GenBank
accession no.
KX098391
KX098389
KX098390
KU886225
KU886224
KU886222
KU886223
KX397365
KX397366
KX397367
KX397368
KX397369
KX397370
KX397371
KX397372
KX397373
KY448244
MF459646
MF459647

Sequencing
type
Illumina
454
454
454
Illumina
454
Illumina
Illumina
454
Illumina
454
Illumina
454
454
454
454
Illumina
Illumina
Illumina

Minimum–maximum
fold coverage
(avg read depth)
423–2,415 (662)
79–1,779 (862)
69–1,780 (885)
61–1,780 (873)
335–910 (677)
19–1,779 (874)
150–831 (282)
84–249 (174)
66–1,780 (874)
75–243 (164)
75–1,779 (880)
192–554 (362)
65–1,780 (879)
64–1,779 (880)
59–1,779 (873)
64–1,779 (874)
5–265 (99.5)
50–293 (138.6)
232–1,065 (522.2)

Genome
length (bp)
71,173
75,147
75,448
273,501
271,182
273,224
271,088
241,147
244,840
223,935
240,761
246,390
241,654
241,050
229,501
243,953
259,700
235,108
235,374

aORFs,
bNA,

open reading frames.
no tRNAS were identiﬁed.

assembled using Newbler version 2.9 (Roche Diagnostics, Branford, CT) and Consed (4)
for 454 pyrosequencing reads or Geneious version R8 (5) for Illumina reads. Assembled
genomes were annotated using DNA Master (6) and other programs as described
previously (7, 8).
The 19 phages fell into ﬁve distinct clusters according to genomic analysis. The ﬁrst
group included the jumbo myoviruses vB_EamM_Deimos-Minion, vB_EamM_RAY,
vB_EamM_Simmy50, and vB_EamM_Special G, which share a minimum of 97.2%
average nucleotide identity to one another. The second group included two jumbo
myoviruses, vB_EamM_RisingSun and vB_EamM_Joad, which differ by only two putative gene products. The third group included diverse jumbo myoviruses vB_EamM_Caitlin,
vB_EamM_ChrisDB, vB_EamM_EarlPhillipIV, vB_EamM_Huxley, vB_EamM_Kwan, vB_EamM_
Machina, vB_EamM_Parshik, vB_EamM_Phobos, and vB_EamM_Stratton, which share a
minimum of 50.5% average nucleotide identity. An additional jumbo myovirus,
vB_EamM_Yoloswag, did not have any close phage relatives. Podovirus phages
vB_EamP_Frozen, vB_EamP_Gutmeister, and vB_EamP_Rexella share at least 97.2%
average nucleotide identity. The four jumbo myovirus groups package DNA by headful
packaging based on homology of their putative terminase genes to the phiKZ termi- nase
(9). Three of these genomically permuted myovirus groups were assigned their base pair
(bp) 1 by alignment to previously published genomes by use of BLASTN (10) and
Gepard (11) (Ea35-70 for the Deimos-Minion group [12], EL [13, 14] for the RisingSun
group, and SPN3US [15] for the Caitlin group). vB_EamM_Yoloswag shared very little
DNA homology with any other phage; therefore, its bp 1 was assigned to position its
putative terminase at the beginning of the genome. The podovirus group genomes
were assigned bp 1 by their relation to N4, in terms of both terminase similarity and
whole-genome alignment, suggesting they have small terminal repeats. Accession
number(s). GenBank accession numbers for the 19 Erwinia bacteriophages are listed in Table 1.
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No. of
ORFsa
84
92
92
326
319
324
322
271
277
241
271
285
272
271
247
276
334
243
245

No. of
tRNAsb
8
8
7
NA
1
NA
1
7
11
NA
9
8
9
10
NA
12
NA
NA
NA

G+C
content (%)
46.9
46.9
46.9
49.9
49.9
49.8
49.9
52.2
49.4
50.6
51.1
52.1
51.0
51.0
49.1
51.3
46.91
48.32
48.29
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